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Summary 
 
AMP-activated protein kinases (AMPK) are structurally and functionally highly conserved in all 
eukaryotes. The most profoundly studied yeast AMPK ortholog, Snf1, plays a role in the sensing and 
response to low energy and nutrient levels. There is much less information available about the function 
of plant Snf1 orthologs, termed Snf1-related protein kinases (SnRKs) and their regulatory roles in 
plant specific nutrient regulated mechanism, such as photosynthesis, plant hormone signaling and 
metabolism. 
 Genetic studies of plant SnRK1 kinases are impeded by the lack of T-DNA insertion mutants 
in the SnRK1 catalytic subunits and the lack of male transmission of mutations affecting the SnRKγ 
subunit. The present work describes the isolation of T-DNA insertion mutations in SnRK1 β subunit 
genes and characterization of these mutants. Single and double mutant plants did not show any 
observable developmental or sugar signaling phenotype. Triple SnRK1β mutant could not be 
generated because no mutant allele is available for the third beta subunit. In our experiments 
overexpression of GFP-tagged SnRK1 beta subunits did not show subcellular relocalization in 
response to nutritional stress, a mechanism which was described in yeast. Instead, rapid proteasomal 
degradation of Arabidopsis SnRK1 subunits was observed in response to sugars and light. Proteasomal 
degradation of SnRK1 subunits prevented their efficient overexpression for biochemical studies. 
Former in vitro and in vivo studies found SnRK1 kinases in proteasomal complexes in Arabidopsis. 
This observation correlates with the fact that numerous nutrient status regulated metabolic enzymes 
are proteasomal substrates in Arabidopsis as in yeast and their degradation is controlled by 
phosphorylation and sugar availability. In order to identify SnRK1 interacting partners in vivo, it was 
attempted to isolate protein complexes from Arabidopsis through tagged SnRK1 subunits. In contrast 
to a former and mostly unsuccessful immunoaffinity purification approach, this work applies a rapid 
tandem affinity chromatography-based protein purification method. In addition to developing a 
biochemical approach for identification of SnRK1 interacting partners, we further explored the 
proteasomal connection of SnRK1 kinases and searched for their potential substrates using in vitro 
phosphorylation studies. Several sugar-regulated proteasomal substrates and F-box proteins were 
overexpressed in E. coli and purified to near homogeneity along with similar purification of SnRK1 
kinase catalytic subunits. The purified proteins were subjected to in vitro kinase reactions using 
radioactive γ32P-ATP and phosphorylation was detected in more cases. Some of the phosphorylation 
sites were successfully identified by mass spectrometric analysis. Site-directed mutagenesis of the 
phosphorylation site on IAA6 and overexpression of the mutant construct indicates the importance of 
phosphorylation site in vivo. In order to provide further evidence for interaction of SnRK1 kinases 
with their substrates in vivo, an assay system for testing the stability of kinase substrates was 
developed.  
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Zusammenfassung 
 
AMP-aktivierte Proteinkinasen (AMPK) sind in allen Eukaryoten strukturell und funktionell in hohem 
Maße konserviert. Am besten ist die Hefe Protein Kinase Snf1 erforscht. Sie spielt eine große Rolle 
beim Erkennen und Reagieren auf niedriges Energieangebot und Nährstoffmangel. Es gibt weit 
weniger Information über die Funktionen der Snf1-Orthologe in Pflanzen. So sind zum Beispiel deren 
regulatorische Rolle in pflanzenspezifischen, ernährungsabhängig regulierten Mechanismen wie 
Photosynthese und Pflanzenhormon-Signal Transduktion unbekannt. 
Genetische Studien an Pflanzen-SnRK1 Kinasen werden durch den Mangel an T-DNA 
Insertionsmutanten in katalytische Untereinheiten der SNRK1 und durch Mutationen in der SnRKγ-
Untereinheit, die männliche Sterilität verursacht, erschwert. Die vorliegende Arbeit beschreibt die 
Isolation von T-DNA Insertions-Mutanten in SnRK1-ß -Untereinheiten und deren Charakterisierung. 
Einfach und zweifach mutierte Pflanzen zeigten keine sichtbaren Entwicklungs- oder Zucker 
anzeigenden Phänotypen. Dreifach mutierte Pflanzen konnten nicht aufgezogen werden, da für die 
dritte Beta –Untereinheit kein Mutantenallel erhältlich ist. Überexpression der GFP-markierten SnRK1 
Beta-Untereinheiten zeigte keine subzelluläre Relokalisation als Antwort auf ernährungsbedingten 
Stress, ein Mechanismus, der in Hefe beschrieben wurde. Stattdessen wurde als Antwort auf Zucker 
und Licht ein rascher proteosomaler Abbau der Arabidopsis SnRK1 Untereinheiten beobachtet. Der 
proteosomale Abbau von SnRK1-Untereinheiten verhinderte ihre effiziente Überexpression für 
biochemische Studien. Frühere in vivo und in vitro Studien entdeckten Arabidopsis SNRK1 Kinasen 
in proteosomalen Komplexen. Diese Beobachtung wird dadurch unterstützt, dass zahlreiche durch die 
Ernährung regulierte metabolische Enzyme in Arabidopsis wie auch in Hefe proteosomale Substrate 
sind, und ihr Abbau durch Phosphorylierung und die Verfügbarkeit von Zucker kontrolliert wird. Um 
SnRKl interagierende Partner in vivo zu identifizieren, wurde versucht, Proteinkomplexe aus 
Arabidopsis durch markierte SnRK1-Untereinheiten zu isolieren. Im Gegensatz zu frühereren, meist 
erfolglosen Versuchen durch Immunoaffinitätsreinigung, verwendet diese Arbeit eine rasche auf 
Tandem-Affinitäts-Chromatographie basierende Proteinreinigungsmethode. Außer der Entwicklung 
eines biochemischen Versuchs zur Identifizierung SnRK1 interagierenden Partner, erforschten wir 
auch die proteosomale Verbindung der SnRK1 Kinasen und suchten durch die Anwendung von in 
vitro Phosphorylierungsexperimenten nach deren potentiellen Substraten. Einige Zucker-regulierte 
proteosomale Substrate, F-box - Proteine und auch SnRK1-Kinase Untereinheiten wurden in E.coli 
überexprimiert und mittels einer chromatographische Reinigung nahezu homogen gereinigt. Die 
gereinigten Proteine wurden durch Einsatz von radioaktivem γ32-ATP in in vitro Kinase-Reaktionen 
unterworfen, wobei mehrere Phosphorylierungen detektiert wurden. Einige der 
Phosphorylierungsstellen wurden durch Massenspektrometrie erfolgreich identifiziert. Zielgerichtete 
Mutagenesis der  IAA6 Phosphorylierungsstelle und Überexpression des Mutantenkonstruktes 
bestätigte die Bedeutung dieser Phosphorylierungsstelle in vivo. Um weitere Belege für die Interaktion 
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der SnRK1 Kinasen und ihre Substrate in vivo zu liefern, wurde ein Versuchs-System zum Test der 
Stabilität der Kinase-Substrate entwickelt. 
 
 
 
INTRODUCTION  1 
1. INTRODUCTION 
1.1. NUTRIENT AVAILABILITY AND PLANT GROWTH CONTROL 
Nutrient availability is an environmental and physiological factor that controls growth and 
development. Growth retardation is the most general consequence of nutrient limitation. The growth 
limiting effect of nutrient shortage was first recognized in agricultural science and formulated in the 
principle of “Liebig’s low of the minimum”, which states that plant growth is limited by the lowest 
amount of an essential nutrient (Carl Sprengel 1828 [1]). A more precise examination of this 
phenomenon was carried out on isolated plant meristematic cells in the 1960s. When pea root tips 
were cultured in a medium depleted for sucrose or treated with uncouplers of oxidative 
phosphorylation the roots stopped growing and the cells became arrested in either G1 or G2 phase of 
the cell cycle [2,3]. Regulation of cell cycle by nutrient starvation implies the existence of nutrient 
status sensing and signal transduction mechanisms.  
Nutrients and their shortage are not mere metabolic growth signals but are able to evoke 
specific physiological and developmental responses similarly to hormones. In response to carbon and 
energy source depletion budding yeast (Saccharomyces cerevisiae) turns into an enduring form, in 
which metabolic activity decreases to a minimal level, growth and cell cycle stops, reserve nutrients 
are accumulated, and a high degree of stress tolerance develops against multiple physical and chemical 
environmental impacts [4]. A distinct developmental program is triggered by nitrogen source depletion 
that evokes drastical morphological changes: the generally unicellular yeast cells switch to 
multicellular pseudohyphal development that provides a higher penetrating ability and enables yeast to 
actively search for nitrogen.  
In multicellular organisms nutrients are generally stored in differentiated storage organs, from 
which they are released and reallocated to other tissues of the body. Coordinated release and uptake of 
nutrients requires sophisticated regulatory mechanisms. Failures in this process cause life-threatening 
diseases, like diabetes, in mammals. Plants as photoautotroph organisms are able to produce the 
carbohydrates they require and have developed mechanisms to coordinate carbohydrate production 
with its metabolism. Carbohydrate-derived signals control photosynthesis itself through negative 
feedback regulation [5-8]. In addition, sucrose and glucose influence a wide range of developmental 
processes including seed germination, seedling development, root and leaf differentiation, floral 
transition, fruit ripening, embryogenesis and senescence, as well as responses to light, stress and 
pathogens.  
Sugar signaling mechanisms are partly integrated with other nutrient and hormonal signaling 
cascades to form a complex signaling network [7]. For instance, carbon and nitrogen assimilation is 
strictly coordinated in plants at the enzymatic level [9]. Phosphate and nitrate availability controls 
starch accumulation [10-11] and sugar and nitrogen content regulate sulphate assimilation [12-13]. In 
spite of high level of integration in the nutrient signal transduction, certain nutrient species can evoke 
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specific responses. In order to identify components of the nutrient sensing and signaling network, 
genetic screens were carried out in yeast and E.coli, and also in Arabidopsis.  
 
1.2. GLUCOSE REGULATED MECHANISMS IN YEAST 
Glucose-dependent regulatory mechanisms are very common in fungi including the genetic model 
organism budding yeast [4,14]. Although yeast is capable of aerobe respiration, in the presence of high 
levels of glucose it prefers anaerobe fermentation. Alcoholic fermentation does not yield as many ATP 
molecules per moles of sugar as oxidative phosphorylation but it can proceed at much higher rate and 
the produced ethanol helps to compete with less ethanol tolerant organisms. High concentration of 
glucose induces its exclusive and optimal use in yeast, whereas the utilization of other fermentable and 
non-fermentable carbon sources are inhibited by glucose through a specific regulatory mechanism 
called glucose or catabolite repression. Approximately one sixth of genes in the Saccharomyces 
cerevisiae genome is controlled by glucose repression [14]. The metabolic changes caused by glucose 
repression are well represented by the distinct sets of genes, which are active during the presence or 
absence of glucose. For instance, glucose induces its uptake and metabolic processing by stimulating 
the expression of hexose transporters (HXT) and glycolytic enzymes. In the presence of glucose, the 
growth rate dramatically increases, which is accompanied by intensive protein synthesis and 
characteristic upshift in ribosomal RNA and protein expression. Conversely, the expression of genes 
required for transport of sugars other than glucose is inhibited similarly to the expression of enzymes 
involved in respiration (Krebs cycle). A large group of genes whose promoters contain the yeast stress 
responsive element (STRE) and are involved in the yeast’s response to various stresses are also 
repressed by glucose. 
Depletion of glucose induces gluconeogenesis from other fermentable sugars, which requires 
the reactivation, so-called derepression, of glucose repressed genes. After glucose depletion, first other 
fermentable sugars, such as sucrose, are utilized, which is followed by the catabolism of non-
fermentable sugars that require the reactivation of complete respiratory system. Sucrose is a 
disaccharide (α-D-glucose + β-D-fructose) and its metabolic processing requires the expression of only 
few additional genes encoding e.g., sucrose transporters and invertase, which are subjected to glucose 
repression. Invertase catalyzes the first step in the breakdown of sucrose to hexose monosaccharides. 
In case of glucose depletion the abundant presence of sucrose still maintains high growth rate, whereas 
yeast growing on non-fermentable carbon sources grows slowly and shows similarity to the enduring 
form accumulating reserve nutrients.  
Dominant mutations in the glucose repression pathway or failures in the derepression process 
during low glucose concentrations result in growth defect in sucrose medium. This easily recognizable 
growth phenotype on sucrose medium helped to identify several “sucrose non-fermenting” (snf) yeast 
mutants defective in central regulators of the catabolite repression pathway. 
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1.2.1. Snf1 (Sucrose non-fermenting 1) 
 
The yeast snf1 mutant is unable to grow on any other carbon source than glucose [15]. The Snf1 gene 
encodes a serine/threonine protein kinase [16, 17], which is highly conserved in all eukaryotes. In the 
sugar signaling pathways of yeast, Snf1 plays a role in the derepression of glucose repressed genes 
under glucose starvation, as Snf1 is activated by low glucose concentration. Besides its role in the 
response to glucose limitation, Snf1 has been implicated in several other processes including aging, 
thermotolerance, peroxisome biogenesis, invasive growth, biofilm formation, meiosis and sporulation 
[14]. Comparison of Snf1 to its relatives in other organisms resulted in the recognition that Snf1 is not 
merely a sugar signaling component but a general sensor and regulator of cellular energy level.  
Mammalian Snf1 orthologs, the AMP-activated protein kinases (AMPK), are activated in 
response to AMP (i.e. high AMP/ATP ratio) [18]. AMP is produced in the adenylate kinase reaction 
(2ADP ↔ ATP + AMP), which restores residual energy of ADP into the more accessible form of ATP 
on the price of generating AMP. High AMP/ATP ratio refers to conditions of general cellular energy 
depletion and thereby AMPKs are able to sense the cellular energy level. AMPKs play a role in the 
maintenance of energy balance by phosphorylating metabolic enzymes, such as acetyl-CoA 
carboxylase [19,20] and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) [21] representing rate 
limiting enzymes of energy demanding fatty acid and cholesterol biosynthesis pathways, respectively. 
AMPKs also respond to stimuli that do not cause detectable change in the AMP/ATP ratio, for 
instance to hyperosmotic stress [22] and the application of anti-diabetic agent metformin in mammals 
[23]. 
Plant Snf1 and AMPK orthologs phosphorylate and inactivate the sucrose phosphate synthase 
(SPS) and nitrate reductase (NR) enzymes [24]. NR catalyzes the first step in the energy consuming 
process of nitrate assimilation. Posttranslational control of NR is very important in the coordination of 
carbon- and nitrogen assimilation intensity [25]. NR produces nitrite (NO2-), a toxic intermedier of 
nitrate assimilation, which is immediately processed further, finally to ammonia, with the reducing 
power provided by photosynthesis (carbon assimilation and water lysis). When carbon assimilation is 
not intensive enough (e.g., during night) and reducing hydrogen is not abundantly available, NR 
activity must be stopped to prevent toxic nitrite accumulation. Nitrite is not only a harmful oxidative 
molecule, but might also induce apoptosis through reactive oxygen species signaling.  
There are further evidences that link Snf1-related kinases to nutrient metabolism. The TOR 
kinase, a known regulator of nitrogen responses has been revealed to control Snf1 activity [26]. Light 
and glucose has been also shown to regulate sulphate assimilation [13, 27], which is also in connection 
with nitrate processing [12]. Therefore, Snf1 and its orthologs are considered as general metabolic 
regulators with important roles is stress signaling. Exposure of yeast cells to sodium ion stress, 
alkaline pH, or oxidative stress causes an increase in Snf1 kinase activity, whereas heat shock or 
osmotic shock (sorbitol treatment) not [28]. Snf1 is also involved in genotoxic stress adaptation in 
response to hydroxyurea and oxidative stress [29]. In natural growth conditions, yeast generally does 
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not live at so high sugar concentrations like in laboratory mediums or in the fermenting grape juice 
during wine production. Yeast cells cultured in nutrient-limiting conditions exhibit a robustly periodic 
metabolic cycle. Over a cycle of 4-5 hours yeast cells rhythmically alternate between glycolysis and 
respiration and the DNA replication takes place only during the fermentative phase that might shield 
DNA from oxidative damage [30]. 
 
1.2.2. Nomenclature of the Snf1-related protein kinases 
The family of Snf1 orthologs is classified under the designation 5’-AMP-activated protein kinases 
(AMPKs) that belong to the superfamily of CDPK/SnRK protein kinases [31]. In plants, members of 
the AMPK family are named class 1 SNF1-related protein kinases (SnRK1). In different plant species 
there are specific names for SnRK1s, such as AKIN in Arabidopsis, RKIN in rice, NPK5 in tobacco, 
BKIN in barley, PKIN in potato etc. [32]. 
 
1.2.3. Structure of the AMP-activated protein kinases 
The AMP-activated kinases form heterotrimeric complexes that consist of one catalytic α subunit, one 
β [33] and one γ non-catalytic subunits [34]. Alternative AMPK subunit isoforms exist that constitute 
multiple trimeric complexes due to combinatoric assembly [35] (Table 1).  
 
 Saccharomyces 
cerevisiae 
Homo sapiens Arabidopsis thaliana 
α subunit Snf1 AMPKα1, α2 AKIN10,11,12 
β subunit Gal83, Sip1,Sip2 AMPK β1, β2 AKINβ1, β2, β3 
γ subunit Snf4 AMPK γ1, γ2, γ3 (AKINγ), AKINβγ 
Table 1. Alternative subunit isoforms of AMP-activated protein kinase orthologs 
 
Budding yeast contains one catalytic α subunits (Snf1), three alternative beta subunits (Gal83, Sip1 
and Sip2) and one gamma subunit (Snf4). The individual loss of function mutations of beta subunits 
show little or no phenotypes, whereas the triple mutant displays snf1- phenotype, similarly to the snf4 
mutant (albeit it is less pronounced at lower growth temperatures) [34]. This indicates that the trimeric 
composition is obligatory for the kinase activity in vivo in yeast. The same can be observed in 
mammals, where co-expression of all three subunit types increases the kinase activity 50-110 fold with 
the formation of a heterotrimeric complex, whereas the catalytic subunit expressed alone or together 
with one other subunit shows hardly detectable activity [36].  
In Arabidopsis there are three alternative SnRK1α subunits (AKIN10, 11 and 12), three 
SnRKβ subunits (AKINβ1, AKINβ2 and AKINβ3) and one true SnRKγ subunit (AKINβγ) [35]. A 
formerly reported AKINγ is shown in parenthesis because it interacts with other Arabidopsis α and β 
subunits in the yeast two hybrid system and contains conserved domains, which are generally present 
in AMPKγ subunits, but it is unable to complement the yeast snf4 mutation, unlike AKINβγ [149,150]. 
Some of the plant SnRK1 subunits are atypical (see below). 
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1.2.4. Relatives of AMPKs 
The catalytic α subunit is comprised of an N-terminal kinase domain and a C-terminal regulatory 
domain. The kinase domain of AMPKα subunits is highly conserved and shows significant similarity 
to other kinases, whereas the sequence of the α regulatory domain is specific to the AMPK family. 
Based on sequence similarity of the kinase domain, a broader AMPK-related kinase family is defined. 
In yeast 5 relatives of Snf1 are found in the CaMK group of protein kinases but they don’t substitute 
for Snf1 [31,37,38]. In mammals, in addition to the two genuine orthologs, AMPK1 and 2 which can 
complement the yeast snf1 mutation, there are 13 other members of the family [39, 40]. In Arabidopsis 
the AMPK-related kinases can be further classified into SnRK1 class which contains three true Snf1 
orthologs, AKIN10, 11 and 12, and the likewise stress-related SnRK2 and SnRK3 classes, which are 
plant specific and fail to complement the yeast snf1 mutation. The 10 SnRK2 kinases of Arabidopsis 
are monomers and involved in ABA and osmotic stress responses, whereas the SnRK3 family counts 
25 members [31]. The SnRK3 kinases, which are also termed the SOS2 (salt overly sensitive 2)-like 
protein kinases (PKS), differentially interact with the SOS3 family of Ca2+ sensors (CBLs, calcineurin-
B-like) and show trimeric structure [41]. Also, the yeast Snf1 family member Hsl1 interacts with a 
yeast Ca2+-sensor Cnb1 [42], suggesting further stress-related functional similarities among members 
of the complete interspecific superfamily. 
 
1.3. REGULATION OF AMPKS 
The kinase domain of AMPK alpha subunits contains a conserved activation loop threonine (also 
named T-loop threonine, position T175 in AKIN10), which is phosphorylated during activation. Site-
directed mutagenesis of the T-loop threonine to alanine completely abolishes the kinase activity [43-
46]. In its unphosphorylated state the T-loop sterically occupies the catalytic center. Phosphorylation 
of the activation-loop threonine causes an outward rotation of the activation loop, thus making the 
catalytic cleft accessible to substrates and aligning the active site residues for catalysis [47-48]. 
Upstream activating kinases have been identified in yeast (Pak1 recently renamed as Sak1, Elm1 and 
Tos3 encoded by paralogous genes) [49-52], in mammals (LKB1, CaMKK α and β, TAK1 MAPKKK) 
[53-57] and recently in Arabidopsis (Tos3-like kinase 1 and 2 or alternatively SnAK1, SnAK2) [38, 
58]. In yeast, upstream activation is essential for the kinase function, because the elm1pak1tos3 triple 
mutant shows snf1 phenotype [49]. Similarly, bacterially expressed and reconstructed mammalian 
heterotrimeric AMPK is not active in vitro, but can be activated by upstream kinase treatment [59]. In 
contrast, the Arabidopsis SnRK1 catalytic subunits AKIN10 and AKIN11 show basic activity due to 
autophosphorylation and phosphorylate SPS-KD (sucrose phosphate synthase catalytic domain 
peptide) as artificial substrate in vitro [60]. The different upstream kinases represent distinct signaling 
pathways [61]. Other phosphorylation sites were identified on purified AMPKs by mass spectrometric 
analysis (T258 and S485 in AMPKα1) but their mutations don’t affect the kinase activity [62].  
Specific phosphatase activity removes T-loop phosphorylation during inactivation. In yeast 
Reg1, one of the targeting subunits of the essential PP1 phosphatase Glc7, directly interacts with and 
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negatively regulates the Snf1 kinase [63,64]. Reg1 is phosphorylated by Snf1 upon glucose limitation 
but dephosphorylated by Glc7 in the presence of glucose [65]. Other poorly investigated components, 
such as Sip5, might play a role in the kinase regulation. Sip5, binds to both Reg1/Glc7 and Snf1 kinase 
complex, and may stabilize their interaction thereby facilitating glucose repression [66]. Decrease of 
Glc7 phosphatase activity in the reg1 mutant and in the absence of glycolytic enzyme and metabolic 
glucose sensor hexokinase2 (hxk2) also contribute to Snf1 activation [64-65,67]. Hxk2 is part of a 
nuclear glucose repressor complex [68-69], constitutively interacts with Snf1 under both low and high 
glucose concentration [70] and inhibits Snf1 activity at high glucose concentrations [71]. Assumingly, 
the glucose-binding of Hxk2 plays a role in the inactivation process. Hxk2 also interacts with the Glc7 
phosphatase complex [72]. 
The other major mechanism that activates AMPKs is mediated by the γ subunit. Yeast two 
hybrid experiments indicate that the kinase domain (KD) and C-terminal regulatory domain directly 
interact with each other within the catalytic subunit. This conformation represses the kinase activity 
and depends on high glucose concentration in yeast. The C-terminal autoinhibitory domain (AID) 
alternatively interacts with the γ subunit [73]. Upon glucose removal the AID is released by the kinase 
domain and at the same time bound by the γ subunit leading to an intramolecular rearrangement and 
relief of kinase activity.  
Mammalian and plant AMPKs can be activated by AMP in vitro [18,74] that is mediated by 
the γ subunit. Despite high level of conservation between yeast Snf4 and other AMPKγ subunits, 
purified and active Snf1 could not be further activated by AMP in vitro [75]. However, 
dephosphorylated and thereby inactivated trimeric Snf1 can be reactivated by mammalian AMPK 
upstream kinase and this process is facilitated by the presence of 100μM AMP. So, although not 
evident, it seems that AMP might directly activate also the yeast Snf1 complex. Snf1 activity 
correlates with changes in the AMP/ATP ratio also in vivo. AMP-activation of Snf1 is further 
supported by the fact that Snf4 binds AMP and ATP in vitro. Trimeric Snf1 complex from 
Saccharomyces pombe could be crystallized in association with AMP and ATP and the partial three-
dimensional structure of the complex was resolved recently by X-ray crystallography, shedding light 
on the mechanism of AMP/ATP-regulation [76]. It is the conserved cystathione-beta-synthase-repeat 
based nucleotide-binding pocket of γ subunits that binds AMP or alternatively ATP [77]. The binding 
imposes different electrical charge distribution on the molecular surface, controlling the interactions 
within the kinase complex. AMP-binding activates whereas ATP binding inhibits the AMPK kinase. 
The binding depends on the AMP/ATP concentration ratio, but AMP has higher affinity. 
High glucose concentration inhibits the interaction of Snf1 with Snf4 in the yeast two hybrid 
assay [75, 78]. In contrast to the KD-AID interaction, the binding of isolated AID to γ subunit is not 
dependent on glucose in the yeast two hybrid assay [73]. Moreover, in experiments with the full length 
α subunit the T-loop phosphorylation is a preequisite of the γ subunit – AID binding, because site-
directed mutagenesis of the T-loop threonine to alanine prevents it. Conversely, the inhibition by 
glucose depends on PP1 phosphatase activity [79], and Reg1 overexpression interferes with the AID-
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Snf4 interaction at low glucose levels [65]. Therefore, it is likely that the glucose inhibition is 
transmitted by T-loop dephosphorylation by Glc7, and conversely T-loop phosphorylation by an 
upstream kinase leads to the release of AID, which is taken over by the AMP-bound γ subunit 
resulting in Snf1 activation. Importantly, the T-loop phosphorylation itself is not sufficient for 
activation because the yeast snf4Δ mutant shows a snf1- phenotype [34].  
 
1.3.1. Domain structure of the catalytic subunit 
The sequence motifs involved in autoinhibition of Snf1 were precisely mapped in yeast. Deletion 
analysis located the AID to amino acid position 392-518 in Snf1, which is nearly identical to the γ–
binding sequence (392-495) [73]. In mammals, the role of a short motif immediately downstream of 
the kinase domain was revealed in rat AMPK (315-392) as autoinhibitory sequence [80]. This motif 
was verified and also structurally analyzed in human AMPK (313-335) [81]. At the same steric and 
sequence position a UBA1 domain is present in plant AMPK orthologs and in many of human AMPK-
related family members. The UBA1 domain is approximately 45 amino acids long and folds into a 
bundle of three tightly packed helices, exposing a hydrophobic patch that generally interacts with 
monoubiquitin or polyubiquitin chains [82-83]. In the yeast Snf1 kinase, the sequence of AID locates 
to the area of a UBA2 domain (309-482). Notwithstanding their low sequence homology, both UBA1 
and UBA2 domains are generally able to bind ubiquitin.  
Ubiquitin has various functions in the cell. Monoubiquitin acts as a sorting signal throughout 
the endocytotic pathway. Polyubiquitin chains, which are linked through Lys48 are signals for 
proteasomal degradation, whereas Lys63-linked chains are implicated in DNA damage repair, signal 
transduction and endocytosis [84]. One major role of UBA1 domain is to inhibit ubiquitin chain 
elongation and thereby prevent the degradation of proteasomal substrates [85-86]. In mammals, 
protein kinases containing UBA domain can only be found in the AMPK-related kinase family [87]. 
The presence of UBA domain in many AMPKs supports the observation that Arabidopsis SnRK1 
kinases were found in association with the 26S proteasome and SCF type E3 ubiquitin ligases [88], 
and thereby could be regulatory components of the proteasomal degradation machinery. However, a 
recent publication showed that surprisingly none of the isolated UBA domains found in AMPK-related 
kinases can interact with any form of ubiquitin or ubiquitin-like molecules (SUMO1, SUMO2, 
SUMO3, NEDD8) in vitro [87] and this observation is also supported by crystallographic data. 
Compared to published structures of mono- and polyubiquitin docked onto UBA domains of other 
proteins there would be a steric clash between the ubiquitin and the N-terminal lobe of the kinase 
domain, indicating that binding of the two would be mutually exclusive. Also the conformation of the 
UBA domain is abnormal in AMPK-related protein kinases [89]. However, it is still possible that the 
UBA domain might bind ubiquitin in the active state of the kinase, which is accompanied by major 
structural changes and might shift also the UBA domain structure into its regular conformation. 
Recently, it has been proposed that instead of binding ubiquitin the UBA domain of the 
AMPK-related kinases might be involved in regulating the kinase activity. Still it is not clear how, 
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because the results are inconsistent. Jaleel et al (2006) [87] reported that the UBA domain is necessary 
for efficient T-loop phosphorylation of the MARK2 AMPK-related kinase by an upstream kinase in 
vitro. Deletion of the UBA domain leads to complete loss of activity of this kinase. In case of the 
autophosphorylating and thereby self-activating MELK, a mammalian AMPK-related kinase, the UBA 
domain is also essential for the kinase activity in vitro [90]. In contrast, Marx et al (2007) [91] could 
not verify the activating role of UBA domain. Instead, they found it modestly inhibitory in MARK2, 
suggesting that the UBA domain probably enforces an inactive open conformation of the catalytic 
domain. This is also supported by the fact that the autoinhibitory α helix identified in the human 
AMPK1 (residues 313-335) overlaps with the position of UBA domain in AMPK enzymes. Based on 
the structural information of multiple AMPK-related kinases (MARK1, MARK2 and MARK3) the 
binding ability of the UBA domain to the N-terminal kinase lobe has probably evolved on the expense 
of loosing ubiquitin-binding ability [92]. 
The extreme C-terminus of the α subunit (515-633) of Snf1 is responsible for β subunit 
binding, which is also indispensable for the activity [93]. In the Arabidopsis AKINs and some related 
kinases the extreme C-terminus forms a distinct KA1 domain (kinase associated) that has been 
implicated in autoinhibition [81].  
 
1.4. THE ROLE OF BETA SUBUNITS IN REGULATION 
The beta subunits serve as scaffold for the trimeric kinase complex, having distinct interaction 
domains on their conserved C-termini for both the catalytic (KIS domain, kinase interaction sequence) 
and activator subunits (ASC domain, association with the Snf1 complex) [33, 93-94]. In addition to 
their structural roles, the beta subunits determine the subcellular localization of trimeric kinase 
complexes, and play important roles in selective substrate recognition. The beta subunits are essential 
for the kinase function because deletion of genes encoding all beta isoforms inactivates the Snf1 
kinase in yeast and leads to snf1- phenotype.  
 
1.4.1. Subcellular localization 
In response to nutritional stress the localization patterns of beta subunits change in yeast [95]. When 
the cells are grown on glucose, each beta subunit is predominantly cytoplasmic but upon shift to non-
fermentable carbon source Gal83 is imported into the nucleus, Sip1 moves into the vacuolar 
membrane, whereas Sip2 seems to remain cytosolic. Yeast Sip2 is implicated in the control of aging in 
response to metabolic stress [96]. In this process a plasma membrane bound form of Sip2 tethers Snf1 
and Snf4 to the cell membrane, and thereby prevents their nuclear import, and assumingly negatively 
regulates nuclear Snf1 activity [97]. Location of the Snf1 kinase complex at the nuclear periphery was 
observed recently, and the nuclear membrane-associated form of Snf1 might play role in the release of 
glucose repression [98].  
Post-translational modifications of the beta subunits also affect the Snf1 kinase activity and its 
cellular localization [99-100]. The variable β N-terminal sequence is necessary and sufficient factor 
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for the correct localization [101]. The membrane binding ability of some beta subunits is provided by 
N-terminal myristoylation, a secondary modification which targets proteins to membranes. Sip1 and 
Sip2 of yeast are optionally myristoylated on their Gly2 residue [97, 102-104] and the same potential 
myristoylation site is present in the Arabidopsis SnRK1 beta subunits AKINβ1 and AKINβ2. Mutation 
of the critical glycine to alanine in the myristoylation site prevents relocalization of Sip1 in yeast 
[103]. Very recently the myristoylation site mutations were studied also in the Arabidopsis AKINβ1 
and AKINβ2 proteins [104]. Wild type AKINβ1 and AKINβ2 were mostly associated with the plasma 
membrane. When myristoylation is inhibited by a Gly2Ala substitution, AKINβ1 is relocalized into the 
nucleus, whereas AKINβ2 moves to the cytosol. In another approach, bimolecular fluorescent 
complementation (BiFC) was used to explore the localization and interactions of Arabidopsis SnRK1 
kinase subunit isoforms in a highly artificial system, using overexpressed kinase subunits in N. 
benthamiana leaf epidermis [105]. This resulted in the detection of all three beta subunits incorporated 
into trimeric kinase complexes in the cell membrane, cytoplasm and nucleus. 
The beta subunits are also phosphorylated at multiple sites in vivo and in vitro in yeast [105-
107] and mammals [100]. In case of AMPKβ1, the phosphorylation sites were identified by mass 
spectrometry [62, 99]. Site-directed mutagenesis of serine 108 to alanine resulted in loss of AMPK 
kinase activity, whereas the SS 24, 25 AA double mutation and S182A mutation resulted in nuclear 
redistribution of the β subunit [107].  
 Using trimeric Snf1 complex purified from yeast cells, Snf1 itself was found to be implicated 
in phosphorylation of its beta subunits in vitro [107]. However, the possibility couldn’t be excluded 
that that the phosphate incorporation is mediated by a different kinase copurified in minor amounts 
with Snf1. Bacterially expressed and reconstituted trimeric AMPK complex is entirely inactive but can 
be activated by externally added upstream kinase [59]. However, so far such kinase sample has not 
been assayed for beta subunit phosphorylation. Other protein kinases acting in the sugar signaling 
pathways have been implicated in the regulation of subcellular AMPK movements, including the 
upstream Snf1-activating kinase Pak1 [109] and the cyclic-AMP dependent protein kinase PKA [110]. 
Nevertheless, subcellular movements of beta subunits are clearly independent of Snf1 and Reg1 
because they are normally localized in a snf1Δ strain [95]. 
 
1.4.2. Substrate definition 
Genetic and biochemical observations indicate that in yeast only the nuclear Gal83 beta subunit 
containing Snf1 kinase complex phosphorylates the transcriptional activator Sip4 protein [111,112]. 
Subcellular localization probably plays a major role in the selectivity of various Snf1 complexes by 
allowing access to sequestered substrates. Interestingly, the conserved Snf4-binding ASC domain, and 
not the variable N-terminus, of Gal83 was shown to be necessary and sufficient for Sip4 interaction 
[111]. 
The β subunits contain a functional glycogen-binding domain (GBD) positioned N-terminally 
of KIS and ASC domains, which certainly plays a role in the substrate definition. The GBD (residues 
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68-163 in AMPKβ1) is most closely related to iso-amylase domains found in glycogen and starch 
branching enzymes [113-115]. The GBD of beta-subunit is able to bind glycogen in vitro in a 
saturating manner. Moreover, overexpressed AMPKβ1 co-localizes with glycogen-bound phosphatase 
(glycogen phosphorylase) in vivo. Mutations in AMPKγ subunits cause glycogen storage disease in 
humans [116] and glycogen synthase is an identified AMPK substrate [117]. Phosphorylation site 
mutation S108A of AMPKβ partially inhibits glycogen binding. There might be additional sequences 
in the holoenzyme involved in glycogen association because binding affinity of the trimeric kinase to 
glycogen is about 10-fold higher than the GBD alone. AMPK activity is not inhibited by glycogen. 
 
1.5. GLUCOSE SIGNALING IN YEAST 
For more exact illustration of the role of Snf1 in cell signaling, the following section provides a short 
overview of key components of yeast glucose signal transduction machinery [4,14,118].  
Extracellular glucose is sensed by plasma-membrane integrated receptors. Such 
intramembrane glucose receptor is Gpr1 that belongs to the G-protein coupled receptor family. Upon 
external glucose binding, Gpr1 releases its trimeric G protein α-subunit partner (Gpa2) that activates 
the cyclic-AMP producing enzyme adenylate cyclase (Cyr1). An alternative way for adenylate cyclase 
activation is through small G-proteins Ras1 and Ras2, but less is known about this part of the cascade. 
They might be activated by intracellular glucose signal that finally leads to cAMP production through 
Cyr1. In yeast, cAMP enhances proliferation and down-regulates stress resistance. Cyclic-AMP 
allosterically activates the cAMP-dependent protein kinase A (PKA), which directly phosphorylates 
and regulates metabolic enzymes and transcription factors. For instance, PKA phosphorylates and 
inactivates the Msn2 and Msn4 transcriptional activators of stress-induced genes that carry the stress 
responsive element (STRE) in their promoter. Transcription factor Rap1, another direct PKA 
substrate, regulates the expression of ribosomal proteins and thereby is an indicator of general 
intensity of protein synthesis. An important link between nutrient limitation and cell cycle control is 
established through translational regulation of yeast cyclin 3 by PKA. PKA integrates multiple nutrient 
responses including glucose, sulphate, phosphate and nitrogen sources. The convergence is in part due 
to antagonistic interaction with the TOR kinase pathway, another major nutrient signaling cascade 
mostly described in nitrogen responses. Interestingly, glucose availability correlates with PKA activity 
but not with high cAMP levels, because cAMP is present only during the transition from repressed 
state to derepressed state. 
Other glucose receptors, evolved from glucose transporters and enzymes of glucose 
metabolism, have intrinsic ability to bind glucose. Such glucose transporter-derived intra-membrane 
receptors are Rgt2 and Snf3 that lost their transporting activities. In response to extracellular glucose 
they interact with casein kinase1 (Yck1), which in turn phosphorylates the cytoplasmic form of Mth1 
and Std1 transcriptional repressor proteins marking them for proteasomal degradation through the 
SCFGRR1-E3 ubiquitin ligase. When localized in the nucleus, Mth1 and Std1 participate in the 
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repression of hexose transporter gene expression (Hxt family) through interaction with the Rgt1 
transcriptional repressor. 
The main glucose repression pathway requires the intracellular presence of glucose. Once 
glucose is imported to the cytoplasm it becomes phosphorylated, which has multiple purposes. The 
addition of a phosphate group to the sugar acts to trap it in the cell, since the negatively charged 
phosphate cannot easily traverse the plasma membrane. From metabolic aspect, phosphorylation of 
glucose is the entry step into glycolysis. Glucose phosphorylation is also implicated in the activation 
of glucose repression pathway. Glucose phosphorylation is catalyzed by hexokinase1, hexokinase2 
and glucokinase (Hxk1, Hxk2 and Glk1) in yeast. Mostly Hxk2, but to less extent also Hxk1, is able to 
mediate glucose repression, whereas glucokinase not. Hxk1 and Hxk2 are therefore not only metabolic 
enzymes but also glucose sensors. Long-term glucose repression specifically requires Hxk2, which is 
the most active glucose-phosphorylating enzyme and exists as phosphorylated monomer and 
unphosphorylated active dimer. Overexpression of Glk1 does not restore glucose repression in hxk 
mutants indicating that not phosphorylated glucose but instead the active forms of hexokinases play 
important roles in glucose signal transduction. Mannoheptulose, a specific inhibitor of hexokinases, 
blocks the glucose repression pathway. Interestingly, mutant alleles of Hxk2 have been identified in 
which catalytic activity and signal transducing abilities are uncoupled. Hxk2 is present also in the 
nucleus and its nuclear localization is dependent on glucose [119].  
An additional pathway with emerging importance is linked to trehalose metabolism. Trehalose 
is a disaccharide comprised of two glucose subunits linked in α,α-1,1 configuration. Being a non-
reducing sugar, trehalose is chemically more inert than glucose whose aldehyde and ketone groups 
react with lysine or arginine residues of proteins. Trehalose is involved in desiccation tolerance and 
known as a general stress protectant and storage carbohydrate in microorganisms, accumulated mainly 
during starvation conditions. Similarly to glucose-6-phosphate, trehalose-6-phosphate (T6P) is not 
only a metabolic intermediate but a regulator of enzyme activity. In yeast T6P inhibits Hxk2 and 
thereby controls the flux of sugars into glycolysis. Mutant alleles of trehalose-6-phosphate synthase 
(Tps1) confer general glucose-sensing defect. 
There is a prevalent crosstalk between the glucose signaling cascades represented by the above 
mentioned receptors. Therefore, this pathway is considered as a complex signaling web, which is also 
interconnected with other nutrient and hormone signal transduction cascades. For example, cAMP 
synthesis through Ras2 requires glucose phosphorylation by the hexokinases or glucokinase [120]. On 
the other hand, full glucose response (glucose induction and also repression) can be triggered by 
expressing either activated Ras2 or Gpa2. Therefore, Hxk2 must generate the glucose repression signal 
through G-proteins [121]. The transcriptional response of Snf3/Rgt2 target genes (e.g. Hxt1-4) can 
also be generated in the absence of glucose by the expression of hyperactive Ras or Gpa2. Snf3 and 
Rgt2 appear either to act upstream of Ras/cAMP/PKA or to play an ancillary, redundant role in the 
initial detection of glucose. PKA, activated by cAMP, is involved in glucose-induced removal of Rgt1 
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repressor, and thereby activates the expression of Hxk2, hexose transporters (Hxt) and Snf3 receptor 
genes.  
 
1.5.1. Snf1 is a central regulator in yeast glucose signaling 
The canonical Snf1 function is the release of glucose repressed gene expression. Glucose repression is 
transmitted by the Hxk2 pathway, which indeed shows interactions with Snf1 and with its negative 
regulator, the Glc7 PP1 phosphatase. However, Snf1 and Glc7 interact with several other elements of 
glucose signaling network and therefore they cannot be obviously assigned to any of the signaling 
cascades represented by the above described receptors. It is also unknown, which signals activate and 
which signaling cascades integrate the Snf1-activating upstream kinases. Moreover, AMPKs are 
directly activated by AMP, which is a metabolic signal, so they can be interpreted as a sensor or 
receptor component of a distinct signaling pathway.  
Both Snf1 and the Reg1-targeted Glc7 PP1 phosphatase directly interact with Hxk2 [70,72]. 
This is a substrate level interaction at least in case of Glc7, which directly dephosphorylates and 
thereby activates Hxk2. Since Snf1 and Glc7 are direct interacting partners and functional antagonists, 
Snf1 might phosphorylate and inactivate Hxk2. In support of this hypothesis, increasing extracellular 
glucose concentration and hyperactivation of PKA (that are both opposing the conditions when Snf1 is 
active) result in reduced Hxk2 phosphorylation, whereas attenuation of PKA activity increases 32P 
labeling of HXK2 [122]. Snf1 also prevents Hxk2 gene expression through multisite phosphorylation 
and activation of Rgt1 transcriptional repressor. Snf1 phosphorylates Mig1 (the binding partner of 
Hxk2) on at least four sites [70]. Phosphorylation of serine 311 causes nuclear export of Mig1 and 
thereby prevents Hxk2 to access to its promoter targets by heterodimerization with Mig1. In yeast cells 
grown in glucose medium, Mig1 is nuclear whereas in cells grown in ethanol medium it is 
cytoplasmic. However, in hxk2 mutant cells Mig1 has always cytoplasmic localization even in cells 
grown on glucose, which is due to its Snf1-mediated phosphorylation because in hxk2snf1 double 
mutant Mig1 is constitutively nuclear. Furthermore, Hxk2 appears to regulate Snf1 activity, perhaps 
through Glc7. In the Snf3-Rgt2 glucose induction pathway Snf1 phosphorylates Mth1 and Std1, 
thereby preventing their proteasomal degradation targeted by Grr1. In the PKA signaling route Snf1 
phosphorylates Msn2 and thereby probably regulates its nucleo-cytoplasmic distribution. Snf1 also 
interacts with the Nrg1 and Nrg2 transcriptional repressors of stress responsive genes involved in the 
transcriptional control of about 150 genes, including a set of genes regulating haploid invasive growth. 
 
1.5.2. Snf1 and controlled protein degradation 
Protein products of many genes whose expression is regulated by glucose are also controlled post-
translationally by glucose signaling. These control mechanisms include conformational changes, 
subcellular redistribution (e.g., Rgt1, Mig1, etc.) and proteolytic degradation by the 26S proteasome. 
Many of these events are mediated by phosphorylation. Grr1 (glucose repression resistant 1), the F-
box protein substrate recognition subunit of an SCF type E3 ubiquitin ligase, was identified in genetic 
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screens as component of glucose signal transduction but it is also involved in nitrogen response and 
cell cycle regulation [123]. SCFGrr1 recognizes phosphorylated substrates via the cationic surface of its 
leucine-rich repeat (LRR) protein interaction motif [124] but phosphorylation of substrates on other 
residues can prevent their degradation. In case of Mth1 and Std1, it is casein kinase (Yck1) which 
facilitates their degradation, whereas phosphorylation by Snf1 stabilizes them. Other proteasomal 
substrates, such as Gis4, are also known to be ubiquitylated by SCFGrr1 and to interact with Snf1 [125]. 
Gis4 has been implicated in glucose responses [126] and is also a regulator of ion homeostasis in yeast 
[127]. SCFGrr1 mediates the degradation of several other glucose regulated proteins, for instance, Gal2 
[128] and Mks1 [129]. One major means of cell cycle regulation by nutrient availability is represented 
by proteasomal degradation of G1 cyclins Cln1 and Cln2 targeted by Grr1.  
Reg1, the targeting subunit of Glc7 phosphatase also interacts with Grr1 in a complex with 14-
3-3 proteins [130]. Snf1 does not bind to Grr1 directly but it also co-purifies with the 14-3-3 proteins 
Bmh1 and Bmh2 of yeast [52] as well as the γ subunit Snf4 [131]. Members of the 14-3-3 protein 
family are binding partners of phosphoproteins [132]. It has been shown in some cases that the 
phosphorylated 14-3-3 binding partners are also substrates for the Glc7 phosphatase [133]. Through 
interaction with numerous binding partners, the 14-3-3 proteins play important roles in the regulation 
of diverse cellular processes including transcription, signaling, cell cycle control and metabolic 
regulation [134]. Moreover, it is established that the 14-3-3 proteins Bmh1 and Bmh2, together with 
Reg1, actively participate in glucose-induced degradation of maltose permease [135]. The 
involvement of 14-3-3 proteins in the control of proteasomal degradation explains their interaction 
with Grr1. Genetic evidence indicates that the yeast 14-3-3 proteins Bmh1 and Bmh2 are involved in 
the regulation of glucose repression. Deletion of Reg1 and both Bmh genes causes a synergistic relief 
of glucose repressed gene expression [136]. Supporting this, among 14-3-3 interacting partners there 
are several proteins involved in gluconeogenesis [137]. In addition, 14-3-3 proteins also respond to the 
Ras/PKA pathway [138]. 14-3-3 proteins are also involved in glucose signaling related mechanisms, 
including the control of DNA damage [139] and replication checkpoints in yeast [140]. 
Phosphoprotein binding ability of 14-3-3 proteins can stabilize active or inactive conformation 
of enzymes, it can stimulate protein-protein interactions and anchor proteins to cellular compartments 
through which 14-3-3s regulate nucleo-cytoplasmic distribution of proteins [141]. Since active Snf1 is 
predominantly located in the nucleus, whereas fluorescently tagged Reg1 appears to be exclusively 
cytoplasmic, it was proposed that upon glucose-related signals Snf1 would rapidly shuttle between the 
nuclear and cytoplasmic compartments allowing inactivation by Glc7/Reg1 in the cytoplasm [142]. 
Based on this assumption, Snf1 might be exported from the nucleus still in an active form and 14-3-3 
proteins might serve as mediators of Glc7/Reg1 function. In the mammal QSK and SIK kinases, which 
are members of the AMPK-related protein kinase family, it is the phosphorylated T-loop which has 
been shown to confer binding to a 14-3-3 protein that controls their activity and localization [143]. 
Phosphorylated form of another mammalian AMPK-related kinase MARK3 also interacts with 14-3-3 
proteins. Wild type MARK3 is present in both cytoplasm and plasmamembrane, whereas mutation of 
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the T-loop phosphorylation sites to alanine results in a loss of 14-3-3 binding ability and exclusive 
plasmamembrane localization of MARK3. Nevertheless, 14-3-3-binding of MARK3 does not affect its 
activity [144]. 14-3-3 proteins themselves are also regulated by phosphorylation which further 
complicates the understanding of their regulatory interactions with kinases. The above listed examples 
assume a complex regulatory mechanism in which AMPK kinases in cooperation with 14-3-3 proteins 
control proteasomal degradation of enzymes and components of various signaling pathways. 
 
1.6. SNF1-RELATED KINASES IN PLANTS AND THEIR ATYPICAL SUBUNITS 
Snf1-related kinase subunits were identified in plants based on sequence homology to yeast Snf1 and 
its related subunits [145]. In Arabidopsis three SnRK1α subunits (AKIN10, AKIN11 and AKIN12), 
three SnRK1β subunits (AKINβ1, AKINβ2 and AKINβ3) and at least one true SnRK1γ (AKINβγ) 
subunit were identified [35]. Based on data available in the Genevestigator microarray database 
AKIN10 and AKIN11 represent the variants expressed in most tissues, whereas AKIN12 expression is 
restricted to siliques and its expression level is very low. 
In contrast to the two typical β subunits in Arabidopsis (AKINβ1 and AKINβ2), AKINβ3 is a 
shorter variant and does not carry N-terminal GBD. Nonetheless, it still contains the KIS and ASC 
domains. Therefore, AKINβ3 is still able to mediate interactions within the trimeric SnRK1 complex 
in vitro and in vivo [146]. Although atypical, AKINβ3 can complement the yeast mutations 
sip1Δsip2Δgal83Δ. Such short β subunit variant exists also in other plant species. The GBD-containing 
N-terminal sequence, which is missing from the short beta subunits, appears on the N terminus of the 
plant specific γ subunit as a result of natural domain swap [147], therefore the Arabidopsis SNF4/γ 
subunit is named AKINβγ. This longer γ subunit version also complements the yeast snf4 mutation. A 
putative distant ortholog of SnRK1γ subunit was found in Arabidopsis (At3g48530) that contains CBS 
repeats, but its overall homology to other γ subunit orthologs is very low [148]. Although it interacts 
with other Arabidopsis SnRK1 subunits in the yeast two-hybrid system, it is unable to complement the 
yeast snf4 mutation. Therefore, this protein might not be a true γ subunit but rather another CBS-repeat 
protein with different function. Interestingly in maize (Zea mays) two ZmAKINβγ sequences were 
found [147]. 
An atypical functional feature of plant SnRK1 kinases is, at least in tobacco and Arabidopsis, 
that the catalytic subunits AKIN10 and AKIN11 can autophosphorylate and show a moderate substrate 
phosphorylating activity in vitro, unlike yeast Snf1 and mammal AMPK orthologs [60].Nevertheless, 
recently upstream activating kinases had been identified also in Arabidopsis [38,58].  
 
 
1.6.1. Physiological roles of SnRK1 kinases in plants 
Reverse genetic approach of functional dissection of Arabidopsis SnRK1 subunit genes is limited 
because no T-DNA insertion mutations are available for AKIN11, and only one T-DNA tag is found in 
the 3’-region of AKIN10 gene (not studied yet in detail). For AKIN12 more T-DNA insertion mutant 
lines exist.  
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Two SnRK1-encoding genes, PpSnf1a and PpSnf1b, have been cloned from the moss 
Physcomitrella patens and shown to functionally replace Snf1 in yeast [149]. In Physcomitrella, gene 
function can be studied by homologous recombination based mutagenesis method (gene targeting), 
which is applied in the haploid gametophyte. The snf1asnf1b double mutant of Physcomitrella is 
viable but requires continuous light for survival and deficient in starch accumulation. This phenotype 
correlates with properties of the yeast snf1 mutant, which is able to grow only on glucose medium and 
unable to accumulate reserve nutrients. (However, the analogy between plant SnRK1 and yeast Snf1 
function is not obvious because yeast accumulates reserve nutrients when glucose is depleted, whereas 
plants accumulate mesophyll starch when performing photosynthesis and producing sugars in the 
light). The snf1asnf1b double knockout grown on continuous light shows developmental 
abnormalities, premature senescence and altered sensitivity to plant hormones (hypersensitivity to 
auxin and reduced sensitive to cytokinin). The increased senescence phenotype is similar to enhanced 
aging phenotype of the yeast sip2Δ mutant [97,98] and AMPK-related aging phenotype of human 
fibroblasts [150]. In potato, antisense expression of Snf1-related protein kinase sequence results in 
decreased expression of sucrose synthase in tubers and loss of sucrose-inducibility of sucrose synthase 
transcripts in leaves [151], whereas SnRK1 overexpression leads to increased starch accumulation and 
low glucose concentration in tubers [152]. In barley, the absence of SnRK1 expression causes 
abnormal pollen development and lack of starch accumulation in pollen and thereby results in male 
sterility [153]. In cultured wheat embryos, embryo specific expression of an antisense SnRK1 variant 
represses transient expression of α-amylase promoter thereby inhibits starch breakdown [154]. (The 
result is the latter quite artificial experiment is opposite to those mentioned before, indicating that 
there are still questions in the role of SnRK1 kinases in starch metabolism.)  
Reserve nutrient reallocation occurs also in other cases during development, in which SnRK1 
kinases play a role. For instance, herbivore attack during early phases of development increases root 
reserves, which in turn delays senescence and prolongs flowering. In Nicotiana attenuata, reallocation 
of reserve carbon to root in response to herbivore attack is mediated by the downregulation of a 
SnRK1 β-subunit NaGal83 in the leaves [155]. 
In pea (Pisum sativum), antisense expression of SnRK1 causes defects in seed maturation, 
reduced conversion of sucrose into storage products, lower globulin content, frequently altered 
cotyledon surface, shape and symmetry, as well as occasional precocious germination. Gene 
expression analysis of pea embryos using macroarrays of 5548 seed specific genes revealed 183 
differentially expressed genes in two clusters, either delayed down-regulated or delayed up-regulated 
during the phase transition from intensive cell division to maturation [156]. The delayed down-
regulated genes are related to mitotic activity, gibberellin and brassinosteroid synthesis, stress 
response and Ca2+-signal transduction. The delayed up-regulated genes are mainly related to storage 
protein synthesis and stress tolerance. Most of the phenotypes exhibited by antisense SnRK1 
expressing plants resemble abscisic acid (ABA) insensitivity. The close connection between SnRK1 
and hormone signaling, especially with ABA responses, was also studied in tomato seeds where ABA 
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and gibberellin were shown to differentially regulate SnRK1 expression [157]. The role of γ subunit 
was studied in Medicago truncatula seeds [158]. MtSnf4b accumulated during seed filling whereas it 
disappeared during water uptake by mature seeds. However, desiccation stress lead to reactivation of 
the Snf1 complex in seedlings. Silencing of MtSnf4b using an RNA interference (RNAi) approach 
resulted in the accumulation of 60% more sucrose in the seeds and caused reduced seed germination.  
In Arabidopsis no mutant phenotype of any SnRK1 subunit has been published so far. Very 
recently, phenotypes of AKIN overexpressor transgenic Arabidopsis plants were published as well as 
knock-down lines using virus-induced gene silencing (VIGS) [159]. AKIN10 overexpression showed 
some advantage in seedling primary root growth and development under low light with limited energy 
supply, whereas exogenous glucose application resulted in reduced root and shoot growth. In contrast, 
AKIN10 silenced lines were able to use exogenously supplied sucrose and glucose and exhibited 
enhanced shoot and root growth. Whereas wild type plants undergo rapid senescence in response to 
nutrient deprivation, AKIN overexpressing lines display delayed flowering and delayed onset of 
senescence. In contrast, the AKIN10 and 11 double knock-down plants exhibit so rapid aging that in 
the most severe cases senescence occurs before flowering. Unlike in Physcomitrella, the growth 
phenotypes could not be rescued by exposure to continuous light. RNA-silencing of AKINs also 
causes defects in starch metabolism. In the double knock-down lines leaf starch content remained high 
at the end of the night suggesting a failure of carbon transport from source leaves to the roots during 
the dark period. However, this result is opposite to the majority of former observations in different 
plant species engineered for overexpressing or silencing SnRK1 kinases. Most of the former results 
suggest that SnRK1 kinases enhance the accumulation of starch whereas this recent observation 
suggests that SnRK1 kinases intensify starch breakdown. 
Global transcript analysis of AKIN overexpression in an artificial protoplast system identified 
1021 putative AKIN target genes belonging to various catabolic pathways including cell wall, starch, 
sucrose, amino acid, lipid and protein degradation that provide alternative sources of energy and 
metabolites [159]. Similarly to the glucose repression mechanism of yeast, also in Arabidopsis a large 
set of genes were repressed, which are involved in the ribosome biogenesis. Importantly, the results 
also revealed an extended role of SnRK1 in signal transduction, since mRNA levels of a large number 
of transcription factors, chromatin remodeling factors and signal transduction components changed in 
response to AKIN expression. These microarray data suggested that AKIN function should be 
repressed by sugar abundance. This is again opposite to the prevailing view, which supposes that 
SnRK1 kinases enhance starch accumulation that can only be supported with sugars abundantly 
available [60, 151, 160].  
Data from Physcomitrella indicate that the day/night changes play a critical role in the control 
of SnRK1 kinases. In Arabidopsis light regulation of the transcript levels of AKINβ1, β2 and AKINγ 
subunits was proposed. AKINβ1 and AKINγ transcripts reversibly accumulate in the darkness whereas 
AKINβ2 expression seems to be repressed in the dark [148]. In addition, public transcriptome database 
survey revealed that dark-induced genes are activated under various stress conditions and repressed 
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not only by light but also by sugars, obviating the connection between sugar-, light- and stress 
responses [159].  
Several SnRK1 kinase substrates have been identified in plants. Most of them are enzymes 
related to metabolism, although an important role of SnRK1 kinases is expected in signal transduction 
as well. For example, SnRK1 kinases phosphorylate and inactivate nitrate reductase (NR), sucrose 
phosphate synthase and 3-hydroxy-3-methylglutaryl-coenzyme A reductase in spinach [161]. A 
genetic example for the involvement of SnRK1 kinases in signal transduction was published recently: 
coexpression of AKIN10 with the G-box binding basic leucine-zipper transcription factor GBF5/bZip2 
resulted in a strong synergistic effect on the activation of the dark and stress induced DIN6, a 
candidate target gene for the GBF5 bZIP transcription factor [159].  
 
1.6.2. Involvement of SnRK1 kinases in plant sugar signaling 
Our knowledge about the roles of plant SnRK1 kinases in cell signaling at the molecular level is very 
limited. Neither the recently identified upstream SnRK1-activating kinases are characterized yet, nor 
their orthologs in yeast. On the other hand, SnRK1 kinases are in close connection with nutrient-, 
especially sugar signal transduction pathways. Therefore, it is reasonable to study SnRK1 kinases in 
the context of sugar signaling and its cross-talk with stress-, light- and hormone signaling.  
In multicellular organisms sugars are produced or taken up and temporarily stored in 
specialized organs from where they are reallocated to every tissues of the body. The necessity for 
long-distance sugar transport, tissue specific and cell autonomous sugar signaling mechanisms, and 
coordination with complex hormonal networks makes sugar signaling far more complicated in 
multicellular organisms than in single cell organisms. In plants, depending on the net flux of sugar, net 
sugar exporting (source) and sugar importing (sink) tissues can be distinguished. Leaf mesophyll cells 
are considered as source tissue whereas the non-photosynthetic root contains sink tissues, similarly to 
developing embryos and other rapidly developing organs, such as ripening fruits and meristematic 
regions. Diurnal changes in sugar allocation are well known in plants. Accumulated excess 
carbohydrates are transported from the leaves to the roots during the night. Sugar fluxes also 
dramatically change through development and in response to biotic and abiotic stresses [5].  
The major form of transported sugars in plants is sucrose. Sucrose can be imported to sink 
tissues through plasmodesmata or by apoplastic transport through the cell wall and sucrose 
transporters. In sink tissues sucrose is cleaved by cytoplasmic, vacuolar and cell wall invertases 
generating glucose and fructose. The convertibility of sucrose to glucose gives a possible explanation 
why most sucrose-induced responses can also be triggered by glucose. In case of sugar repression of 
photosynthesis genes, hexoses are effective at lower concentration than sucrose indicating that sucrose 
is perhaps not the primary signaling molecule. However, in a few known cases sucrose and glucose 
exhibit distinct signaling functions. An important example is that the presence of glucose induces 
intensive cell division during early embryo development, whereas embryonic cell expansion in the 
following developmental phase is triggered in response to sucrose signal [6]. 
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In plants sucrose and glucose influence a wide range of developmental processes including 
seed germination, seedling development, root and leaf differentiation, floral transition, fruit ripening, 
embryogenesis and senescence, as well as responses to light, stress and pathogens. The sugar induced 
phenotypes used in genetic screens reflect the effects of high concentrations of externally applied 
sugars (e.g. 6% glucose) that repress photosynthesis, cause stunted growth and inhibit lateral root 
formation and true leaf development. (The germination arrest on high-sugar media occurs only in a 
sensitive period during the initial stages of seedling development.) Similarly to yeast, trehalose and 
some enzymes of its metabolism are sugar-signaling components of emerging importance [162, 163]. 
 
1.6.3. Conserved and divergent elements in yeast and Arabidopsis glucose signal 
perception 
Although there is a candidate G-protein coupled glucose receptor in Arabidopsis, intriguingly no 
obvious ortholog of PKA has been identified [38]. Therefore, it is not clear how these receptors 
contribute to glucose signal transduction in plants. Arabidopsis apparently contains only one G-protein 
α-subunit, GPA1, which is implicated in various developmental, light, hormone, phospholipid and 
stress responses. GPA1 interacts with two putative G-protein coupled receptors GCR1 and RGS1. 
Loss of RGS1 increases GPA1 activity, which results in increased hypocotyl elongation in the 
darkness and increased cell production in roots grown in the light. RGS1 overexpressors are 
hypersensitive to glucose, whereas the rgs1 mutant is insensitive to glucose inhibition of germination 
[6]. 
Other potential cell surface located glucose receptors are found also in plants, but our 
knowledge about them is limited. The SUT2 sucrose transporter homolog in Arabidopsis and tomato is 
reminiscent to Snf3 and Rgt2 of yeast showing no transporter activity but possessing a long 
cytoplasmic loop not present in active transporters [6]. 
Hexokinases are the most ancient and evolutionarily conserved sugar sensors in E.coli, yeast, 
mammals and plants, but there are differences between the orthologs. In Arabidopsis two hexokinases 
AtHXK1 and AtHXK2 and four additional hexokinase-like (AtHKL) genes exist, from which 
AtHKL1 has detectable kinase activity and therefore is also named AtHXK3. Null mutation of 
AtHXK1 leads to glucose insensitivity, which cannot be compensated by overexpression of HXK2. 
AtHXK1 overexpression confers glucose hypersensitivity. Arabidopsis hxk1 mutants still have about 
50% of the wild type glucose kinase activity provided by AtHXK2 and HXLs, and accumulate sugar 
phosphates to normal levels. These data indicate that as in yeast, the product glucose-6-phosphate 
itself does not play a role in HXK1-dependent glucose signaling in Arabidopsis. However, the glucose 
analogues 6-deoxyglucose and 3-O-methylglucose, which are transported to the cytoplasm but not 
phosphorylated, do not trigger sugar responses, unlike 2-deoxyglucose which can undergo 
phosphorylation. Similarly to Hxk2 of yeast, mutants of Arabidopsis AtHXK1 were also generated 
with impaired kinase activity, which still show normal glucose signal transducing ability. These 
mutants are deficient in ATP-binding and phosphoryl transfer and not in glucose binding. 
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Interestingly, yeast Hxk2 and Arabidopsis HXK1 are only interchangeable with respect to glucose 
kinase activity, but they fail to replace each other in their glucose signaling function [6].  
Similarly to yeast, AtHXK1 can also translocate to the nucleus where it was reported to 
participate in a DNA-binding signaling complex together with RPT5B proteasomal 19S cap subunit 
and VHA-B1 vacuolar H+-ATP-ase [164]. Plant hexokinases also associate with membranes of 
subcellular compartments [165], for instance mitochondria, where they participate in the control of 
programmed cell death in response to oxidative stress [166].  
 
1.6.4. Sugar response mutants and developmental impact of sugar signaling  
Further components of plant sugar signal transduction pathways were identified in several genetic 
screens based on either enhanced or reduced sugar responses [8]. The screening strategies followed 
changes either in transcriptional activity of sugar responsive promoter elements in mutants or 
alterations in the sugar-induced germination arrest phenotype. The mutants were screened on various 
sugar concentrations using different types of sugars. (The osmotic effects of sugar treatments were 
excluded by comparison with plants treated with non-metabolizable sugars.) For instance, glucose 
insensitive (gin) mutants are able to establish seedling growth on 330mM externally applied glucose 
(6%), which induces developmental arrest and bleaching in wild type seedlings. By contrast, in 
glucose overly sensitive (glo) mutants developmental arrest occurs already at 220mM glucose 
concentration (4%). These mutant screens identified AtHXK1 as gin2 and unravelled many formerly 
annotated hormone signal transduction components showing sugar response phenotypes. In addition to 
being glucose insensitive, the gin2 mutant is also hypersensitive to cytokinin and insensitive to auxin, 
exhibits delayed leaf senescence and retarded growth under high light irradiance [167]. These 
observations also underscore a close connection between sugar, hormone and light signal transduction 
cascades. 
The interaction of sugar responses with abscisic acid and ethylene signal transduction is 
especially close. The mutations identified in the sugar-related screens include both hormone 
biosynthesis genes and downstream hormone signaling elements indicating a broad interaction 
interface between sugar and hormone signaling cascades. ABA2, a sort chain dehydrogenase/reductase 
enzyme involved in ABA biosynthesis, was defined by the gin1 [168], sis4 (sucrose insensitive4) 
[169] and isi4 (impaired sucrose induction4) mutations [170], whereas aba3 proved to be allelic with 
gin5 [171]. Genetic analysis of the gin2 mutant indicated that AtHXK1 acts upstream of aba2 in the 
glucose signaling pathway [168]. Abscisic acid insensitive 4 was originally isolated because of its 
ability to germinate on ABA containing media normally inhibitory for germination of wild type 
Arabidopsis seeds [172]. The encoded gene was identified to code for an AP2-domain transcription 
factor [173], and has been since found in a large number of sugar response screens (sun6 [174], sis5 
[169], gin6 [171], isi3 [170]) and also in salt tolerance screens [175]. ABI4 regulates lipid 
mobilization in the embryo and is also involved in the repression of seed germination [176]. Although 
ABI4 is mostly expressed in developing seeds, it is able to repress the expression of plastocyanin, a 
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nuclear encoded photosynthetic gene. Moreover, ABI4 mediates the effects of exogenous trehalose on 
Arabidopsis growth and starch breakdown [177]. Another ABA-signaling transcription factor 
identified in sugar response screens is ABI5 [172], which contains a basic leucine zipper DNA binding 
domain [178]. Expression studies suggest that ABI5 is present during a short post-germination 
developmental window that correlates with the sugar sensitive period [179]. ABI5 is 
posttranslationally modified by phosphorylation on multiple residues, which is essential for its activity 
[179,180]. ABI5 is not only a sugar signaling factor but, in contrast to ABI4, it plays a role in the 
sugar-mediated regulation of senescence [181], which is an important link also towards SnRK1 
kinases. (ABA promotes senescence but it is not required for the sugar-dependent induction of leaf 
senescence.) Not all ABA signal transduction components play a role in sugar response. For instance, 
the abi1 and abi2 mutations affecting two closely related PP2C type phosphatases and abi3 do not 
cause alteration in germination-related sugar responses [182].  
ABA and sugar signal transduction is so closely related that the existence of mutants specific 
only to sugar signaling is an important question. Some mutants with gin or sis (sugar insensitive) 
phenotypes (e.g. sis3 [9]) seem to be unrelated to plant hormone responses. High concentrations 
(100μM and higher) of externally applied ABA evokes the same developmental arrest phenotype in 
seedlings as sugars do. Considering also the sugar response phenotypes of mutants in ABA 
biosynthesis and signaling, it is likely that sugars exhibit many of their developmental effects through 
components of ABA signal transduction. However, all this applies only to high concentrations of these 
agents accordingly to their application in genetic screens. Low concentrations of sugars (15 to 90 mM 
glucose, fructose and sucrose but not sorbitol or mannitol) strongly repress the inhibition of seed 
germination by exogenous ABA [183]. Low concentration effects of sugars and ABA are not 
completely revealed yet. ABA has long been considered as a stress hormone and growth inhibitor but 
relatively recent data indicate that low concentration of ABA is essential for normal shoot and root 
development [183-185].  
The antagonism between abscisic acid and ethylene signaling pathways is a well known 
phenomenon: generally the positively acting elements of ethylene signal transduction down-regulate 
ABA signaling and vice versa, except of some cases when ethylene and ABA act synergistically for 
instance in root, where ABA promotes growth at low concentrations [186-187]. The opposite effect of 
ethylene and ABA reflects also in their interaction with sugar responses: sugar acts synergistically 
with ABA, but in antagonism with ethylene [188]. This finding is also supported by the fact that 
ethylene promotes hypocotyl elongation in the light (which inhibits it) even in the presence of high 
sugar levels, but inhibits the same process in the dark [189]. Furthermore, gin1/aba2 and gin2/hxk1 
mutations down-regulate a branch of ethylene signaling pathways that stimulates germination, and 
cotyledon and leaf development [188]. Mutations affecting the negatively acting factors in ethylene 
responses were identified also as glucose insensitive mutants (e.g., eto1, ethylene biosynthesis mutant 
[188], and ctr1, which is allelic to gin4 [183], and sis1 [190]), whereas mutations of positive 
regulatory elements in ethylene signaling confer glucose overly sensitive phenotype (etr1, ein2, ein3, 
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ein6 [7]). However, analysis of the double mutants gin1 etr1 and gin1 ein2, that display the glucose 
insensitive phenotype of the gin1/aba2, indicate that ethylene probably affects glucose signaling 
through ABA [8].  
HXK1 (GIN2) plays an important role also in growth promotion because under high light 
irradiance gin2 plants remain small with reduced cell expansion whereas wild type plants benefit from 
the increased energy supply and their growth is accelerated [167]. Analysis of the effects of 
proliferation promoting plant hormones on gin2 revealed that gin2 is relatively insensitive to auxin-
induction of cell proliferation and root formation, but hypersensitive to shoot induction by cytokinin. 
Consistent with this observation, seedling development of the auxin resistant axr1, axr2 (IAA7), and 
tir1 (transport inhibitor response) mutants, as well as that of plants that display constitutive cytokinin 
response (or are supplemented with exogenous cytokinin), are insensitive to high glucose levels and 
also relatively insensitive to ABA and ethylene suggesting a possible convergence point between the 
three signaling pathways [191]. Mutation in AXR2/IAA7 and other Aux/IAA family members, such as 
AXR3/IAA17 and SHY2/IAA3, also result in constitutive photomorphogenesis in the dark including 
true leaf development and greening [192]. 
Metabolizable sugars alter the responsiveness of plants to light, which has been described for 
the PhyA-specific far-red light signaling pathway. Sugars can inhibit the far-red light-induced block of 
greening that is caused by the PhyA-specific repression of protochlorophyllide oxidoreductrase [193]. 
In the sun6/abi4 (sucrose uncoupled 6) mutant PhyA signaling is no longer inhibited by sugars [194]. 
Intriguingly, the vegetative developmental mechanisms controlled by PhyA and B are repressed by 
ethylene [195] that, at least in the above mentioned aspects, acts antagonistically to sugars.  
In most cases the effects of sugars on complex developmental events are only described at the 
phenotypic level but are not completely understood molecularly. Sugars regulate the timing of many 
developmental phase-changes, such as the progression from juvenile to adult phases, floral transition, 
senescence and phases of embryo development. Expression of antisense RUBISCO small subunit 
transcript in tobacco resulted in decreased leaf source strength with concomitant extension of early 
phase of shoot development [196]. In Arabidopsis, a species that flowers earlier under long-day 
conditions, a correlation was found between greater export of carbohydrates from the leaves and 
enhanced induction of flowering [197]. Application of exogenous sucrose to the aerial part of plant has 
also been observed to induce flowering in Arabidopsis even in complete darkness [198]. In 
accordance, trehalose-6-phosphate synthase (AtTPS1), a regulator of glucose, ABA and stress 
responses is an essential factor for flowering in Arabidopsis [199]. However, growth on high and low 
concentration of sucrose (5%, 150mM, 30mM) has been shown to significantly delay flowering [200]. 
From another view, instead of sugars rather the C:N ratio might be important  to regulate the timing of 
flowering transition [201] and other developmental processes, such as lateral root formation [202], 
which is a potential interference point with SnRK1 signaling. A major determinant of flowering 
transition is the day length, which is perceived in plants by comparing diurnal light changes and 
outputs of the circadian clock. In addition to the characterized close interaction between sugar 
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signaling and diurnal expression changes, whose regulation involves SnRK1 kinases [159], global 
transcriptome analysis revealed that sugars also modify the gene expression of about 50% of known 
clock regulated genes [203].  
 
1.7. SUGAR SIGNALING AND PROTEIN DEGRADATION 
Arabidopsis SnRK1 kinases have been found to interact with components of the 20S proteasomal 
central cylinder (α7 proteasomal subunit) and the common SKP1 subunit of SCF type E3 ubiquitin 
ligases in yeast two hybrid screen and in vivo [89]. Recent bioinformatics analyses suggest that over 
5% of the Arabidopsis proteome may be involved in ubiquitin- and 26S proteasome-dependent protein 
degradation [6]. In the most prevalent type of SCF type E3 ubiquitin ligases that contain CULLIN1 
subunit, the estimated number of alternative substrate recognition F-box protein subunits is 694 in 
plants [204]. F-box proteins themselves have also been shown to become ubiquitylated and degraded 
in a proteasome-dependent mechanism [205]. There are identified ubiquitin ligase components and 
proteasomally degraded elements in hormone response (AIP2, ABI5 family, EBF1, EBF2, EIN3 EILs, 
DELLA proteins, TIR1 family, AUX/IAA family, COI1, SLY1 etc.), light signaling (HY5, COP1), 
flowering (FKF1, CDF1, CO, ZTL), circadian clock (ZTL, TOC1, LKP2), leaf senescence (ORE9) 
and many other pathways. Sugar signal transduction pathways also utilize controlled protein 
degradation in their regulation. Solely based on sequence similarity, there are no obvious Arabidopsis 
orthologs of yeast F-box protein GRR1, which was assigned to glucose signal transduction [123]. 
However, there are several potential functional orthologs, which show considerable similarity to 
GRR1, including the F-box proteins EBF1 and EBF2 assigned to ethylene signaling and the nuclear 
auxin receptor F-box protein TIR1 (and its three other family members, the AFB proteins) [206], 
which function as auxin hormone receptors. EBF1- and EBF2-dependent proteasomal degradation of 
EIN3 transcription factor in ethylene signaling is enhanced by glucose but inhibited by ethylene [207]. 
In addition, the TIR1 family member AFB1/AtGRH1 (GRR1 homolog 1) can restore glucose 
repression activity in the grr1 mutant yeast, in a way still dependent on the Mig1 repressor [208]. 
 Integration of metabolic signals with cell division has been proposed to be controlled at the 
level of CyclinD proteins. Cyclins are essential cofactors of cyclin-dependent kinases that are main 
regulators of the cell cycle. Whereas wild type Physcomitrella patens exhibits a prolonged juvenile 
phase when grown in the presence of glucose, the CyclinD knockout is insensitive to this glucose-
mediated developmental delay [209]. In Arabidopsis, cyclinD3;1 is transcriptionally upregulated by 
sugars and cytokinins to enable G1/S transition [210] and appears to be a highly unstable protein 
which is degraded in a 26S proteasome-dependent fashion upon sucrose depletion [211]. Moreover, 
cyclinD3;1 is phosphorylated in response to sugar starvation, and the hyperphosphorylated form 
accumulates in response to proteasome inhibitor treatment [211]. Cyclin D1 is also proteasomally 
degraded and its stability is controlled by phosphorylation [212]. 
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1.7.1. Conserved mechanisms suggest involvement of SnRK1 kinases in sugar 
dependent proteolysis 
14-3-3 proteins participate in sugar signal transduction also in plants. In cultured sugar-fed 
Arabidopsis cells many proteins are phosphorylated and bound to 14-3-3 proteins, whereas in response 
to sugar starvation the 14-3-3 binding partners are subjected to selective proteolytic degradation [213]. 
The identity of protease involved is still a question, but it can be inhibited by MG132, a cysteine 
protease inhibitor of 26S proteasome, and cannot be inhibited by PMSF, a serine protease inhibitor. 
Importantly, the corresponding protease can only cleave target proteins in vitro when they are free of 
14-3-3 proteins. Phosphorylation and 14-3-3-binding completely protect the proteolytic substrates 
from degradation [214]. Another potential connection with SnRK1 kinases is the involvement of 14-3-
3 proteins in the regulation of senescence. 14-3-3 protein overexpressing potato displays prolonged 
stay-green phenotype with delayed leaf senescence, whereas antisense 14-3-3 plants show early 
senescence [214]. Additionally, in a screen searching for Arabidopsis suppressors of yeast grr1 
mutation, the 14-3-3 protein AtGF14 was identified [208]. 
 Many 14-3-3 binding partners are enzymes of carbon and nitrogen metabolism, for instance 
nitrate reductase (NR) [215], glutamine synthetase [216], sucrose phosphate synthase (SPS) [217], 
trehalose-6-phosphate synthase 1 (TPS1) [218] and 6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase [219]. Phosphorylation of NR, SPS and HMGR by SnRK1 inhibits their activity in 
spinach and 14-3-3-binding of NR in response to darkness is also inhibitory [24]. In contrast, an 
Arabidopsis protein kinase, PKS5, inactivates a plasmamembrane H+-ATP-ase by preventing its 
interaction with a 14-3-3 protein [220]. Leaf NR is rapidly inhibited by phosphorylation and 14-3-3 
binding in response to darkness. In addition, after a prolonged dark period NR is degraded. These 
results led to the assumption that 14-3-3-binding is a prerequisite for degradation. Furthermore, 
immunodepletion of 14-3-3 proteins from leaf extracts prevented NR degradation. Therefore, 14-3-3 
proteins might play a role in targeting NR for proteolysis in the dark. However, other experiments 
provide evidence for the contrary mechanism, in which 14-3-3 binding would prevent the degradation 
of proteolytic substrates. Consistent with the latter scenario, the relative abundance of 14-3-3 proteins 
has been reported to decline gradually during prolonged darkness [214]. In conclusion, the function of 
14-3-3 proteins is not completely understood, but their conserved roles in the control proteasomal 
degradation and their connection to SnRK1 kinases supports the model that SnRK1 kinases are 
components of the sugar-dependent proteasomal degradation machinery. 
 
 
1.8. AIMS OF THE PRESENT WORK 
The yeast AMPK kinase, Snf1, plays a widely conserved role in cell signaling. Plant orthologs of yeast 
Snf1 represented by the class I SnRK1 kinases have been so far characterized concerning their roles in 
the regulation of activity and stability of key metabolic enzymes. Therefore, major aim of the present 
work was to obtain information about the roles of SnRK1 kinases in cell signaling. 
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The project was based on former yeast two-hybrid and in vivo studies of interactions of 
Arabidopsis SnRK1 kinases with the proteasome and the conserved common ASK1/SKP1 component 
of SCF-type E3 ubiquitin ligase complexes. These results provided the first data about the presence of 
SnRK1 kinases in proteasomal complexes. However, the number of proteasome containing complexes 
is very high because of the associated variable ubiquitin ligases are represented by 694 different 
substrate receptor F-box proteins in Arabidopsis. Therefore, one aim of the project was to determine, 
whether the presence of SnRK1 kinases in proteasomal-SCF complexes is general or restricted to 
some specific complexes. This part of the work was supported by a grant of the German National 
Science Foundation (DFG Ko1438/3-3) for two years. The project employed epitope-tagging and 
subsequent immunoaffinity chromatography of proteasomal substrates and F-box proteins but failed to 
produce sufficient resolution of SnRK1-SCF-proteasome complexes by mass spectrometry. In contrast 
to yeast and mammal cells, intensive proteolytic degradation in plant tissues and low level production 
of affinity tagged proteins proved to be serious technical obstacles. 
 In parallel with the biochemical approach, genetic analysis of T-DNA insertion mutations in 
genes encoding SnRK1 kinase subunits was performed to obtain information on possible regulatory 
roles of SnRK1 kinases in the plant signaling web. This approach is described in the present thesis. 
Other approaches, such as transcript profiling of SnRK1α overexpressing plants and characterization 
of Arabidopsis SnRK1βγ subunit involved other members of our laboratory. To identify and 
characterize candidate SnRK1 substrate, this work was largely devoted to study the phosphorylation of 
transcription factors and other proteins by the purified SnRK1 kinase AKIN10. Major aims of the PhD 
thesis work were 
 
• Isolation and characterization of SnRK1α and SnRK1β subunit T-DNA insertion mutants in 
Arabidopsis, in order to gain information about the role of SnRK1 kinases in cell signaling 
• Improvement of protein purification strategy to increase protein complex stability and yield 
• Study of subcellular localization of individual SnRK1β subunits, in order to identify nuclear 
components of SnRK1 kinases  
• Identification of candidate SnRK1 substrates  
• Localization and mutagenesis of phosphorylation sites in SnRK1 substrates 
• Verification of in vitro SnRK1-substrate interactions in vivo 
• Characterization of upstream SnRK1-activating kinases in order to get information about the 
signals that activate SnRK1 kinases. 
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2. MATERIALS AND METHODS 
2.1. MATERIALS 
2.1.1. Chemicals and laboratory supplies 
2.1.1.1. General chemicals 
Beckman Instruments Inc., Palo Alto, USA Centrifuge tubes 
  
Biomol GmbH, Hamburg, Germany MG132 
  
BIO-RAD, München, Germany Bradford Reagent 
 Precision  Plus, pre-stained molecular weight standard 
for protein electrophoresis 
 Polypeptide SDS-PAGE Molecular Weight Standard 
 Cat. No. 161-0326 
  
Calbiochem Corp., Darmstadt, Germany Miracloth 
  
Cambrex Bio Science Inc., Rockland, USA Seakem LE Agarose 
  
Corning Inc., Corning, USA Costar, Disposable Serological Pipettes 
  
Eppendorf AG, Hamburg, Germany Safe-lock microcentrifuge tubes (0.5, 1.5 and 2.0 ml)  
  
Invitrogen GmbH, Karlsruhe, Germany 1kb molecular mass marker for agarose electrophoresis 
 Tris-HCl, ultrapure 
  
Grenier bio-one GmbH Kermsmünster, Austria Petri dishes 
 Falcon tubes (15 and 50ml) 
  
Heirler Cenovis GmbH, Radolfcell, Germany milk powder 
  
Lehle Seeds, Round Rock, TX, USA Vac-in-stuff, Silwet L-77 
  
Merck, Darmstadt, Germany General chemicals: 
 ethanol, methanol, 2-propanol, acetone, chloroform, 
glycine, N,N dimethylformamide, acetic acid, Na-
acetate, NaCl, NaOH, MgCl2, NaH2PO4, Na2HPO4, NaF, 
TCA, Isoamyl alcohole, EDTA (TitriplexIII),  
  
Metabion International AG, Martinsried, Germany oligonucleotides 
  
Millipore, Badford, USA Nitrocellulose filter VSWP 0.025μm 
 Sterivex filter units 
 Immobilon-P (PVDF membrane for immunoblot) 
 Glass vacuum filter set 
  
Peqlab Biotechnologie GmbH, Erlangen, Germany E.Z.N.A. plasmid miniprep kit I. 
  
Riedel da Haen, Seelze, Germany Ca-hypochlorite 
  
Roche Diagnostics GmbH, Mannheim, Germany anti HA antibody 
 anti c-Myc antibody 
  
Carl Roth GmbH, Karlsruhe, Germany dNTP solutions 
 preequilibrated phenol (Rotiphenol) 
 Acrylamide mix, Rotiphorese 40, 29:1 
 Alufoil, 30μm thick 
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 IPTG 
  
Sartorius AG, Göttingen, Germany Minisart, 0.22μm and 0.45μm filter units 
  
Serva Electrophoresis GmbH, Heidelberg, Germany Bromophenol Blue – Na Salt 
 Visking® dialysis tubes, 6mm diameter 
 Dodecyl sulphate, Na-salt (SDS) 
 Ponceau S solution 
  
Whatman, Maidstone, USA 3MM paper 
  
Sigma-Aldrich General chemicals: 
 abscisic acid, D-glucose, TEMED, EtBr, Sucrose, APS, 
CNBr, 2-estradiol, 2-mercaptoethanol, DTT, ATP, 
PMSF, tricine, Na3VO4, CTAB, Triton X-100,  
Tween-20 
 Protease inhibitor cocktail for plant cells (Cat.No.P9599) 
  
Fluka Biochemika TFA 
  
GE Healthcare ECL Detection Reagent, chemiluminescence kit 
 disposable chromatographic columns (PD-10 column) 
  
Starlab GmbH, Ahrensburg, Germany disposable pipette tips, TipOne 
  
Thermo, Electron Corporation, Milford, MA, USA electroporation cuvette, 2mm diameter 
 
2.1.1.2. Enzymes  
Boehringer Mannheim, Germany RNaseA 
 Calf Intestinal Phosphatase 
  
New England Biolabs, Frankfurt am Main, 
Germany 
Restriction endonucleases 
T4 DNA ligase 
 T4 DNA polymerase 
 Antarctic Phosphatase 
  
Takara Bio Inc., Otsu, Shiga, Japan TaKaRa LA Taq DNA polymerase 
  
Invitrogen GmbH, Karlsruhe, Germany Taq DNA polymerase, recombinant 
  
Roche Diagnostics GmbH, Mannheim, Germany Endoproteinase Arg-C Sequencing Grade 
  
Worthington DNase 
 
2.1.1.3. Culture media and hormones  
Duchefa, Haarlem, the Netherlands Phytoagar 
  
BD Biosciences, Franklin lakes, NJ, USA Bacto® Yeast Extract (Ref. No. 212750) 
 BBLTM Beef Extract (Ref. No. 212303) 
 Bacto® Peptone (Ref. No. 211677) 
 BD Difco Beef extract 
  
Carl Roth GmbH, Karlsruhe, Germany Trypton / peptone (from casein pancreatically digested) 
  
Invitrogen GmbH, Karlsruhe, Germany Select Agar 
  
Sigma-Aldrich Murashige & Skoog Medium basal salt mixture (MS) 
 Murashige & Skoog Medium basal salt with minimal 
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organics (MSMO) (Plant cell culture tested) (M6899) 
 2,4 dichlorphenoxy acetic acid 
 αNaphtaleneacetic Acid 
 Nicotinic acid 
 Pyridoxin HCl 
 Thiamine HCl 
 Myo-inositol 
 
2.1.1.4. Antibiotics 
Sigma-Aldrich Ampicillin 
 Carbenicillin 
 Kanamycin 
 Tetracyclin 
 Spectinomycin 
 Chloramphenicol 
 Streptomycin 
 Sulphadiazine 
 Rifampicin 
 Gentamycin 
  
Roche Diagnostics GmbH, Mannheim, Germany Hygromycin B 
  
Duchefa Biochemie, Haarlem, the Netherlands Cefotaxime sodium (Claforan) 
 Ticarcillin disodium mixture 15:1 & 
Potassium Clavulanate 
 
2.1.1.5. Chromatography resins 
Glutathion Sepharose 4B (GE Healthcare) 
Ni-NTA resin (Qiagen) 
 Amylose resin (New England Biolabs) 
StrepII-tactin sepharose (IBA) 
Sephadex G-25, G-50 (GE Healthcare) 
HiTrapDEAE FF 1ml IEX column (GE Healthcare) 
Talon resin (Clontech) 
 
2.1.1.6. Antibodies 
2.1.1.6.1. Primary antibodies  
Anti-HA Rat monoclonal antibody (clone 3F10) against a peptide derived from influenza 
haemagglutinin peptide (Roche). Dilution 1:1000 
Anti-c-Myc Mouse monoclonal antibody raised against a peptide from human c-Myc protein 
(Roche). Dilution 1:1000 
2.1.1.6.2. Secondary antibodies 
Goat anti-rat heavy plus light chains, horseradish peroxidase conjugate, dilution 1:5000 
   (Sigma, A9037) 
Goat anti mouse heavy plus light chains, horseradish peroxidase conjugate, dilution 1:10000 
   (Pierce 31430) 
 
2.1.1.7. Radiochemicals 
γ32P-ATP (GE Healthcare) 
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2.1.2. Bacterial strains 
2.1.2.1. E.coli strains 
 
DH10b (Invitrogen) 
(E. coli F-mcrA∆(mrr-hsdRMS-mcrBC)Φ80lacZ∆M15∆lacX74recA1endA1araD139∆(ara, 
leu)7697galUgalKλ-rpsLnupG 
 
BL21(DE3)pLysS (Novagen) 
(E. coli B F- dcm ompT hsdS(rB- mB-)galλ(DE3)[pLysS Camr]) 
 
BMH 71-18 mutS (BD Biosciences) 
(E.coli thi supE Δ(lac-proAB) [mutS::Tn10][F' proAB, lacIq ZΔM15]) 
 
S17.1  
(E.coli 294::RP4-2 (Tc::Mu) (Km::Tn7)) 
 
 
2.1.2.2. Agrobacterium strains 
Agrobacterium tumefaciens GV3101 (pMP90) 
C58C1, rif, pMP90 (pTiC58∆T-DNA), Gmr [221]  
 
Agrobacterium tumefaciens GV3101 (pMP90RK)  
C58C1, rif, pMP90RK (pTiC58∆T-DNA), Gmr, Kmr [221] 
 
 
2.1.3. Plasmid vectors and constructs 
2.1.3.1. Plasmid vectors 
 
vector drug resistance in bacteria drug resistance 
in plants 
reference 
pER8 XVE Sp50, Hyg50 Hyg15 Zuo et al, 2000 [222] 
pPCV002 Amp100, (Cb100) Km50 Koncz et al 1994 [223] 
pPCV812 Amp100, (Cb100), Hyg50 Hyg15 Koncz et al 1994 [223] 
pPILY Amp100, (Cb100) - Ferrando et al 2000[224] 
pMENCHU Amp100, (Cb100) - Ferrando et al 2000[224] 
pLOLA Amp100, (Cb100) - Ferrando et al 2000[224] 
pGEM-T Amp100, (Cb100) - Promega 
pGEX-5X-1 Ap100, (Cb100) - GE Healthcare 
pMAL-c Ap100, (Cb100) - New England Biolabs 
pET201 Ap100, (Cb100) - - 
pET201 is an unpublished vector similar to pET32 (Novagen). It is a thioredoxin-His6 double tagging bacterial 
expression vector, AmpR, IPTG inducible, driven by T7 promoter.  
 
 
2.1.3.2. Plasmid constructs 
 
2.1.3.2.1. Formerly published constructs 
PRL1-pMAL-c2 [59] 
AKIN10 pGEX-5X-1 [59] 
AKIN11 pGEX-5X-1 [59] 
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2.1.3.2.2. Newly prepared vectors and constructs 
 
AKINβ1-pGFP 
AKINβ2-pGFP 
AKINβ3-pGFP  
AKINβ1-pPCV812 
AKINβ2-pPCV812 
AKINβ3-pPCV812 
p3xtag vector 
TRX-AKIN11-PIPL  
AKIN10-p3xtag  
AKIN10 3x in pER8 binary vector 
AKIN11-p3xtag  
AKIN11 3x in pER8 binary vector 
AKINβ1-p3xtag 
AKINβ1 3x in pPCV002 binary vector 
AKINβ2-p3xtag 
AKINβ2 3x in pPCV002 binary vector 
AKINβ3-p3xtag 
AKINβ3 3x in pPCV002 binary vector 
GST-AKIN10-His in pGEX-5X-1 
GST-AKIN11-His in pGEX-5X-1 
TRX-AKIN10-His in pET201 
TRX-AKIN11-His pET201 
TRX-AKIN10 T175D -His in pET201  
TRX-AKIN11 T176D-His in pET201  
TRX-AKIN10 K48R-His in pET201  
TRX-AKIN11 K49R-His inpET201  
TRX-ABI5-His in pET201 
TRX-DPBF4-His in pET201 
TRX-ABI4-His in pET201 
TRX-EIN3-His in pET201 
GST- EIN3 in pGEX-5X-1 
MBP-EIN3-His in pMAL-c2 
TRX-CYCD1-His in pET201 
TRX-CYCD2-His in pET201 
TRX-CYCD3;1-His in pET201 
TRX-CYCD3;3-His in pET201 
TRX-IAA3-His in pET201 
TRX-IAA6-His in pET201 
TRX-IAA6 S39A-His in pET201 
TRX-IAA6 S39E-His in pET201 
TRX-IAA7-His in pET201 
TRX-CO-His in pET201 
TRX-CDF1-His in pET201 
TRX-HY5-His in pET201 
TRX-TIR1-His in pET201 
TRX-EBF1-His in pET201 
GST-EBF1 in pGEX-5X-1 
TRX-EBF2-His in pET201 
GST-EBF2 in pGEX-5X-1 
TRX-FKF1-His in pET201 
GST-FKF1 in pGEX-5X-1 
GST-ZTL in pGEX-5X-1 
TRX-AKINβ1-His in pET201 
TRX-AKINβ2-His in pET201 
TRX-AKINβ3-His pET201 
TRX-AKINβγ-His in pET201 
GST-AKINβγ in pGEX-5X-1 
TRX-TLK1-His in pET201 
TRX-TLK2-His in pET201 
TRX-AKIN10_280aa-His in pET201 
TRX-AKIN10_T175D_280aa-His in pET201 
TRX-AKIN10_340aa-His in pET201 
TRX-AKIN10 T175D_340aa-His in pET201 
IAA6 HA-pPILY 
IAA6 S39A HA-pPILY 
IAA6 S39E HA-pPILY 
IAA6 HA-pPCV002 
IAA6 S39A HA-pPCV002 
IAA6 S39E HA-pPCV002 
pUPRX vector 
IAA6-HA in pMenchu(SalI-) 
IAA6-HA in pUPRX 
IAA6-HA UPRX in pPCV002 
IAA7-HA in pMenchu(SalI-) 
IAA7-HA in pUPRX 
IAA7-HA UPRX  in pPCV002 
ABI5-HA in pMenchu(SalI-) 
ABI5-HA in pUPRX 
ABI5-HA UPRX in pPCV002 
EIN3-HA in pMenchu(SalI-) 
EIN3-HA in pUPRX 
EIN3-HA UPRX in pPCV002 
TIR1-HA in pMenchu(SalI-) 
TIR1-HA in pUPRX 
TIR1-HA UPRX in pPCV002 
EBF1-HA in pMenchu(SalI-) 
EBF1-HA in pUPRX 
EBF1-HA UPRX in pPCV002 
EBF2-HA in pMenchu(SalI-) 
EBF2-HA pUPRX 
EBF2-HA UPRX in pPCV002 
 
2.1.4. Plant material 
2.1.4.1. Arabidopsis thaliana wild type and mutant lines 
wild type: Col-0 ecotype 
AKIN10 GABI 579E09 
AKINβ1 SALK 235B06 
AKINβ1 SAIL 40A07 
AKINβ1 SALK 008325 
AKINβ1 Koncz 66465 
AKINβ1 Koncz 14344 
AKINβ2 SALK 037416 
AKINβ2 Koncz 87453 
SnAK1 SALK 000044 
SnAK1 SALK 015230 
SnAK2 SALK 142938 
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2.1.4.2. Arabidopsis cell suspension cultures  
All constructs were transformed into Arabidopsis plants, dark and green cell suspension cultures. 
35S-AKINβ1-GFP in pPCV812 (Hyg) 
35S-AKINβ2-GFP in pPCV812 (Hyg) 
35S-AKINβ3-GFP in pPCV812 (Hyg) 
35S-AKINβ1-PIPL-Strep-HA in pPCV002 (Km) 
35S-AKINβ2-PIPL-Strep-HA in pPCV002 (Km) 
35S-AKINβ3-PIPL-Strep-HA in pPCV002 (Km) 
estradiol inducible AKIN10-PIPL-Strep-HA in pER8 (Hyg) 
estradiol inducible AKIN11-PIPL-Strep-HA in pER8 (Hyg) 
35S-IAA6wt-HA in pPCV002 (Km) 
35S-IAA6S39E-HA in pPCV002 (Km) 
IAA6-UBRX in pPCV002 (Km) 
IAA7-UBRX in pPCV002 (Km) 
TIR1-UBRX in pPCV002 (Km) 
EIN3-UBRX in pPCV002 (Km) 
EBF1-UBRX in pPCV002 (Km) 
EBF2-UBRX in pPCV002 (Km) 
ABI5-UBRX in pPCV002 (Km) 
 
2.1.5. Arabidopsis cDNA libraries 
To obtain cDNA clones of plant genes, I have used several Arabidopsis cDNA libraries prepared from 
different starting materials: e.g., Arabidopsis suspension cultures, Arabidopsis roots, rosette leaves and 
stems; seedling and flowers. These libraries were either provided by other laboratories or prepared by 
in our group by former lab members. One frequently used library was prepared by Klaus Salchert in 
1997, where the cDNA products were cloned in fusion with the Gal4-DNA activation domain (GAD), 
using EcoRI (5’) and XhoI (3’) adaptors, in the plasmid pACT2 [225]. 
 
2.1.6. Oligonucleotides 
2.1.6.1. Oligonucleotides for cloning 
GFPfwd   5’-CGCCCATGGGTAAAGGAGAAGAAC-3’ 
GFPrev   5’-CGCGGATCCTTATTTGTATAGTTCATCCATG-3’ 
AKINβ1GFPfwd  5’-CCGCCATGGGAAATGCGAACGGC-3’ 
AKINβ1GFPrev  5’-GGGCCATGGGCCGTGTGAGCGGTTTGTAGAG-3’ 
AKINβ2GFPfwd  5’-GGGCCATGGGTAACGTGAACGCGAGAG-3’ 
AKINβ2GFPrev  5’-GGCCATGGTCCTCTGCAGGGATTTGTAGAG-3’ 
AKINβ3GFPfwd  5’-GCGCCATGGCGATGAACAGTCAAAATCCTGATG-3’ 
AKINβ3GFPrev  5’-CGCCCATGGGAACATTGGCGCTCCCTCTTC-3’ 
Piplfwd   5’-CCCGAATTCGGTCATGATGATCATCACC-3’ 
Piplrev   5’-GGCGAATTCTCAGTCATGGGTGTGATCATGAG-3’ 
3xtagfwd  5’-CGAAGCTTATGGTCGACAGATCTAGAGGTCATGATGATCATCACCATG-3’ 
3xtagrev  5’-GCGGATCCTTTTTCGAACTGCGGGTGGCTCCAGTCATGGGTGTGATCA 
TGAGAATG-3’ 
A10_3xfwd  5’-GGGGTCGACATGGATGGATCAGGCACAGGC-3’ 
A10_3xrev  5’-CCTCTAGAGAGGACTCGGAGCTGAGCAAG-3’ 
A11_3xfwd  5’-GGGGTCGACATGGATCATTCATCAAATAGATTTG-3’ 
A11_3xrev  5’-GGAGATCTGATCACACGAAGCTCTGTAAG-3’ 
AKINβ1_3xtag_fwd 5’-GGGGTCGACATGGGAAATGCGAACGGCAAAGAC-3’ 
AKINβ1_3xtag_rev 5’-GGGTCTAGACCGTGTGAGCGGTTTGTAGAGGAC-3’ 
AKINβ2_3xtag_fwd 5’-GGGGTCGACATGGGTAACGTGAACGCGAGAG-3’ 
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AKINβ2_3xtag_rev 5’-GGGTCTAGACCTCTGCAGGGATTTGTAGAGC-3’ 
AKINβ3_3xtag_fwd 5’-GGGGTCGACATGAACAGTCAAAATCCTGATG-3’ 
AKINβ3_3xtag_rev 5’-GGGTCTAGAAACATTGGCGCTCCCTCTTCTTTG-3’ 
MISI2   5’-GTTGGCTTGAGATCTCAATACCC-3’ 
MISI4   5’-GTGGCTATCTAGAATCCGAG-3’ 
MISI1   5’-CCCTGGGTCGACTCAGTGATGGTGATGGTGATGGAGGACTCGGAGCTGAGC-3’ 
MISI3   5’-CCCTGGGTCGACTCAGTGATGGTGATGGTGATGGATCACACGAAGCTCTG-3’ 
ABI5fwd   5’-GGCTCGAGATGGTAACTAGAGAAACGAAG-3’ 
ABI5rev  5’-CCCTCGAGGAGTGGACAACTCGGGTTCC-3’ 
DPBF4fwd  5’-CCCGCTAGCATGGGTTCTATTAGAGGAAAC-3’ 
DPBF4rev  5’-GGGGTCGACGAGAGAAGCAGAGTTTGTTCG-3’ 
ABI4fwd  5’-GCGGGATCCATGGACCCTTTAGCTTCCCAACAT-3’ 
ABI4rev  5’-GGCGTCGACATAGAATTCCCCCAAGATGGGATC-3’ 
EIN3_pGEX_fwd 5’-CGCGGATCCTTATGATGTTTAATGAGATGGGAATG-3’ 
EIN3_pMAL_fwd 5’-GGGGGATCCATGATGTTTAATGAGATGGGAATG-3’ 
EIN3_pMAL_rev  5’-GGGGTCGACTCAGTGGTGGTGGTGGTGGTGGAACCATATGGATACATCTTG-3’ 
CYCD1fwd  5’-GGCTCGAGATGAGGAGTTACCGTTTTAGTG-3’ 
CYCD1rev  5’-CCCTCGAGATTAGAGGTAGATGTTTCATCACC-3’ 
CYCD2fwd  5’-GGCGGGGATCCAGCTGAGAATCTTGCTTGTG-3’ 
CYCD2rev  5’-CCGCGTCTAGAAACAAAAGAGGAGGAGAAC-3’  
CYCD3;1fwd  5’-GGCGGGTCGACGGCGATTCGGAAGGAGG-3’ 
CYCD3;1rev  5’-CCGCGCCATGGACCTCACCGATGCTAAC-3’ 
CYCD3;3fwd  5’-GGCTCGAGATGGCTTTAGAAGAGGAGGAAG-3’ 
CYCD3;3rev  5’-CCCTCGAGGCGAGGACTACTACTAAGCAC-3’ 
IAA3fwd  5’-CCCGTCGACATGGATGAGTTTGTTAACCTC-3’ 
IAA3rev  5’-CCCCTCGAGTACACCACAGCCTAAACCTTT-3’ 
IAA6fwd  5’-GCGGGCCATGGCAAAGGAAGGTCTAG-3’ 
IAA6rev  5’-GCGCGAGATCTATCTTGCTGGAGACCAAAAC-3’ 
IAA7fwd  5’-GCGCAAGCTTATGATCGGCCAACTTATGAACCTCAAG-3’ 
IAA7rev  5’-CCCTCGAGAGATCTGTTCTTGCAGTACTTC-3’ 
COfwd   5’-GCGGGATCCGTTGAAACAAGAGAGTAACGAC-3’ 
COrev   5’-CGCAAGCTTGAATGAAGGAACAATCCC-3’ 
CDF1fwd  5’-GGGGTCGACATGGAGACTAAGTTCTGTTAC-3’ 
CDF1rev  5’-GGGGTCGACCATCTGCTCATGGAAATTGATTG-3’ 
HY5fwd  5’-CCCTCGAGATGCAGGAACAAGCGACTAGCTC-3’ 
HY5rev   5’-CCCTCGAGAAGGCTTGCATCAGCATTAGAAC-3’ 
EBF1_pGEX_fwd 5’-CGCGGATCCTTATGTCTCAGATCTTTAGTTTTG-3’ 
EBF2_pGEX_fwd 5’-CGCGGATCCTTATGTCTGGAATCTTCAGATTTAG-3’ 
FKF1fwd  5’-CCGTCGACATGGCGAGAGAACATGCGATC -3’ 
FKF1rev  5’-GGGTCGACCAGATCCGAGTCTTGCCGGCTAG -3’ 
AKINβ1fwd  5’-GCGCGCCATGGGAAATGCGAACGGC-3’ 
AKINβ1rev  5’-GCGCGGGATCCCCGTGTGAGCGGTTTGTAG-3’ 
AKINβ2fwd  5’-GGGGTCGACATGGGTAACGTGAACGCG-3’ 
AKINβ2rev  5’-GCGGTCGACCCTCTGCAGGGATTTGTAG-3’ 
AKINβ3fwd  5’-CCCGTCGACGATGAACAGTCAAAATCCTGATG-3’ 
AKINβ3rev  5’-GCGGGATCCAACATTGGCGCTCCCTCTTCTTTG-3’ 
AKINβγfwd  5’-CGCGCTAGCATGTTTGGTTCTACATTGGAT-3’ 
AKINβγrev   5’-GGGAAGCTTAAGACCGAGCAGGAATTGG-3’ 
AKINβγ_pGEX_fwd 5’-CGCGGATCCTTATGTTTGGTTCTACATTGG-3’ 
AKINβγ_pGEX_rev  5’-GGGGTCGACAAGACCGAGCAGGAATTGG-3’ 
TLK1fwd  5’-GGGGTCGACATGTTTCGTGATAGTTTTTTG-3' 
TLK1rev  5’-GCGGTCGACGTTAGGATCTGAGGTTTCAG-3’ 
TLK2fwd  5’-CCCGTCGACATGTTTTGTGATAGTTTTGCC-3’ 
TLK2rev  5’-GCGGTCGACGCTATGGTTTTGATCTTCTTC-3’ 
AKIN10_280_rev 5’-GGGGTCGACAGCTAAATACCTCGGAAGATG-3’ 
AKIN10_340_rev 5’-CCCCTCGAGACCACTAGAGGCACGGAAAC-3’ 
AKIN10fwd  5’-CGCGTCGACATGGATGGATCAGGCAC-3’ 
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IAA6_fwd_Pily  5’-GCGGGCCATGGCAAAGGAAGGTCTAG-3’ 
IAA6_rev_Pily  5’-GCGCGAGATCTATCTTGCTGGAGACCAAAAC-3’ 
IAA6_UBR_fwd  5’-GCGCGCCATGGGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
GCAAAGGAAGGTCTAG-3’ 
IAA6_UBR_rev  5’-GCGCGAGATCTATCTTGCTGGAGACCAAAACC-3’ 
IAA7_UBR_fwd  5’-GCGCGAAGCTTGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
ATCGGCCAACTTATGAAC-3' 
IAA7_UBR_rev  5’-GCGCGAGATCTGTTCTTGCAGTACTTC-3’ 
ABI5_UBR_fwd  5’-GGCCGGGATCCGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
GTAACTAGAGAAACGAAGTTG-3’ 
ABI5_UBR_rev  5’-GCGCGGATCCGAGTGGACAACTCGGGTTCCTC-3’ 
EIN3_UBR_fwd  5’-GCGCGCCCATGGGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
ATGTTTAATGAGATGGGAATG--3’ 
EIN3_UBR_rev  5’-GGCGGGGATCCGAACCATATGGATACATCTTG-3’ 
TIR1_UBR_fwd  5’-GCGCGAGATCTGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
CAGAAGCGAATAGCCTTG--3’ 
TIR1_UBR_rev  5’-GCGCGAGATCTTAATCCGTTAGTAGTAATGATTTGC-3’ 
EBF1_UBR_fwd  5’-GGCCGCCATGGGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
TCTATCTTTAGTTTTG-3’ 
EBF1_UBR_rev  5’-GGCGGGGATCCGGAGAGGATGTCACATTTG-3’ 
EBF2_UBR_fwd 5’-GGCCGCCATGGGTCGACCTTACATCTTGTCTTAAGACTTAGAGGTGGTATG- 
TCTGGAATCTTCCAGATTTAG-3’ 
EBF2_UBR_rev  5’-GGCGGGGATCCGTAGAGTATATCGCACCTC-3’ 
 
2.1.6.2. Oligonucleotides for sequencing 
pETF      5’-TAATACGACTCACTATAGG-3’ 
pETR      5’-CTAGTTATTGCTCAGCGG-3’ 
35S promoter primer    5’-TCCTTCGCAAGACCCTTCCTCTAT-3’ 
nosT(R)     5’-GCAAGACCGGCAACAGGATT-3’ 
GEX5      5’-GGGCTGGCAAGCCACGTTTGGTG-3’ 
GEX3      5’-CCGGGAGCTGCATGTGTACAGAGG-3’ 
AKIN10midrev (559-539bp in AKIN10) 5’-CTGGAGCGGCATAATTTGGAC-3’ 
AKIN10midfwd (409-429bp in AKIN10) 5’-AACATGGTGTTCACAGAGAC-3’  
AKIN10endfwd (1078-1102bp in AKIN10) 5’-GAAAGCGTTGCTTCACCTGTTAGC- 3’ 
AKIN11midrev (559-539bp in AKIN11) 5’-CGGGAGCAGCGTAGTTGGGGC-3’ 
AKIN11midfwd (417-437bp in AKIN11) 5’-TGTCCATAGAGACCTGAAGCC-3’  
AKIN11endfwd (951-974bp in AKIN11) 5’-CAACAGAACACAAAACGATGCTAC-3’ 
 
 
2.1.6.3. Oligonucleotides for site-directed mutagenesis 
AKIN10 T175D   Pho5’---GATGGTCATTTTTTGAAG GAC AGTTGTGGAAGTCCAAATT---3’ 
AKIN10 K48R  Pho5’---GGACATAAGGTTGCTATC CGG ATCCTCAATCGTCGCAAAATC ---3’ 
AKIN11 T176D  Pho5’---GATGGTCATTTTCTAAAG GAC AGTTGTGGAAGCCCCAAC---3’ 
AKIN11 K49R   Pho5’---GGGCATAAGGTTGCTATC CGA ATCCTTAATCGTCGTAAG ---3’ 
IAA6 S39A     Pho5’---AAGAAGAAGAGGGTGCTC GCT GATATGATGACCTCATCAG---3’ 
IAA6 S39E     Pho5’---AAGAAGAAGAGGGTGCTC GAG GATATGATGACCTCATCA---3’ 
pET201 AfeI-   Pho5’---CTCAGGGTCAATGCCA GAG CTTCGTTAATACAGATG---3’ 
 
2.1.6.4. Oligonucleotides for T-DNA insertion mutant screens and RT-PCR 
2.1.6.4.1. screening primers 
AKIN10 5’   5'-TCATTTCTGAATCGGGTACGAGAGAT-3' 
AKIN10 3’  5'-CAGGCGACGACACGAAGCGAGTTT-3' 
AKINbeta1 5' 5'-GACCATCTCTATTCTAACCCCACC-3' 
AKINbeta1 3' 5'-GGTTACCGTGTGAGCGGTTTGTAG-3' 
MATERIALS and METHODS   33 
AKINbeta2 5' 5'-GAAGCTTCAGATCACGACTTGTTCC-3' 
AKINbeta2 3' 5'-ATCACGGGCTCAGCAGGTTGGTTCAG-3' 
AKINbeta3 5’ 5’-AGTCTGAGAAGCATAGACAAGGAGTGAAG-3’ 
AKINbeta3 3’   5’-TACAAACAAACAATGCCCACGTCTATCAGC-3’ 
SnAK1 5' 5'-TTGAAGCCCTCGAAACCCCTTTTATC-3' 
SnAK1 3' 5'-AGCTATGGTCTCCTGGACGCACACAA-3' 
SnAK2 5' 5'-CATTTCTTCTCATGTGCCATGGATATTG-3' 
SnAK2 3' 5'-TTGGAGTTGATTTTGGCCGTTTTACCC-3'  
SALK LB 5'-TTTGGGTGATGGTTCACGTAGTGGG-3'  
FISH1  5'-CTGGGAATGGCGAAATCAAGGCATC-3' 
FISH2  5'-CAGTCATAGCCGAATAGCCTCTCCA-3' 
GABI RB  5’-TTCCATTGCCCAGCTATCTGTCAC-3’ 
 
2.1.6.4.2. RT-PCR primers 
AKINβ1 5’ RTPCR:        5’-GGTAGCGGTGGTGCAGATGTTACCTC-3’ 
AKINβ1 3’ RTPCR:        5’-GTGGCACTGAATTTTTAGGGTTACCGTGT-3’ 
AKINβ2 5’ RTPCR:        5’-GCTGAGATTTGTTCCTCGTGAAGCTATGT-3’ 
AKINβ2 3’ RTPCR:        5’-GAATTGCATCATCTTCACTCACCTCTGC-3’ 
FISH1 (LB)               5'-CTGGGAATGGCGAAATCAAGGCATC-3' 
FISH2 (RB)                 5'-CAGTCATAGCCGAATAGCCTCTCCA-3' 
tubulin fwd (At5g62690) 5’-AGGAACTGGATCTGGTATGGGAACAT-3’ 
tubulin rev     5’-GTCACACCAGACATAGTAGCAGAAATCAAG-3’ 
 
 
2.2. GROWTH MEDIA AND STOCK SOLUTIONS 
2.2.1. Stock solutions 
2.2.1.1. Antibiotics 
Antibiotics Stock solution mg/ml Working concentration 
µg/ml 
Ampicillin 50 in water 100 
Carbenicillin 50 in water 100 
Kanamycin 100 in water 25 (for Arabidopsis 50-100) 
Tetracyclin 15 in 50% ethanol, light sensitive 25-50 
Spectinomycin 50 in water 50 (in Agrobacterium 100) 
Chloramphenicol 25 in ethanol 25 
Streptomycin 50 in water 50 
Hygromycin B 15 in water 15 (for E.coli 50) 
Sulphadiazine 7,5 in water 15  
Cefotaxime sodium 
(Claforan) 
200 in water 200 
Ticarcillin disodium mixture 
15:1 & 
Potassium Clavulanate  
150 in water 150 
Rifampicin 25 in methanol 100 Agrobacterium 
Gentamycin 25 in water 25 Agrobacterium 
Antibiotics stock solutions were sterilized by filtration through Millipore filters of 22µm pore size. 
 
 
 
2.2.1.2. Plant hormones 
 
All hormone solutions were filter sterilized and stored at -20oC. 
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Hormone Solvent Stock 
abscisic acid (ABA)  1mg/ml in methanol 
1-naphtyl-acetic acid (NAA) 1N KOH 1mg/ml in water 
2,4 dichlorophenoxy acetic acid (2,4D)  2mg/ml in ethanol 
kinetin 1N NaOH 1mg/ml in water 
 
 
2.2.1.3. Protease inhibitors 
Material Stock Working concentration 
PMSF 200mM in ethanol 1mM (half life time in water is 
approximately 30 min) 
leupeptin 1mg/ml in water 5μg/μl 
aprotinin 1mg/ml in water 1μg/μl 
benzamidine hydrochloride 50mM in water 1mM 
pepstatin 1mg/ml in water 1μg/μl 
 
 
2.2.1.4. Other stock solutions 
Material Stock Working concentration 
β-estradiol 10mM in DMSO 5-20 μM 
MG-132 50mM in DMSO 20-50 μM 
IPTG 1M in water 1mM 
NaF phosphatase inhibitor 2M 50 mM 
Na3VO4 phosphatase inhibitor 200mM 0,2 mM 
EtBr 10mg/ml in water 250μg/l 
 
 
2.2.2. Culture media 
2.2.2.1. LB medium 
(Luria-Bertani medium)  
 
Bacto-tryptone   10g 
Bacto-yeast extract  5g 
NaCl    10g  
   1 liter  
 
The components are dissolved by strirring and the pH is adjusted to 7.2 with 5N NaOH (approx. 0.2 
ml). Upon adjusting the volume to 1 liter with distilled water, the medium is autoclaved for 20 
minutes. If desired, solidified medium is prepared by adding 6.4g of agar powder before autoclaving. 
Antibiotics are added after sterilization, when the temperature of the medium decreases to 
approximately 50°C. 
 
2.2.2.2. YEB medium 
 
Beef extract   5g 
Yeast extract   1g 
Peptone   5g 
Sucrose   5g 
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   1 liter 
The pH is adjusted to 7.2, and add 18 g bacto-agar is added optionally for solidified medium. The 
medium is autoclaved for 20 minutes. After autoclaving the YEB medium is supplemented with filter-
sterilized MgCl2 to a final concentration of 1.4 mM. (Stock solution of MgCl2 is 2M.) 
 
2.2.2.3. Culture medium for root-derived dark grown Arabidopsis cell suspension culture 
 
- 4.3g/l MS basal salt mixture  
- 30g/l sucrose (87 mM final concentration, isotonic to 90mM sorbitol (18g/l). If desired isotonic low 
sugar medium is prepared with 5g sucrose (14.5mM) plus 14.5g sorbitol (72.5mM) 
for 1l medium 
- 4 ml/l 100x stock B5 vitamin (filter-sterilize and store at 4oC):   
- Nicotinic acid 1mg/ml 
- Pyridoxin HCl 1mg/ml 
- Thiamine HCl 10mg/ml 
- Myo-inositol 100mg/ml 
After adjusting the pH to 5.8 with 0.5M KOH the medium is sterilized by autoclaving for 20 min. 
Sterile stock solution of  2,4D is added to final concentration of 1mg/l. (Stock 2mg/ml dissolved in 
0.5M KOH and adjusted to pH 6-7 with HCl, filter sterilized and stored at 4oC.) 
 
2.2.2.4. Culture medium for leaf-derived light-grown green (photosynthetic) Arabidopsis 
cell suspension culture 
- 4.4g/l MSMO (Sigma M6899) 
- 30g/l sucrose 
The pH is adjusted to 5.7 with 0.5M KOH. The medium is sterilized by autoclaving for 20 min and 
after cooling it down to room temperature supplemented with hormones: α Naphtaleneacetic acid to 
0.5mg/l and kinetin 0.1mg/l final concentrations. 
 
2.2.2.5. Culture medium for Arabidopsis seedlings 
MSAR medium [223]:  Macroelements 25.0 ml/l 
      Microelements 1.0 ml/l 
      Fe-EDTA  5.0 ml/l 
      CaCl2·2H2O  5.8 ml/l 
      KI   2.2 ml/l 
      B5 vitamin  2.0 ml/l 
      sucrose  5g/l 
 
pH is adjusted to 5.8 with 1M KOH and 0.6 g/l phytoagar is added 
 
Macroelements: 20g/l NH4NO3, 40 g/l KNO3, 7.4 g/l MgSO4·7H2O, 3.4 g/l KH2PO4,  
2 g/l Ca(H2PO4)2·H2O  
 
Microelements: 6.2g/l H3BO4, 16.9 g/l MnSO4·4H2O, 8.6 g/l ZnSO4·7H2O,  
0.25 g/l Na2MoO4·2H2O, 0.025 mg/l CuSO4·5H2O,  
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0.025 mg/l CoCl2·6H2O 
 
Fe-Na2-EDTA: 5.56 g/l FeSO4·7H2O, 7.46 g/l Na2-EDTA·2H2O 
KI:   375 g/l KI 
CaCl2:   75 g/l CaCl2·2H2O 
 
 
2.3. METHODS 
2.3.1. DNA methods  
2.3.1.1. Precipitation of DNA with ethanol or isopropanol 
DNA is precipitated in the presence of 0.3M final concentration of sodium acetate (pH 6.0) with either 
1 volume isopropanol for 30 min at room temperature or on ice, or with 2 volume ethanol for at least 
20 minutes at -20oC and then collected by centrifugation at 14000rpm in a benchtop centrifuge. The 
DNA pellet is washed two times with 400µl 70% ethanol and finally with 200µl absolute ethanol. The 
pellet is dried in vacuum desiccator and dissolved in sterile distilled water. 
 
2.3.1.2. Plasmid DNA miniprep (Alkaline lysis method) 
(Sambrook et al 1989 [226], modified): 
- Harvest 1.5ml of overnight grown bacterial culture by centrifugation at 8000rpm in a tabletop 
centrifuge. 
- Resuspend the bacterial pellet in 200µl Solution I 
- Add 200µl Solution II. Mix the contents gently by inverting the tube many times. 
- Add 200µl Solution III. Mix the contents gently, precipitation of protein occurs. 
- Centrifuge at 13000 rpm for 10 minutes in a tabletop centrifuge at room temperature 
- Decant the supernatant into a new tube. 
- Add 1 vol isopropanol or 1ml ethanol and mix gently. (Optional: for a compact pellet place 
the tube for 20 minutes to -20oC, otherwise the precipitate might spread on the inner wall of 
the microcentrifuge tube.) 
- Centrifuge at 13000 rpm for 10 minutes preferentially at 4oC. 
- Wash the pellet two times with 400µl 70% ethanol and finally with 200µl absolute ethanol. 
- Dry the pellet at 37oC. 
- Dissolve the pellet in 50µl redistilled water 
Solution I: 50mM glucose, 25 mM Tris-HCl (pH 8.0), 10mM EDTA  
Solution II: 0.2N NaOH (freshly diluted from a 10N stock), 1% SDS 
Solution III: 3M sodium acetate pH 4.8 (Adjust pH with glacial acetic acid. The resulting solution 
will be 3M with respect to sodium and 5M with respect to acetate.). 
 
 
 
 
 
MATERIALS and METHODS   37 
2.3.1.3. Peqlab E.Z.N.A. miniprep kit 
This kit was used only to extract plasmid DNA for sequencing, where higher quality is advisable. 
From 5ml well grown bacterial suspension, if eluted in 50µl water, 100υg/µl plasmid concentration is 
attainable. 
2.3.1.4. Plasmid DNA maxiprep by CsCl gradient ultracentrifugation 
(based on Sambrook et al, 1989 [226]) 
- Inoculate 1l or more LB medium with an overnight culture of E. coli containing the required plasmid 
DNA 
- Incubate it in a shaker at 37oC for 16 hrs (reaching stationary phase of growth) 
- Centrifuge bacteria in a Beckman centrifuge at 6000g for 6 min (250ml tubes) 
- Suspend the pellet 30ml solution I (50mM glucose, 25mM Tris-Cl pH 8.0, 10mM EDTA pH 8.0)  
- Add 60ml of freshly prepared solution II (0.2N NaOH, 1% SDS). Mix well but gently till full lysis of 
bacteria (5-10 min) 
- Add 45ml of solution III (3M NaOAc pH 4.8) and incubate the solution for 30 min on ice. Invert the 
tube many times gently while precipitate forms 
- Centrifuge in GSA rotor at 12000 rpm at 4oC for 20 min 
- Filter the supernatant through Miracloth into a new Beckman tube  
- Add 100ml of 2-propanol and mix gently. Keep the tubes on ice for 30min.  
- Centrifuge at 12000 rpm in a GSA rotor for 20 min. The pellet contains the plasmid DNA 
- Pour off the supernatant and wash the pellet with 70% ethanol then with abs. ethanol, and dry the 
pellet in vacuum (not completely because then it takes longer to dissolve it) 
- Dissolve the pellet in 23.3ml THE buffer (50mM Tris.HCl, 20mM EDTA pH 8.0) and after it has 
dissolved add 24.00g CsCl 
- Fill the DNA solution into a Quick-seal ultracentrifuge tube and add 600μl 10mg/ml EtBr solution, 
the fill up the tube with 1.00g/ml CsCl solution (approx. 8,5ml). Balance the tubes with accuracy 
- Centrifuge at 45000rpm in a VTi55 rotor at 20oC for 14-16 hrs in a Beckman ultracentrifuge 
- Take the DNA band in 5ml (visualised with 365nm UV light) 
- Fill it in 5ml Quick-seal tube, balance the tubes and seal them, and then run at 55000rpm in a VTi65 
rotor at 20oC for 4-6 hrs 
- Collect the DNA band and transfer it to eppendorf tubes 
- Remove EtBr by adding 300μl of isoamyl alcohol saturated with 20xSSC (do this step in the 
chemical hood), shake it and centrifuge in a tabletop centrifuge at 8000rpm for 1min. EtBr passes to 
the organic phase (upper layer). Repeat the extraction 4-5 times while the DNA solution becomes 
colorless 
- Split the DNA solution into 300μl aliquots in eppendorf tubes and add to each 300μl sterile distilled 
water, 60μl 3M NaOAc pH 6.0, and 420μl (0.7volume) 2-propanol. Mix gently by inverting the tubes 
and precipitate the DNA for 1h at room temperature. 
- Collect the DNA by centrifugation for 15min at 13000rpm in a benchtop centrifuge 
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- Wash the pellet with 70% ethanol then with abs. ethanol and dry 
- Dissolve the DNA in 100-200μl sterile distilled water and measure OD at 260nm. (1 Abs equals to 
50μg/ml DNA concentration)  
 
2.3.1.5. Restriction endonuclease digestion of DNA  
Generally, restriction endonucleases from the New England Biolabs company were used in 
combination with appropriate buffer sets. In a plasmid analysis reaction, the following components 
were used: 
4µl plasmid DNA (as written above) 
2µl buffer 
2µl RNase 
2µl BSA (if the enzyme requires for stability in solution) 
10µl redistilled water 
0.2µl restriction endonuclease 
The reactions were incubated for 2 hours at 37oC, unless the enzyme required other special condition. 
 
2.3.1.6. Preaparation of DNase free RNase 
Pancreatic RNase (RNase A) was dissolved at a concentration of 10mg/ml in 0.01M sodium acetate 
(pH 5.2) and heat treated at 100oC for 15 minutes. After cooling the solution slowly to room 
temperature the pH was adjusted by adding 0.1 volumes of 1M Tris-HCl (pH 7.4) and the RNase stock 
was dispense into aliquots and stored at -20oC. 
 
2.3.1.7. Phenol-chloroform purification of DNA samples 
The standard way to remove protein contaminations from nucleic acid samples is protein extraction 
with a mixture of phenol and chloroform, then in a second step with chloroform alone. The method 
takes advantage of the fact, that deproteinization is more efficient in the presence of two organic 
solvents instead of one alone. Although phenol denatures proteins very effectively, it does not 
completely inhibit RNase activity and is a solvent for RNA molecules that contain long poly(A) tracts. 
Both problems can be prevented by adding isoamyl-alcohol in a 25:24:1 ratio 
(phenol:chloroform:isoamyl-alcohol). Pure phenol is crystalline, which can dissolve about 8% water. 
Phenol is pre-equilibrated to pH 8.0 prior to use which prevents DNA losses (DNA tends to participate 
to the phenolic phase when using acidic phenol) and saturates phenol with water. Optionally 0.1% 
hydroxyquinoline can be added, which indicates oxidation by changing its color from yellow to 
reddish. Oxidation, which might lead to DNA damage, can be prevented by keeping phenol under a 
layer of 2mM β-mercapto-ethanol in Tris-HCl pH 8.5. During phenol extraction an equal volume of 
phenol:chloroform mixture is added to the sample and mixed thoroughly until an emulsion is formed. 
The sample is centrifuged in a tabletop microcentrifuge at 13000 rpm for 10 min. Normally the 
aqueous phase forms the upper layer, which is carefully removed by a micropipette, not disturbing the 
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potentially cloudy interphase, which might contain precipitated proteins. Discard the organic phase 
and the interphase. Repeat this extraction until no protein precipitate is visible in the interphase. After 
extraction is complete, the lingering amount of phenol is removed by extracting the sample with an 
equal amount of chloroform. Finally DNA is collected by alcohol precipitation. 
 
2.3.1.8. Polymerase chain reaction 
For amplification of DNA fragments recombinant Taq polymerase was used from Invitrogen. 
Generally 32 PCR cycles were peformed. The Tm value of oligonucleotide primers was calculated by 
the manufacturer, but normally the following rough calculation was used: Tm = 4x(G+C)+2x(A+T).  
Ingredients of the PCR reaction mixture for 100 μl: 
  3 μl 50mM MgCl 
  2 μl 10mM (each) dNTP mixture 
  1 μl template DNA 
  10 μl buffer 
  5 μl primer mix, 10 μM each 
  1 μl Taq polymerase 
  78 μl destilled water 
 
The reactions were carried out in 10-20 μl for analysis and in 100 μl for cloning a PCR fragment. The 
following program scheme was followed: 
 
  1. initial denaturation   95oC  5 min 
  2. denaturation  95oC  30 sec     
  3. primer annealing  Tm  30 sec 
  4. chain extension  72oC 1min/kb DNA fragment length    
  5. final extension  72oC  10min 
                     ( 6. storage    4-15oC) 
 
 
2.3.1.9. Agarose electrophoresis of DNA 
The concentration of agarose gel varies depending on the size of DNA fragments, which should be 
separated. 1g/100ml agarose concentration was used for most fragments up to 5kb, whereas above 5kb 
0.8g/100ml gel was poured. The measured amount of agarose powder was filled up with the necessary 
vo1ume of 1xTAE buffer supplemented with 250μg/l ethidium bromide, and dissolved by warming in 
a microwave oven for a few minutes. The solution was allowed to cool down to approximately 50oC 
then poured into a tray formerly sealed by both ends by scotch tape and equipped by electrophoresis 
combs. The solidified gel was immersed into 1xTAE buffer in a gel tank (Horizon 11-14 GibcoBRL). 
The DNA samples were supplemented with 6x loading dye and pipetted into the gel wells. As a 
molecular size marker generally the 1kb DNA ladder from Invitrogen was used. For separation of 
DNA fragments 80V voltage was applied. DNA bands were visualized using a UV light 
transilluminator (TFX35M Gibco BRL) at 254nm except for the recovery of DNA bands for cloning 
[    32x 
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when the less destructive 365nm wavelength was used. Gel images were captured by an imaging 
system consisting of a Kodak DC-120 zoom digital camera and the Kodak Digital Science 1D V 3.0.2. 
software. 
 
1xTAE buffer 50X stock solution 
40mM Tris-acetate (pH 8.0) 242g Tris base 
1mM EDTA 57.1 ml glacial acetic acid 
 100ml of 0.5M EDTA 
 Do not adjust pH 
 
6x loading dye: 50% glycerol, 10mM Tris.HCl (pH 8.0), 1mM EDTA, 0,25% bromophenol blue 
 
2.3.1.10. Preparation of dialysis tube 
Unrolled dialysis tube was boiled in large volume of 1mM EDTA (pH 8.0) and 2% (w/v) sodium 
bicarbonate buffer for 10 minutes using a ballast (Erlenmeyer flask with water) to keep the tubes 
immersed. The liquid may become yellowish. Rinse the tubing thoroughly in distilled water and boil 
the tubes again for 10 minutes in 1mM EDTA. Allow the tubing to cool and then store it at 4oC. From 
this point onward handle the tubing with gloves. Before use wash it inside and out with distilled water. 
 
2.3.1.11. Recovery of DNA fragments from agarose gel 
Separate sufficient amount of DNA fragments on agarose gel (generally few micrograms). It is useful 
to bind more wells with scotch tape to create a large well, in which the DNA runs more dispersed what 
prevents trailing and overlapping. Visualize by ethidium bromide staining and exposure to 365nm UV 
light, which does minimal damage on DNA (in contrast to 254υm). Cut out the required DNA bands 
with a scalpel using minimum of gel size. Put the gel slice into a suitable sized dialysis tube with 
forceps, fill it sterile TAE buffer leaving no bubbles, close the ends with medical clips and place it to 
the agarose electrophoresis running chamber. Run until the band leaves the gel completely and reverse 
the current for 15 sec to release the DNA from the wall of dialysis tubing. (It can be checked with 
365nm UV light without opening the tube.) The DNA solution is removed with a pipette and subjected 
to phenol-chloroform extraction and i-propanol or ethanol precipitation.  
 
2.3.1.12. Measurement of nucleic acid concentration ad purity  
DNA concentration is measured photometrically at OD260 (1 unit equals to 50μg/ml double stranded 
DNA concentration or 40μg/ml RNA concentration). The OD260/OD280 ratio should be approximately 
1.8 in pure nucleic acid samples. 
 
2.3.1.13. Dephosphorylation of DNA 5’ ends  
Dephosphorylation prevents self-ligation of linear plasmid DNA vectors. The dephosphorylation is 
carried out using Antarctic Phosphatase from NEB following the manufacturer’s instructions. I used 
1µl of enzyme in 20µl reaction volume for 1h duration. The enzyme can be heat inactivated in contrast 
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to calf intestinal phosphatase, whose activity can be safely removed only by an additional phenol-
chloroform purification step. After dephosphorylation, the DNA was concentrated by ethanol 
precipitation. 
 
2.3.1.14. Creating blunt ended DNA 
For creating blunt ended DNA fragments by 3’ overhang removal or 3’ recessed end filling I used T4 
DNA polymerase (NEB) according to the protocol given in the manufacturer’s catalog. 
Reaction conditions: 
 1x NEBuffer 2  
 Supplemented with 100µM dNTPs 
 1 unit of T4 DNA polymerase per μg DNA  
 1xBSA (provided by NEB) 
 
 Incubate at 12oC for 15 minutes 
 Stop reaction by adding EDTA to a final concentration of 10mM 
 Heat inactivation of enzyme by incubating at 75oC for 20 minutes 
In addition to heat inactivation, I usually further purified the DNA fragment by phenol-chloroform 
extraction. 
 
2.3.1.15. Dialysis of DNA samples 
Dialysis of DNA may be necessary before electroporation of ligated DNA to eliminate salts. It is a 
good alternative of alcohol precipitation when a buffer exchange is needed (e.g. two subsequent 
restriction endonuclease digests). A Millipore nitrocellulose filter disk (type VSWP, pore size 
0,025µm diameter 25mm) is placed on the surface of deionized water so that one side remain dry. The 
dialyzing DNA solution is pipetted on the upper face of the disk. The dialysis is complete in one hour 
then the solution can be removed with a pipette. In case the dialysis follows digestion with an 
endonuclease which cannot be inactivated by heat, the dialysis can be carried out at 4oC. 
 
2.3.1.16. Ligation of DNA ends 
For ligation NEB T4 DNA ligase was used with the supplied buffer. The buffer contains ATP, which 
is essential cofactor of T4 DNA ligase. The reaction was usually carried out in 10µl final volume using 
1µl of T4 DNA ligase, and an approximate vector to insert concentration ratio of 1:3 that was 
determined from band intensity by agarose gel electrophoresis. Generally the reaction was incubated at 
14°C overnight, or for blunt end ligation for 2h at room temperature and then overnight at 12°C. 
 
2.3.1.17. Preparation of electrocompetent E. coli cells 
Streak out the selected E. coli strain onto an LB agar plate containing the corresponding antibiotics, if 
the strain has any antibiotics resistance. Grow it for 12 hours at 37oC. With a sterile toothpick, 
MATERIALS and METHODS   42 
inoculate a single bacterial colony in 5ml liquid LB medium, including the antibiotics, in a test tube. 
Grow it overnight at 37oC in a shaker with 160rpm or in a rotator. Inoculate with the overninght 
culture 500ml LB medium without antibiotics in a sterile 2 l Erlenmeyer flask and grow at 37oC at 
160rpm shaking until the optical density at 600 nnm reaches 0.4-0.5. Harvest the cells in sterile 200ml 
Beckman centrifuge tubes (cap and tube wrapped in alufoil and autoclave separately) in a Sorvall 
centrifuge in a GSA rotor or compatible at 6000rpm (approx. 6000g) at 4oC for 6 minutes. Gently 
resuspend the bacterial pellet in ice cold, sterile deionized water, and centrifuge again with the same 
parameters. Repeat the washing step twice more then resuspend the pellet in 1-2ml ice-cold 10% 
glycerol or 10% DMSO in sterile deionized water, and aliquot in eppendorf tubes in 50-80µl 
quantities. Snap freeze the aliquots in liquid nitrogen and store at -80oC. 
 
2.3.1.18. Transformation of Escherichia coli by electroporation 
After thawing a frozen aliquot of E. coli electrocompetent cell on ice, the dialyzed DNA solution is 
added to the bacteria and mixed gently with a pipette. The mixture is transferred into a sterile 
transformation cuvette (Peqlab, 2mm) pre-chilled on ice. An electric pulse is applied (in BioRad Gene 
Pulser electroporator) with the following settings: voltage = 2.5kV, capacitance = 25μF, resistance = 
200Ω. After the pulse 600µl LB medium is added and the bacterial suspension is transferred into a 
glass test tube and shaken in a thermostat at 37°C for 30 minutes. When the incubation period is over, 
different aliquots are streaked out on LB plates containing the proper antibiotics. If a ligation mixture 
is transformed, usually 50μl is streaked out, in case of plasmid DNA 5μl or less. 
 
2.3.1.19. Transformation of Agrobacterium tumefaciens 
Transformation of Agrobacterium cells is performed by electroporation for which the protocol is 
basically the same as for E.coli. The main differences are that Agrobacterium cells are grow on 28oC 
in YEB medium. It takes approximately 3 days while Agrobacterium cell grow out on a plate. Plasmid 
preparation from Agrobacterium is not convenient because of low yield. The analysis of agrobacterial 
plasmid content can be facilitated by heating the miniprep solution in the lysis phase to 55oC for a few 
minutes. The extracted plasmid DNA is analyzed by the polymerase chain reaction or transformed into 
E.coli for further analysis after a plasmid extraction. An alternative Agrobacterium transformation 
method is conjugation with E.coli cells, which works in both directions. In the conjugation donor S17-
1 (SmR) E.coli strain is used with GV3101(pMP90RK) Agrobacterium host cells. Both cell types are 
grown to mid-log phase, then centrifuged and resuspended in 0.5 ml antibiotics free medium then 
mixed with each other. Always that medium is used which is required for the recipient bacterium, 
during the transfer of plasmid DNA from E.coli into Agrobacterium the medium is YEB. 50μl 
amounts from the bacterium mixture are pipetted on the surface of a plate with the corresponding 
medium and let evaporated by leaving the plate open in a sterile hood for approximately 15 minutes. 
The plates are incubated for one day at the growth temperature required for the recipient bacteria. 
Then all the bacteria are collected from the plate in 0.5-1 ml liquid medium and streaked onto a 
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selection plate, which contains antibiotics for the recipient bacterial strain and the transferred plasmid. 
The grown up Agrobacterium colonies are analyzed by back conjugation to E.coli cells and a 
subsequent plasmid DNA extraction and restriction analysis. 
 
2.3.1.20. Site-directed mutagenesis 
Site directed mutagenesis was carried out according to the unique site elimination method of Deng and 
Nickoloff [228]. The protocol was based on the TransformerTM Site-Directed Mutagenesis Kit 
(Clontech), with modifications. The mutagenesis occurs on plasmid DNA. Two oligonucleotide 
primers are required, both of them are phosphorylated at their 5’-ends to facilitate ligation. One of 
them introduces a mutation in the target gene (which can be nucleotide exchange, small deletion or 
insertion, as well). The other, selection primer mutates a unique restriction endonuclease cleavage site 
by which it destroys the site in the resulting plasmid. In addition to the mutagenic central part, the 
oligos must contain 15-20 base pairs flanking regions at both ends, complementary to the plasmid 
DNA. The primers are extended by T4 DNA polymerase and the ends are joined by T4 DNA ligase. 
The parental plasmids are eliminated by selective restriction endonuclease digest aided by the 
mutation introduced by the selection primer. The hybrid plasmids are transformed into mismatch 
repair deficient E. coli (BMH 71-18 mutS, tetR), and the bacteria are pooled and grown in liquid 
culture for 12-16 hours under antibiotics selection. A second round of plasmid extraction, restriction 
endonuclease cleavage and transformation provides high frequency of homogenous mutant plasmids 
in the resulting single colonies. The mutagenesis is carried out using the following steps: 
 
1. Denaturation of double-stranded plasmid DNA by boiling for 15 minutes and then cooled 
down slowly to room temperature. The primers are included in the mixture, so during the 
cooling step primer annealing occurs. 
 
Plasmid DNA 50ng/µl final cc.     
Mutagenic primer 1µl 100pmol/µl 
Selection primer 1µl 100pmol/µl 
10x Annealing Buffer 2µl 
DW to a total volume of 20µl 
 
10X Annealing Buffer 
200mM Tris-HCl pH 7.5 
100mM MgCl2 
500mM NaCl 
 
2. Add dNTP mixture to 100µM final cc.  
ATP to 1mM final cc. 
BSA 50 µg/ml 
1µl T4 polymerase (3U) 
1µl T4 ligase (400U) 
DW to 30 µl end volume 
 
Incubate for 30-60 min at room temperature 
 
3. Inactivation of T4 polymerase by adding 10mM EDTA and heating to 75oC for 10 minutes 
4. Dialysis of DNA (as written above) 
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5. Restriction endonuclease digestion for 2 hours with the nuclease according to the selection 
primer 
6. Dialysis of DNA 
7. Transformation by electroporation into BMH 71-18 mutS E. coli strain (tetR). All the 
transformant bacteria are pooled and grown in 5ml liquid LB medium, supplemented with 
corresponding antibiotics, for 12-16 hours at 37oC in a test tube in a rotator.  
8. Plasmid DNA miniprep is prepared. Digested again with the selective restriction 
endonuclease to eliminate parental plasmids, then the DNA is dialyzed, and transformed 
into any basic E coli strain suitable for cloning. The bacteria are plated and grown for 12 
hours. 
9. A single colony is inoculated into 2ml LB medium, plasmid DNA is extracted and the 
mutation is confirmed by sequencing. 
 
 
2.3.2. Protein analytical techniques 
2.3.2.1. SDS polyacrylamide gel electrophoresis 
SDS polyacrylamide gel electrophoresis was carried out as described in the laboratory manual 
Molecular Cloning (Sambrook J., Fritsch E.F. and Maniatis, T.). Here only the buffer and gel 
compositions are listed. The gel component values are accommodated to 40% acrylamide stock 
solution (29:1 acrylamide : metylene-bis acrylamide) instead of using 30%. 
 
5x Tris-glycine electrophoresis buffer: 
 15.1g  Tris base 
 94g  glycine 
 50ml  10% SDS 
 filled up to 1000ml with deionized water 
 
5x SDS gel loading buffer: 
 250mM  Tris-HCl pH 6.8 
 0.5M   DTT (measured from powder) 
 10%   SDS (measured from powder) 
 50%   glycerol 
 
 
Components for 10ml gel 
volume (values in ml) 
8% 10% 12% 15% stacking gel 
2ml (5%) 
H2O 5,275 4,825 4,3 3,55 1,48 
40% acrylamide mix (29:1) 2,025 2,475 3,0 3,75 0,25 
1,5M Tris (pH8,8) 2,5 2,5 2,5 2,5 0,25 
10% SDS 0,1 0,1 0,1 0,1 0,02 
10% ammonium persulfate 0,1 0,1 0,1 0,1 0,02 
TEMED 0,006 0,004 0,004 0,004 0,002 
 
2.3.2.2. Staining SDS polyacrylamide gels with Coomassie Brillant Blue R250 and 
colloidal blue stain 
Staining solution for CBB-R250: 
 0.25g   Coomassie Brillant Blue R250 
 45ml  H2O 
 45ml   methanol 
 10ml   glacial acetic acid 
 
The polyacrylamide gel is immersed into at least 5 volumes of staining solution and placed on a 
slowly rotating platform for minimum 4 hours at room temperature. The gel is destained in the same 
solution without the dye generally for 4-8 hours, changing the destining solution three times. For 
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colloidal Coomassie staining Novex Colloidal Blue Staining kit was used from Invitrogen, and the 
staining was carried out following the manufacturer’s instructions. 
 
2.3.2.3. Tris-Tricine buffered SDS-polyacrylamide electrophoresis of peptides 
Peptide electrophoresis uses a tricine-based buffer system, which in contrast to glycine-based buffers 
allows the separation in the low molecular weight range. We used a three layer gel system that consists 
of a stacking gel, a spacing gel layer and a separating gel. 
 
Special reagents: 
1. Separating/spacer gel acrylamide: 48g acrylamide, 1,5g N,N’-methylene-bis-acrylamide. 
Bring to 100ml and filter through paper to remove cloudiness. 
2. Alternative: separating/spacer gel (2x crosslinked): 48g acrylamide, 3g N,N’-methylene-
bis-acrylamide. 
3. Stacking gel acrylamide: 30g acrylamide, 0.8g N,N’-methylene-bis-acrylamide. Bring to 
100ml and filter through paper to remove cloudiness. 
4. Separating/spacer gel buffer: 3M Tris base (ultra pure), 0.3% SDS. Bring to pH 8.9 with 
HCl. 
5. Stacking gel buffer: 1M Tris-HCl, pH 6.8 
6. Cathode (top) running buffer (10x stock): 1M Tris base, 1M tricine, 1% SDS. Dilute 1:10 
immediately before use. Do not adjust pH, it will be about 8.25 
7. Anode (bottom) running buffer (10x stock): 2M Tris base. Bring to pH 8.9 with HCl. 
Dilute 1:10 immediately before use 
 
2.3.2.3.1. Gel recipes: 
Separating gel:  6.7ml   deionized water 
   10ml  separating/spacer gel buffer 
   10ml   separatin/spacer gel acrylamide (1x or 2x crosslinked) 
   3.2 ml   glycerol 
   10μl   TEMED 
   100μl  10% ammonium persulphate 
 
Spacer gel:  6.9ml   deionized water 
   5.0ml  separating/spacer gel buffer 
   3.0ml   separating/spacer gel acrylamide (1x crosslinked only) 
   5μl  TEMED 
   50μl  10% ammonium persulphate 
 
Stacking gel:  10.3ml  deionized water 
   1.9ml  stacking gel buffer 
   2.5ml  stacking gel acrylamide 
   150μl  EDTA 
   7.5μl  TEMED 
   150μl  10% ammonium persulphate 
 
Tris-tricine sample buffer 4.0 ml  deionized water 
    2.0 ml  0.5M Tris-HCl pH 6.8 
    2.4 ml   glycerol 
    1.0 ml  10% SDS 
    0.2 ml  β-mercapto-ethanol 
    0.4 ml   0.5% Coomassie G-250 
 
Insufficient amount of β-mercapto-ethanol may result in doublets or diffuse bands. 
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Fixation   50%   methanol 
    10%   glacial acetic acid 
    in water 
   
Place the gel into this polypeptide fixative solution for 30 min 
Staining, destaining  25%   isopropanol 
    7%   glacial acetic acid 
    68%   deionized water 
             ( 0.25 g/l  coomassie brillant blue in the staining solution) 
   
Stain the prefixated gel for 1 hour. Destaining: 3x15 minutes or until the desired destaining has 
reached. 
 
Molecular weight standard: Polypeptide SDS-PAGE Molecular Weight Standard (Bio-Rad) 
 
2.3.2.4. Two-dimensional electrophoresis 
Two-dimensional gel electrophoresis was carried out by the proteomics service group of our institute. 
Reference: J Walker: The Protein Protocols Handbook [228]. 
 
 
2.3.2.5. Western blot analysis of proteins 
For blotting proteins generally Immobilon-P PVDF membrane was used in a Bio-RAD mini cell or 
house-made wet blotting system. The Immobilon-P membrane was first wetted with pure methanol for 
a few seconds before using it in a water-based buffer. The gel and membrane is straddled by three 
layers of Whatman paper on both sides and this “sandwich” is covered by a pair of a sponge sheet. The 
transfer is performed in transfer buffer at 25V for 2 hours or alternatively 10V for overnight blotting. 
 
1x transfer buffer (stock is 5x concentrated): 
50mM  boric acid 
50mM  Tris base 
Do not adjust pH 
 
When the transfer is complete, the chamber is disassembled and the membrane is gently shaken in 
blocking solution for two hours. 
 Blocking solution 
  5%  milk powder 
  0.05%  Tween 20 
  in 1x TBS buffer 
 
 10x TBS, (1litre) 
  80g  NaCl 
  2g KCl 
  30g  Tris base 
  Adjust pH to 8.0 with HCl 
 
The primary antibody was applied in 10ml blocking buffer for 2 hours with respect to the 
characteristic dilution ratio of specific antibodies. Before applying the secondary antibody the 
membrane was washed three times in wash buffer (1xTBS + 01% Tween 20). The secondary 
antibodies were also applied for 2 hours in blocking solution in their required concentrations. After the 
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incubation period, the blot was washed 3 times with wash buffer and detected by ECL reagent (equal 
mixture of two components, approximately 200 μl each for a 6 x 9cm minigel blot) and hypersensitive 
X-ray film for different exposition times. 
 
2.3.2.6. Chemical and enzymatic manipulation of proteins 
2.3.2.6.1. Trichloro-acetic acid (TCA) precipitation of proteins 
TCA precipitation of proteins was performed using the following protocol: Add 2 volumes of 10% 
TCA in acetone to 1 volume of protein solution in an eppendorf tube. Allow the mixture to stand for at 
least 2 hours at -20oC. Improved recovery can be achieved by allowing the mixture to stand at -20oC 
overnight. Centrifuge the sample at 14.000 rpm in a tabletop centrifuge for at least 10 minutes at 4oC. 
Immediately and carefully decant the supernatant and remove the residual liquid with a pipette. Wash 
the pellet with pure acetone. Dry the pellet under vacuum (10-15 min). Dissolve the precipitated 
protein by vortexing in a minimal volume (50μl) of either neutral or alkaline buffer. 
 
2.3.2.6.2. Selective chemical cleavage of proteins at methionyl groups by CNBr 
Cyan bromide cleavage of proteins was carried out using the following working steps:  
1. Dry down the sample under vacuum. Heating is necessary to remove bicarbonate completely if 
that was used as a buffer component. Solubilize the sample in 70% aqueous TFA or 70% formic acid 
to protein concentration of 1-5mg/ml.  
2. Add CNBr to the sample in 10 x molar excess to the methyonyl groups. In practice, this means 
equal amount of CNBr to protein pellet. (Other protocols apply 3 x more CNBr or even more). For 
very small amounts of samples add one crystal of CNBr. Alternatively 5M CNBr in acetonitrile 
solution can be used. 
3. Let the reaction proceed for 24 hours at room temperature with gentle stirring. Cover the 
reaction vessel with alufoil. 
4. Dry the sample in vacuum centrifuge. If the sample was solubilized in formic acid, dissolve it 
in water and dry again, which should get rid of the residual formic acid. 
5. Dissolve the sample in 20-40 μl of tricine-SDS-PAGE sample buffer. If it turns yellow, 
residual acids are present and the sample will run badly. Tris buffer can be added to raise pH. 
6. To deactivate CNBr in a solution not exceeding 60g CNBr/liter the recommended method is to 
add 1M NaOH and NaOCl in volumes of ratio 1:1:2 (CNBr solution : NaOH : NaOCl). With low 
concentration of CNBr simply hypochlorite solution can be used. Wait until effervescence stops. 
 
2.3.2.6.3. Enzymatic cleavage of proteins 
In this work we used only Arg-C protease, which cleaves at arginine residues at position P1. 
Sequencing grade Arg-C protease was applied from Roche, which product contains the necessary 
buffer and activation solution. 
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2.3.2.6.4. In-gel digestion of proteins 
(Reference: Shevchenko, A., Wilm, M., Vorm, O and Mann M. (1996) Mass spectrometric sequencing 
of proteins from silver stained polyacrylamide gels. Anal Chem. 68, 850-858) 
 
Excision of protein bands from polyacrylamide gels: Wash the gel with water (2 changes, 10 minutes 
each). Excise the spots or bands of interest from the gel. Cut the excised piece into 1mm3 cubes and 
transfer them to a 0.5 μl microfuge tube. 
Washing of gel pieces:  Wash the gel particles with water and 50mM NH4HCO3/ acetonitrile 1:1 (v/v) 
for 15 min. Remove all remaining liquid and add enough acetonitrile to cover the gel particles. The gel 
shrinks and sticks together. Remove acetonitrile and rehydrate the gel pieces in 50mM NH4HCO3. 
After 5 min, add an equal volume of acetonitrile and then remove all liquid after 15 min of incubation. 
Add enough acetonitrile to cover the gel particles. After the gel pieces have shrunk, remove 
acetonitrile. Dry down the gel particles in a vacuum centrifuge. 
Reduction and alkylation: Swell the gel particles in 10mM dithiotreitol/25mM NH4HCO3 (freshly 
prepared) and incubate them for 45 min at 56oC. Chill tubes to room temperature, remove excess 
liquid and replace it quickly by roughly the same volume as above of freshly prepared 55mM 
iodoacetamide (light sensitive) in 25mM NH4HCO3. Incubate for 30 min at room temperature in the 
dark and then remove iodoacetamide solution and wash the gel particles with 50mM NH4HCO3 and 
acetonitrile (1:1 v/v), one or two changes each, 15 min per change. Add enough acetonitrile to cover 
the gel particles. After the gel pieces have shrunk remove the acetonitrile and dry down the gel 
particles in a vacuum centrifuge. 
In-gel digestion: Add just enough freshly prepared enzyme solution (25mM NH4HCO3 with for 
instance 5ng/μl trypsin solution, sequencing grade) to cover the gel. Incubate at 37oC for 30 minutes. 
Add enough 25mM NH4HCO3 to keep the gel wet overnight, but avoid excess liquid and incubate at 
37oC overnight. 
Extraction of peptides: Make sure that about 3μl of liquid is in the tube (it might be necessary to add 
some water) and sonify for 10 min. Recover the supernatant and add 3μl of 50% acetonitrile with 1% 
trifluoro-acetic acid or formic acid. Sonify for 10 min and recover the supernatant. Repeat the 
acetonitrile/acid step and pool the supernatants. 
Peptide analysis: If purification is necessary, perform microcolumn purification 
 
 
2.3.2.7. In vitro kinase reactions 
In general, 1μg of purified recombinant protein kinase and 1μg substrate was mixed with 1μl of fresh 
radioactive γ32PATP in a reaction buffer containing 100mM Tris-HCl (pH 8.0), 5mM MgCl2, and 
50mM NaCl. High buffering capacity is needed to balance the effect of the acidic ATP. Mg2+ is an 
essential cofactor needed for ATP activation. The reaction runs for at least 1 hour at room temperature. 
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The reagents are separated by SDS-PAGE so, that the front line, which contains most of the 
unincorporated radioactive ATP should not leave the gel. (The bottom of the gel can be cut and 
discarded, which reduces contamination of the equipment.) In order to remove background activity of 
the unincorporated ATP molecules, the gel slab is immersed into 10% acetic acid solution for one 
hour. Subsequently the gel is placed between a Whatman paper and a layer of cellophane and dried in 
a heated vacuum-assisted gel dryer machine. The dried gel is placed into a photo cassette and 
subjected to autoradiography with an X-ray film. With high activity, 5-10 minutes of exposition 
should be sufficient whereas in case of weaker activity the exposition can be extended to hours or even 
days. The signal is fading very slowly, because the half-life time of the 32P isotope is approximately 2 
weeks. To exploit the intensifier layer found inside many photo cassettes, the cassette is placed into a -
70oC deep freezer. After the assay, all the equipment is decontaminated by wiping or immersing into 
deconex solution. 
 
2.3.2.8. Recombinant protein expression in Escherichia coli cells 
For expression of recombinant proteins E. coli strain BL21DE3pLysS was used as host in most 
experiments. This strain is deficient in the lon intracellular protease and ompT extracellular protease 
therefore facilitates the purification of intact proteins. In addition, the strain carries a the gene of T7 
RNA polymerase under the control of lacUV5 promoter and therefore is compatible with IPTG 
inducible expression. The pLysS vector plasmid carries the gene of T7 lysozyme, a natural inhibitor of 
T7 RNA polymerase, which provides a more strict regulation of transgene expression. 
After electroporation of the recombinant plasmid into BL21DE3pLysS E.coli and selection of 
transformants, a starter culture for protein expression was inoculated in 5ml LB with a sterile 
toothpick and grown overnight at 37oC in the presence of the bacterial strain specific (Cm) and 
plasmid specific (Amp) antibiotics. The grown-up starter culture was inoculated into larger amount of 
LB medium (0.5-2.0l, depending on the abundance and solubility of the recombinant protein) and 
grown until it reached OD600=0.6, when 1mM IPTG was added to induce protein expression. Proteins 
were expressed for different time intervals ranging from 3 hours to 10 hours. The protein expression 
was generally carried out at 37oC, although in some cases lower temperature was tried, which 
increases recombinant protein solubility inside the bacterial cells and reduces losses by inclusion body 
formation. After the expression period, the bacteria were pelleted in a Sorvall RC5B centrifuge in 
250ml Beckman centrifuge tubes at 6000xg for 6min at 4oC. The bacterial pellet was frozen in order to 
facilitate the lysis of bacteria or for storage at -80oC. 
 
2.3.2.9. Purification of proteins 
2.3.2.9.1. Affinity purification of His-tagged recombinant proteins on Ni-NTA resin 
cDNA clones for expression of 6xHis tagged proteins were generally cloned in the non-commercial 
pET201 vector (very similar to pET32 from Novagen), which provides an N terminal thioredoxin tag 
to increase solubility of recombinant proteins in E. coli and a 6xHis tag in C-terminal position. 
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(Reference:The QIAexpressionistTM. A handbook for high-level expression and purification of 6xHis-
tagged proteins, QIAGEN). 
The bacterial pellet was taken up in prechilled lysis buffer (2ml/g bacterial pellet, but not less 
than 20ml): 
 
Lysis/binding buffer:  1xPBS pH=8.0 (phosphate buffered saline: 40mM phosphate buffer, 300mM 
NaCl) 
10% glycerol 
1% Triton X-100 
40mM imidazole 
5mM 2-mercapto ethanol 
protease inhibitors (PMSF, leupeptin, pepstatin, aprotinin, but no EDTA) 
 
The bacteria were lysed by sonication on ice. The cell debris was pelleted in a benchtop centrifuge at 
14000rpm at 4oC for 10-20min. All subsequent steps steps were carried out in a cold room at 4oC.  
 
• The supernatant was applied on 1ml (bed volume) pre-equilibrated Ni-NTA matrix filled in a 
disposable chromatographic column (QIAGEN) and was let flow through by gravitation. (The 
binding capacity of Ni-NTA is in the range of 5-10mg His-tagged protein /ml matrix, 
therefore this was the amount generally used.) The flow-through fraction was frozen for 
further analysis. The column was washed with 50-100 ml pre-chilled wash buffer by gravity 
flow (identical to lysis buffer). 
• The His-tagged proteins were eluted from the column in elution buffer containing increasing 
imidazole concentration gradient ranging from 40-250mM in 500 μl fractions or by constant 
300mM imidazole in elution buffer in 6x500μl fractions.  
 
Elution buffer:   1xPBS (pH 7.0, 40mM Nax(PO4)x,300mM NaCl) 
5mM 2-mercapto ethanol 
different imidazole concentrations (elution starts at 100mM) 
protease inhibitors 
 
• The fractions were assayed on SDS-PAGE, stained with coomassie brillant blue R250. The 
protein containing fractions were dialyzed against 1l dialysis buffer with one buffer change or 
size exclusion chromatography was used to change the buffer.  
 
Dialysis buffer:  20mM TRIS-HCl (pH 7.5)  
   50mM NaCl 
   5mM 2-mercapto ethanol  
0.2mM PMSF  
10% glycerol (not applied for gel filtration)  
 
• After buffer exchange, the protein concentration was measured by Bradford assay (Bio-RAD). 
Protein solutions were further purified or aliquoted and frozen in liquid nitrogen, stored at -
80oC. When buffer exchange was done by gel filtration, 10% glycerol was added before 
freezing. 
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2.3.2.9.2. Affinity purification of GST-tagged recombinant proteins on glutathion-Sepharose 
4B 
(Reference: GST gene fusion system, Handbook, GE Healthcare) 
GST-tagged recombinant proteins were purified using the following protocol: 
 
1 The bacterial pellet was taken up in prechilled lysis/binding buffer (2ml/g bacterial pellet, but 
not less than 20ml). 
Lysis/binding buffer: 1× PBS (ice-cold) (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.3) 
10% glycerol 
1% Triton X-100 
5mM 2-mercapto ethanol 
1mM EDTA 
protease inhibitors (0.2mM PMSF, leupeptin, pepstatin, aprotinin, or 
combined protease inhibitor cocktail for bacterial extracts (Sigma)) 
The bacteria were lysed by sonication on ice. The cell debris was pelleted in a benchtop centrifuge at 
14000rpm at 4oC for 10-20min. 
2. All further steps were carried out in a cold room at 4°C. The supernatant was applied onto 1ml 
(bed volume) pre-equilibrated Glutathione-Sepharose 4B matrix filled in a disposable 
chromatographic column (GE Healthcare) and was let flow through by gravitation. (The binding 
capacity of Glutathione Sepharose 4B is approximately 8mg glutathione S-transferase /ml matrix). The 
flow-through liquid was frozen for further analysis. The column was washed with 50-100 ml pre-
chilled wash buffer by gravity flow (identical to lysis buffer). 
3 Elution was performed using 6x500μl elution buffer (50 mM Tris-HCl (pH 8.0) and 25 mM 
reduced glutathione, pH is adjusted to 8.0 after adding glutathione). 
4 Analysis of purified proteins by SDS-PAGE, buffer exchange, protein concentration 
measurement and storage were as described in the Ni-NTA purification protocol. 
 
2.3.2.9.3. Affinity purification of MBP-tagged recombinant proteins on MBP-Sepharose 
(Reference: pMAL™ Protein Fusion and Purification System, New England Biolabs.) 
The bacterial pellet was taken up in prechilled lysis/binding buffer (2ml/g bacterial pellet, but not less 
than 20ml). 
Lysis/binding buffer:  20mM Tris-HCl (pH 7.4) 
200mM NaCl 
1mM EDTA 
10% glycerol 
5mM 2-mercapto ethanol 
protease inhibitors (0.2mM PMSF, leupeptin, pepstatin,  
aprotinin, or combined protease inhibitor cocktail for bacterial extracts 
(Sigma)) 
All further steps were carried out in a cold room at 4oC. The supernatant was applied on 1ml (bed 
volume) pre-equilibrated MBP-sepharose matrix filled in a disposable chromatographic column (NEB) 
and was let flow through by gravitation. (The binding capacity of MBP-Sepharose is approximately 
3mg MBP tagged recombinant protein /ml matrix) The flow-through liquid was frozen for further 
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analysis. The column was washed with 50-100ml prechilled wash buffer by gravity flow (identical to 
lysis buffer). Elution was performed with 6x500μl  
elution buffer:  20mM Tris-HCl pH 7.4 
200mM NaCl 
5mM 2-mercapto ethanol 
10mM maltose 
0.2mM PMSF 
 
The analysis of purified proteins by SDS-PAGE, buffer exchange, protein concentration measurement 
and storage were as described in the Ni-NTA purification protocol. 
 
2.3.2.9.4. Affinity purification of proteins on StrepII-tactin resin 
(Reference: Strep-tag® Purification Protocol, 2005, IBA GmbH, Germany) 
For purification of Ster-tag labeled proteins, the StrepII-tactin column was pre-equilibrated with  
 
bufferW: 100mM Tris-HCl (pH 8.0), 150 mM NaCl and 1 mM EDTA  
 (protease inhibitors can be applied but use buffer without EDTA for metalloproteins) 
 
The bacterial pellet is resuspended in ice cold bufferW, which might be supplemented with bacterial 
protease inhibitors (PMSF, leupeptin, pepstatin, aprotinin, benzamidin, or use combined protease 
inhibitor cocktail). The bacterial cells are homogenized by sonication or French-press cell. The cell 
debris is removed by centrifugation in a cold tabletop microcentrifuge at 14000rpm for 10-20 min. 
Subsequently, the cell extract is loaded onto the column (binding capacity is 50-100nmol protein/ml 
matrix, in the range of 1-2 mg protein). When the sample has passed, the column is washed with 5 
column volume of bufferW. The wash fractions are collected for further analysis. The bound proteins 
are eluted with 6 times 0.5 column volume of 
 
elution buffer: bufferW containing 2.5mM desthiobiotin 
 
• To prevent covalently linked contaminations use 5mM β-mercapto-ethanol 
• To prevent non covalently linked contaminations the following additives can be used:  
NaCl up to 1M concentration, glycerol up to 25% and mild non-ionic detergents (Triton-X 
100, Tween 20, CHAPS) in 0.1% concentration.  
 
2.3.2.10. Tandem affinity purification of plant proteins on NiNTA and Strep-tactin resins 
2.3.2.10.1. Simplified protocol for total cell extract 
Freeze the plant material in liquid nitrogen. Grind the frozen tissues with liquid nitrogen in a mortar 
with pestle to a fine powder. In case the starting material is a cell suspension culture, it is 
recommended to add sand during mortaring or alternatively perform the extraction with dry ice (i.e., 
solic CO2). Let the nitrogen evaporate. When evaporated the color of the tissue changes from gray-
white to dark green in case of leaf material. Transfer the powder to another container e.g. a beaker to 
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prevent freezing of the buffer in the cold mortar. Alternatively, a blender machine can be used 
especially with leaf material. All following steps are carried out at 4oC. Add 3ml/g tissue  
 
Buffer A: 1xPBS pH=8.0 (phosphate buffered saline: 40mM phosphate buffer, 300mM NaCl) 
 5mM 2-mercapto-etanol 
  10% glycerol 
  0.1% Triton-X 100 
1mM Na3VO4 (activated) 
1mM PMSF and 1/100 volume Protease inhibitor cocktail  
for plant extracts (SIGMA P9599) 
(add 2mM ATP pH7.0 if proteasomal complex is to be purified) 
 
Filter slurry on nylon mesh, pore size 100 and 50 μm. Centrifuge in 200ml Beckman centrifuge tubes 
in Sorvall GSA rotor or equivalent with 12500 rpm (approx. 25000g) for 20-30 min at 4oC. Carefully 
decant the supernatant into a new vessel and apply it onto pre-equilibrated NiNTA column in a cold 
room. The volume of the NiNTA resin used should be 2ml/each 20g of fresh sample weight. 
Wash the column with 50-100ml bufferA, containing 10mM imidazole, and then wash the 
column shortly with elution buffer to remove glycerol. Elute proteins with an increasing step gradient 
of imidazole concentration in  
 
Elution buffer (bufferA without glycerol): 
1xPBS (pH 8.0) (phosphate buffered saline: 40mM phosphate buffer, 
300mM NaCl) 
   5mM 2-mercapto-ethanol 
1mM Na3VO4 (activated) 
1mM PMSF + 1/100 volume plant protease inhibitor cocktail 
(add 2mM ATP pH 7.0 if proteasomal complex is to be purified) 
 
The imidazole step gradient starts at 40 mM and increases by 20-40mM intervals. The volume of 
fractions should be equal to the bed size of the column. The fractions can be analyzed on SDS-PAGE 
and western blotting. Typically, the specifically eluted proteins can be found in the 100mM-200mM 
fraction range. It is advisable to proceed further immediately. 
 
Pool the eluted fractions between 100mM and 200mM imidazole and apply it on 1-2ml Strep-tactin 
Sepharose column pre-equilibrated with elution buffer. (Strep tactin Sepharose is compatible with 
250mM imidazole and up to1M NaCl.). Wash the column with 50ml  
 
Strep-washing buffer:  150mM NaCl 
10mM Tris-HCl (pH 8.0) 
    10% glycerol 
    0.1% Triton-X 100 
    5mM β-mercapto-ethanol 
    0.2mM PMSF 
    1mM Na3VO4 
    (2mM ATP for purification of proteasome-associated proteins) 
 
Wash the column shortly with elution buffer without desthiobiotin to remove glycerol and detergent. 
Elute proteins with 6 x 0.5-1ml of  
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Strep-elution buffer:  150mM NaCl 
    10mM Tris-HCl (pH 8.0) 
5mM β-mercapto-ethanol 
2.5mM desthiobiotin (it dissolves in water quite slowly) 
(2mM ATP) 
1/100 volume Protease inhibitor cocktail for plant extracts (SIGMA 
P9599) 
 
The fractions are analyzed on SDS-PAGE and western blotting. If abundant proteins were purified, it 
might be attempted to measure protein concentration by the Bradford assay (BIO-RAD). The protein 
containing fractions can be concentrated by vacuum centrifugation. If the sample is to be frozen, 10% 
glycerol is added prior snap freezing. If the sample is to be processed by mass spectrometry, do not 
add glycerol. Buffer exchange may be necessary to reduce salt concentration for which dialysis or gel 
filtration on a small volume Sephadex-G25 column are the alternatives. 
  
2.3.2.10.2. Alternative protocol for separated handling of nuclear and cytoplasmic fractions 
After tissue homogenization add 3ml/g tissue nuclear grinding buffer: 
 
Nuclear grinding buffer (NGB):  1M hexylene-glycol 
10mM PIPES-KOH pH 7.0 
5mM 2-mercapto-etanol 
10mM MgCl2 
0.2% TritonX-100  
2mM ATP (pH neutralized prior use) 
1mM Na3VO4 (activated) 
0.8mM PMSF (Add extra 0.4mM PMSF in every 20 min of 
preparation time) 
    (Effective concentration 0.1-1mM, half life at pH 7.5 1 hr) 
[Alternatively 0.5mM AEBSF (4-(2-aminoethyl)-
benzenesulfonyl-fluoride hydrochloride)] 
 
Filter slurry on nylon mesh, pore size 100 and 50 μm. Use a wide mouth funnel for filtering especially 
in case of large amount of starting material. It is advisable to rinse the slurry with NGB. Squeeze the 
filter to collect all liquid. Centrifuge in 50ml falcon tubes at 1260xg for10 minutes at 4oC. Alternative: 
centrifuge in Sorvall GSA tubes with 3,000 rpm at 4°C for 15 min (approx 1400xg). Carefully decant 
the supernatant into new GSA tubes and spin at 12,500 rpm (25,000 g) for 30 min at 4°C and process 
further with this fraction as cytoplasmic fraction by binding to Ni2+ or Co2+ beads. 
 
Extraction of nuclear proteins: 
Gently resuspend the nuclear pellet in nuclear wash buffer (1ml/10g starting material, minimum 
0.5ml). The nuclei are very easily damaged and lysed, therefore handle with care. Use wide-mouth 
pipette tips. The buffer contains 0.3% Triton X-100 for cell membrane lysis (experimentally 
determined concentration, specific for Arabidopsis, CelLyticTM PN Isolation/Extraction Kit, Sigma). In 
the presence of Mg2+ the Triton X-100 does not solubilize the DNA and may only strip away the outer 
of the two nuclear membranes. Optionally, view the sample under microscope to see the cells are 
broken but nuclei are intact. 
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Nuclear wash buffer (NWB):  0.5M hexylene-glycol 
10mM PIPES-KOH pH 7.0 
10mM MgCl2 
0.3% TritonX-100 
5mM 2-mercapto-ethanol 
0.8mM PMSF 
2mM ATP 
1mM Na3VO4 
1/100 volume Protease inhibitor cocktail for plant extracts 
(SIGMA P9599, does not contain EDTA) 
 
High purity preparation of nuclei: 
Prepare 40% Percoll in NWB and 2.3M sucrose solution in 10mM PIPES-KOH (pH 7.0), 10mM 
MgCl2. The sucrose solution is dense, may be warmed up to 50-65oC to facilitate solution of sucrose, 
but must be chilled to 4oC before use. Prepare nuclei isolation tube in a 50 ml falcon tube by filling 
10ml sucrose solution to the bottom and carefully adding a 10ml 40% Percoll layer on the top. Two 
separate phases should be formed. The nuclei isolation tube can be scaled in 2ml eppendorf tubes 
(with 0.7ml of each layer) or in 15ml falcon tubes (3ml of each layer). Carefully apply the nuclear 
suspension on the top of the isolation tube. Centrifuge at 3200xg for 30 min at 4oC. Most of the nuclei 
are banded at the interface between the sucrose and Percoll layers. Gently collect the nuclei with a 
Pasteur pipet and transfer into a new 14ml tube. Wash the nuclei to remove Percoll and sucrose in 2x 
the nuclei band volume using NWB. Centrifuge at 3200xg for 5 minutes, decant supernatant and invert 
the tube to remove the hypotonic NWB buffer. 
 
Nuclear lysis: Resuspend the nuclei pellet in 2/3 pellet volume nuclear lysis buffer.  
 
Nuclear lysis buffer (NLS):  150mM KCl 
20mM HEPES-KOH (pH 7.5) 
10% glycerol 
10mM MgCl2 
5mM 2-mercapto-ethanol 
1/100 volume protease inhibitor cocktail (or 1/50) 
2mM ATP 
1mM Na3VO4 
(NH4)2SO4 (Concentration must be experimentally 
determined, should be as low as possible e.g. 80mM, 
maximum 0.4M). 
 
Add 5U/ml Benzoase (Novagen) or 100μg/ml DNase (Worthington, electrophoretically homogenous) 
and 100 μg/ml RNase (electrophoretically homogenous, Serva) and 50U/ml micrococcal nuclease 
(Worthington). Rock the tube for 60 min at 4°C. Check the lysis of nuclei under microscope, DNA can 
be stained with DAPI. Dounce homogenizer can be used to enhance sharing. Centrifuge in SS34 with 
14,000 rpm (25,120g) for 30 min. Keep the pellet, in case re-extraction would be needed. If yes, 
sonicate the pellet in 1ml nuclear lysis buffer, centrifuge and check protein content of the supernatant 
by Bradford reagent and then combine with the first nuclear extract. Measure protein concentration by 
bicinchonic acid method (Pierce) . 
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Proceed further with the chromatographic steps. The use of (NH4)2SO4 is not recommended 
with NiNTA resin (by the manufacturer), whereas the Strep-tactin Sepharose is compatible with 
(NH4)2SO4 up to 2M. (Application of ammonium-sulphate containing samples onto NiNTA resin was 
carried out by us, and ammonium did not reduce Ni2+ ions up to 400mM in the binding phase).  
However, plant tissues contain biotin (vitamin H), which strongly binds to the Strep-tactin Sepharose 
and interferes with sample binding. Therefore, in case of small sample volumes the nuclear extract can 
be first applied to Strep-tactin followed by NiNTa chromatography if necessary, otherwise ammonium 
salts must be first removed by a quick buffer exchange using gel filtration with a diluted sample. 
Alternatively the homogenization of the nuclei can be performed with French-pressure cell, and the 
ammonium free lysate can be first applied to NiNTA resin. 
 
2.3.2.10.3. Gel filtration 
Size exclusion chromatography was used for quick and efficient buffer exchange of protein solutions. 
Generally, 10-15 ml Sephadex G25 or G50 was used filled in disposable plastic columns (e.g. PD-10 
columns, GE Healthcare). Dry Sephadex powder was pre-swollen for 3 hours in distilled water with 
slow shaking, autoclaved and then equilibrated with the chosen buffer. The elution volume (void 
volume) was measured by running Blue-Dextran 2000 on the column. Fractions were collected in 
500μl aliquots and assayed with Bradford reagent (BIO-RAD). The eluted proteins were immediately 
applied to the second chromatographic column (in case of double GST-His tagging or Strep-his 
tandem tagging). 
 
2.3.2.10.4. Anion exchange chromatography 
The purification of AKIN10 kinase included an anion-exchange chromatography step. 1ml pre-packed 
HiTrap DEAE-Sepharose FF anion exchange matrix was used with Tris-HCl buffer pH 8.0. Elution 
was performed by increasing NaCl concentration in a step gradient using 50mM intervals. The anion 
exchange chromatography was otherwise carried out according to the manufacturer’s instructions (GE 
Helathcare). 
 
2.3.2.10.5. Activation of sodium orthovanadate (phosphatase inhibitor) 
Isolation of active protein kinases requires the inhibition of protein phosphatases during the kinase 
purification procedure. This protocol is applied to depolymerisation of vanadate converting it into a 
more potent inhibitor of protein phosphatases. DTT application in the chromatography buffers should 
however be avoided as DTT rapidly inactivates sodium orthovanadate. 200mM stock solution of 
sodium orthovanadate Na3VO4 is adjusted to pH to 10.0 using either 1N NaOH or 1N HCl. At pH 10.0 
the solution will be yellow and is boiled until it turns colorless (approximately 10 minutes) and then 
cooled to room temperature. The pH is readjusted to 10.0 and the boiling procedure and pH 
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readjustment is repeated until the solution remains colorless. The stock solution is stored in aliquots at 
-20oC. Applied final concentration of sodium orthovanadate is 0.2mM 
 
2.3.2.11. Mass spectrometry 
Mass spectrometry was carried out by the help of the MS service group of our institute. We used 
MALDI-TOF and ESI-Q-TOF mass spectrometers equipped with an ion-trap device. 
 
2.3.3. Plant techniques 
2.3.3.1. Crossing Arabidopsis plants 
There are approximately 3 to 5 flower buds on each floral axis at a given day that are feasible for 
crossing Arabidopsis. These are the most developed flower buds, which are still closed and did not 
undergo self-pollination as their anthers are immature. These flower buds are emasculated with 
pointed forceps taking off the sepals and petals under a stereomicroscope or using a magnifying glass 
headset. An open mature flower is taken from the crossing partner plant and its stamens are used to 
fertilize the prepared carpel by touching it several times. 
 
 
2.3.3.2. Arabidopsis seed sterilization 
Instead of regular bleach, Arabidopsis seeds are sterilized with Ca-hypochlorite, which secured better 
viability and germination. Seeds in an eppendorf tube (not more than 200 μl) are treated with 1ml of 
hypochlorite solution with gentle shaking for 10 minutes (note: prolonged exposition time might 
reduce the seed’s germination ability) and subsequently collected by centrifugation at 6000 rpm for 1 
min in a tabletop centrifuge). The hypochlorite solution is removed using sterile pipette tip and the 
seeds are washed three times with 1ml sterile distilled water. Subsequently, the seeds are suspended in 
1ml sterile water, stratified overnight at 4°C and spread on the surface of an MS agar plate. 
Alternatively the seeds can be dried after the final washing step leaving the open eppendorf tube for 4-
5h or overnight in a sterile hood. In this case sterile toothpicks are used to loosen the cohesive seeds. 
 
Hypochlorite solution: Dissolve 5g Ca(OCl)2 in 100ml distilled water and then add 1ml 10% Triton X-
100 and mix well the solution using a magnetic stirrer. Centrifuge the solution in a 50ml Falcon tube 
at minimum 2000 rpm and then decant the supernatant into a clean 50ml Falcon tubes. The solution 
might be stored at 4oC for 2-3 weeks. 
 
2.3.3.3. Transformation of Arabidopsis using the floral dip method [229] 
Agrobacterium is grown in YEB medium to OD600 1.2-1.5 in the presence of antibiotics to select for 
the resistance marker of binary vector. Bacteria from 500ml culture are collected by centrifugation and 
resuspended in 200ml IM medium (0.5 consentration of MS basal salt mixture (Sigma), 1 x B5 
vitamins (Sigma), 5% sucrose, 0.05μM BAP and 0.005%(v/v) Silwet L-77 (Ambersil). Inflorescences 
of 3-4 week-old plants (10-15 cm high) are immersed into the bacterial suspension for 3-5 min and 
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then the plants are covered with plastic bags for 24h. In order to obtain more susceptible flowers per 
plant, the stems can be cut back once in the growth period prior to transformation when the first stems 
are few cm high. This results in a branching stem structure. 
 
2.3.3.4. Selection of Arabidopsis transformants  
Sterile Arabisopsis seeds are resuspended in 1ml water and pipetted on the surface of a (15cm 
diameter) MSAR plate, containing the corresponding antibiotics (Km100, Hyg15). Some more 
milliliters of sterile water is added and the seeds are equally spread by the tilting the plate. Seed 
density should be 5-10 seeds to cm2. When the seeds are settled, the water is removed by the 
circumference of the plate with a pipette. When using kanamycin selection the sensitive seedlings will 
turn yellow soon after germination whereas the resistant seedlings remain green. Under hygromycin 
the selection the sensitive seedlings remain green for about 10 days, but do not develop leaves and 
subsequently become stunted and brown, and their root development is strongly inhibited. 
 
 
2.3.3.4.1. Seed strorage 
Arabidopsis seeds are dried in a demisted chamber (silica particles absorb humidity from its air). The 
seeds are stored at -20oC. 
 
2.3.3.5. Arabidopsis genomic DNA extraction by the CTAB method [230] 
CTAB (Hexadecyl trimethyl ammonium bromide) is a cationic detergent. 
Approximately 300mg Arabidopsis tissue (seedlings, leaves) is collected into a 1.5ml eppendorf tube 
and frozen in liquid nitrogen. The sample is grinded with a glass rod while it becomes unfrozen and 
subsequently 0.3ml of preheated CTAB 2x buffer is added. Upon mixing the extract is incubated at 
65oC for at least 5 minutes with repeated shaking and then placed on ice. Following addition of 0.3 ml 
chloroform, the extract is mixed and centrifuged for 5 minutes at top speed in a benchtop centrifuge. 
0.4ml from the upper phase of the samples is pipetted into new eppendorf tubes containing 40μl 
preheated CTAB 10x buffer (it is too viscous at room temperature) and 0.4ml chloroform is added. 
The samples are mixed and centrifuged again for 5 minutes. 0.3ml of the upper phase is pitted into 
new eppendorf tube containing 0.3ml CTAB precipitation buffer, the solution is mixed and upon 5 
min incubation is centrifuged for 10 minutes. After removal of the supernatant the pellet is dried 
briefly and then dissolved in 0.3ml high salt TE buffer. The DNA is precipitated with 0.6ml ethanol at 
-20oC for 30 min and collected bycentrifugation for 10 min at maximum speed in a tabletop centrifuge. 
The pellet is washed two times with 70% ethanol, and then with absolute ethanol and dried to dissolve 
the DNA in 100μl distilled water. For PCR analysis 1μl DNA sample is used. 
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CTAB 2x buffer: 
2% (w/v)  CTAB  
100mM   Tris-HCl pH 8.0  
20mM  EDTA 
1.4M  NaCl 
1% (w/v)  polyvinylpyrrolidone 
 
CTAB 10x buffer: 
10% (w/v)  CTAB 
0.7M   NaCl 
 
CTAB precipitation buffer: 
1%  CTAB 
50mM   Tris-HCl pH 8.0 
10mM   EDTA pH 8.0 
 
High salt TE buffer: 
10mM   Tris-HCl pH 8.0 
1mM   EDTA pH 8.0 
1M   NaCl 
 
 
 
 
2.3.3.6. Transformation and maintenance of Arabidopsis cell suspension cultures 
Cell suspension culture is a homogenous population of rapidly dividing plant cells in liquid media. It 
is ideal to get larger amount of plant material relatively quickly for e.g. biochemical purposes. Protein 
expression can be easily and relatively quickly studied in this system. Nevertheless, its disadvantage is 
that it has no organ and tissue structure. Basic organ modeling is possible using root derived or leaf 
originated culture forms or by triggering cell differentiation (e.g., embryogenesis) using various 
combination of plant hormones. Culture media ingredients for both types of cell cultures are described 
under 2.2.2.3. and 2.2.2.4. 
 
Propagation of cell culture: To 10-15 ml one week old culture 35-40 ml fresh media is added, 
supplemented with the corresponding antibiotics. 
 
2.3.3.6.1. Cell culture transformation by Agrobacterium tumefaciens 
 
All the following steps are carried out in sterile conditions. 
 
1. 20-25ml Agrobacterium (OD600: 0.8-1.0) suspension is collected by centrifugation in a Falcon tube 
in a suitable centrifuge at 4000rpm for 20 min  
2. The bacteria are gently resuspended in the corresponding Arabidopsis cell suspension medium and 
centrifuged again. (This step removes the antibiotics from the bacterial medium). The pellet should 
be about 100-200μl. Resuspend the bacteria in 1-2 ml Arabidopsis cell culture medium, then the 
bacteria are ready to use. 
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3. Collect Arabidopsis cells from 50ml 1-week-old cell suspension culture in a falcon centrifuge at 
1000rpm for 1 min. 
4. When preparing a double transformant cell suspension line, wash the starting single transformant 
cell suspension once with sterile cell suspension medium containing no antibiotics. 
5. Resuspend 10-20 ml of Arabidopsis cell pellet in the corresponding cell culture medium to 50ml in 
the sterile hood. Transfer the cells into a sterile 250ml Erlenmeyer flask with a 25 ml serological 
pipette. 
6. Add 1ml of the Agrobacterium suspension to 50ml Arabidopsis cell suspension. Close the flask 
with a sterile paper plug (sterilized together with the flask) and cover the plug with alufoil. 
7. Incubate the cells with gentle agitiation (120rpm) for 2-3 days. When using root derived culture, 
incubate in the dark. 
8. After 3 days the cells are centrifuged in a Falcon centrifuge at 1000rpm for 1min, which separates 
the Arabidopsis cells from the majority of Agrobacteria. Discard the supernatant, and transfer the 
plant cells into a fresh flask. 
9. Add cefotaxime to 200μg/ml and tricarcillin to 150μg/ml end concentration to stop bacterial 
growth. Add selection antibiotics in the required concentration (Km 50, Hyg 15). Incubate the 
culture for a few days, but check it every day. If the cell lysis is too intensive, change the medium. 
10. In the first weeks subculture is performed by keeping the majority of living cells. If there are many 
cells, half of the culture is transferred into new medium, if there are fewer cells, the cells are 
sedimented by leaving the flask undisturbed for a few minutes and the supernatant is removed by a 
sterile pipette. Then, the cells are supplied with fresh medium (with antibiotics) and transferred into 
a new flask. The cultures have to be passed regularly in every 7 days. 
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3. RESULTS 
3.1. T-DNA INSERTION MUTATIONS IN GENES ENCODING ARABIDOPSIS 
SNRK1 KINASE SUBUNITS AND UPSTREAM ACTIVATING KINASES 
3.1.1. Isolation of a T-DNA insertion mutation in the SNRK1 α catalytic subunit gene 
AKIN10 (At3g01090) 
In our research group, Kenneth Berendzen has previously identified two insertion mutant alleles 
SAIL_834G03 and SALK_127939 of the AKIN10 gene encoding a catalytic α-subunits of Arabidopsis 
SnRK1 kinases. Both of these insertions are located outside of the AKIN10 coding region, one 603 bp 
upstream of the start codon and the other 4 bp downstream of the stop codon, respectively. These 
insertion mutants did not show any phenotypic alteration related to SnRK1 kinases. Screening of the 
Koncz and Wisconsin collections could not identify additional SnRK1α mutant alleles in AKIN10 and 
in its close relative AKIN11, but three T-DNA insertion mutants could be isolated in the AKIN12 
(At5g39440) gene that encodes a seed specific third Arabidopsis SnRK1α variant (SAIL_598H08, 
SALK_053616 and Koncz 7986). Due to overlapping expression patters of AKIN11 and AKIN12 
during embryo and seed development, none of the akin12 mutants showed alteration in seed 
development, and stress, sugar and hormone responses. In addition, 9 point mutations were identified 
by TILLING in the AKIN genes without yielding a reliable mutant phenotype. 
Recently, we found that an additional AKIN10 mutant allele exists in the GABI-KAT 
collection (GABI_579E09), which is discussed here. Sequence data deposited in the Arabidopsis 
thaliana Integrated Database (www.atidb.org) indicated that the insertion is located in the last exon 
corresponding the extreme C-terminus of AKIN10 at the sequence position 1426 of AKIN10 ORF, 
which is 1539 bp (Figure 1). Upon selecting sulfadiazine resistant plants carrying the GABI_579E09 
T-DNA insertion genomic DNA was extracted from 10 x 10 T2 lines using the CTAB method, and 
analyzed by polymerase chain reaction to search for homozygous mutant lines. For genotyping two 
gene specific oligonucleotide primers were designed to the ends of AKIN10 gene (AKIN10 5’ and 
AKIN10 3’) and two additional primers were used which were specific to the right and left border 
sequences of the T-DNA (GABI RB and FISH1, respectively; Figure 2).  
      
 
Junction sequence: AKIN10_GABI_579E09         
TGATGGTGAAACAGTTGTATAAAACTCGGGACGACAAGTATCTACTG 
                              LB 2593 
Figure 1. Location of the T-DNA inserts in the GABI_579E09 mutant AKIN10 allele. 
The downstream junction of the T-DNA insert is located in the last exon at position 1426 of At3g01090.1 coding 
sequence. Deletion of the original sequence due to T-DNA integration is indicated in red. (The upstream junction 
sequence has not been determined.) The number indicates nucleotide position in the genomic sequence related to 
the start codon.  
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                       AKIN10 5’ + AKIN10 3’                                               FISH1 + AKIN10 3’ 
Figure 2. Identification of a homozygous AKIN10 GABI_579E09 T2 insertion mutant lines by PCR-
analysis. 
Ten individual T2 progeny was analyzed by PCR using combinations of AKIN10 5’ (5'-
TCATTTCTGAATCGGGTACGAGAGAT-3') and AKIN10 3’ (5'-CAGGCGACGACACGAAGCGAGTTT-3') 
gene specific primers with the FISH1 (5'-CTGGGAATGGCGAAATCAAGGCATC-3') left border specific and 
GABI RB (5’-TTCCATTGCCCAGCTATCTGTCAC-3’) right border specific primers. The AKIN10 5’ + GABI 
RB and AKIN10 5’ + FISH1 combinations did not yield a PCR product. Therefore, the upstream junction 
sequence remained unknown. The expected product size of gene specific primers is 4.3 kb (C = wild type 
genomic DNA template control). 
 
 
3.1.2. SnRK1 β subunit alleles in public T-DNA insertion mutant collections 
 
In Arabidopsis there are three SnRK1 beta subunits, AKINβ1 (At5g21170), AKINβ2 (At4g16360) and 
the atypical AKINβ3 (At2g28060) that contains no N-terminal glycogen binding domain (Figure 3.). 
We have identified mutant alleles for AKINβ1 in the GABI-KAT (GABI_235B06), Syngenta 
(SAIL_40_A07) and SALK (SALK_008325) collections. Characterization of these insertion mutants 
showed that in all three alleles the T-DNA insertions were located in the first intron. Here we present 
therefore only the GABI and SALK alleles. We also identified a T-DNA insertion mutation 
(SALK_037416) in the AKINβ2 gene but failed to find an insertion mutation in AKINβ3 in the publicly 
available collections and by screening insertion mutant lines generated in our laboratory (Figure 3.). 
The mutant screening approaches yielded also T-DNA insertion mutations in the 5’-UTR regions of 
AKINβ2 and AKINβ3, but these were not used because the SALK, SAIL and GABI T-DNA insertions 
contain a CaMV35S promoter upstream to the left border junction and thus in these lines the AKINβ2 
and AKINβ3 genes are transcribed by the 35S promoter (i.e., leading to overexpression of 
corresponding transcripts).  
For PCR-based genotyping gene specific oligonucleotidesAKINβ1 5’, AKINβ1 3’, AKINβ2 
5’, AKINβ2 3’, AKINβ3 5’ and AKINβ3 3’ were used in combinations with T-DNA border sequence 
specific primers [FISH1 (LB), FISH2 (RB), SALK LB, GABI RB] (Figure 4). The GABI mutants 
were selected on sulfadiazine but in the SALK lines silencing of the kanamycin resistance gene 
(NPTII) prevented the identification of transformants using antibiotics selection and therefore they 
were not selected prior to genotyping. We found that in both SALK and GABI lines the T-DNA 
insertions were frequently represented by inverted repeats formed by ligation of T-DNA right 
boundaries. In such arrangement, the LB left border regions are joined to plant DNA and therefore the 
CaMV35S and mannopine synthase 2 promoters located upstream of LB junctions transcribe in both 
5’ and 3’ direction of truncated genes. Therefore, all screens were first performed with the LB + 3’ 
gene specific primer combination along with gene specific primer pairs.  
- 4361bp 
 
- 2322bp 
- 2027bp 
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AKINβ1 
Junctions: The numbers indicate position related to the start codon in the genomic sequence. Nucleotides 
indicated in red are replaced by the T-DNA insertion. 
 
Koncz_66465 
CCATTTTTCTTCACGTCTGGTTTTCTCTCTCTTTTCCTCTATCTCTCTCCTCTCTT        (7205644-7205662) 
                                -78   RB                     RB  -60                                                                     in the genomic sequence) 
GABI_235B06 
GACTTTTCATTTGTTTCACTAATTGTGAGACACTTTCTTCATTTAGATAGGATCC      (7206112-7206120) 
                                                 367 RB LB 375 
SALK_008325 
TTGTGGGAATAGTGAAATATCTTTTGCTAATAAGGTCTTGTCTGTACTCTGTATG      (7207134-7207152) 
                                              1912 LB                          RB 1931 
KONCZ_14344 
TTGGCACRACTGAAGAGACAGCCATAGCCACAAAGCCTCAACATGTGGTGCTTA     (7208088-7208107) 
                                2868 LB                 LB  2886 
   
The red box in the gene structure diagram indicates the N-terminal extension of the open reading frame as a 
result of reannotation by Kenneth Berendzen. 
 
AKINβ2 
Junctions: 
SALK_037416 
AGGTTTTTTGTTTTGGTTTCAGATTCGATGTCTTAATCTGGAGGATGTGATGAAAG      (9245826-9245842) 
                                          107 LB          RB LB 123 
KONCZ_87453 
TTTCAGATTCGATGTCTTAATCTGGAGGATGTGATGAAAGAGAGAGATCTGTAGCTTTTAAAGTTTGTGTCTTTTTTTAG 
                                  139 LB                                                                    LB 178        (9245880-9245919) 
  
AKINβ3 
No insertions in the coding region. 
Figure 3. Details of SnRK1 β subunit mutations 
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AKINβ1 SALK_008325 
           
          AKINβ1 5’ + AKINβ1 3’        AKINβ1 5’ + SALK LB         FISH2 (RB) + AKINβ1 3’       AKINβ1 3’ + SALK LB 
expected sizes: 3.0 kb for wt               1.9 kb                             1.1 kb                                 - 
Samples 1, 2, 3 and 4 are homozygous mutants, sample 5 is heterozygous and sample 6 is wild type 
[C = genomic DNA control, S = molecular weight standard (bacteriophage λ HindIII digest)] 
 
          
AKINβ1_GABI_235B06 
           
           AKINβ1 5’ + AKINβ1 3’        AKINβ1 5’ + GABI RB        FISH1 (LB) + AKINβ1 3’ 
expected sizes:     3.0kb                                           0.8 kb                                           2.2 kb 
Samples 1, 2, and 10 were selected as homozygous mutants (3, 5 and 6 are ambiguous) 
 
 
 
AKINβ2_SALK_037416      
 
      AKINβ2 5’ + AKINβ2 3’  AKINβ2 5’ + SALK LB  AKINβ2 5’ + FISH2     AKINβ2 3’ + SALK LB 
expected sizes:  5.24 kb                               -                                3.3 kb                               1.9 kb 
Samples 3, 5, 6 and 8 are homozygous for the AKINβ2 mutation. 
primers 
AKINbeta1 5' 5'-GACCATCTCTATTCTAACCCCACC-3'  
AKINbeta1 3' 5'-GGTTACCGTGTGAGCGGTTTGTAG-3'  
AKINbeta2 5' 5'-GAAGCTTCAGATCACGACTTGTTCC-3'  
AKINbeta2 3' 5'-ATCACGGCTCAGCAGGTTGGTTCAG-3'  
SALK LB 5'-TTTGGGTGATGGTTCACGTAGTGGG-3'  
GABI RB 5’-TTCCATTGCCCAGCTATCTGTCAC-3’  
FISH2  5'-CAGTCATAGCCGAATAGCCTCTCCA-3' 
FISH1  5'-CTGGGAATGGCGAAATCAAGGCATC-3'  
 
Figure 4. Isolation of homozygous akinβ2 mutants 
 
 
 
-4361bp 
 
-2322bp 
-2027bp 
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3.1.3. Isolation of SnRK1 β subunit mutations in the Koncz collection 
In order to isolate additional mutant alleles for the SnRK1 β subunit genes, a T-DNA insertion mutant 
collection (referred to as “Koncz collection”) generated by our laboratory was also screened. The 
Koncz collection of T-DNA-tagged Arabidopsis thaliana plants contains 92500 transgenic lines. 
Identification of individual mutations in the Koncz collection employs a PCR based screen in two 
rounds. The mutant population was split into pools each containing 100 different mutant lines. 
Genomic DNA was extracted from the pools and arranged into a two dimensional array. Aliquots of 
the DNA extracts located in one row or one column of the array are pooled again and serve as a 
template for PCR reaction, thereby reducing the total number of PCR reactions necessary for the 
identification of one pool. The result of this screen is a pool of 100, which is screened further with the 
same strategy by arranging its 100 members into a 10x10 array. Each screen requires a pair of gene 
specific primers designed upstream and downstream to the gene of interest and these primers are used 
in combination with T-DNA right and left border specific primers.  
 The screen resulted in the identification of a mutation in the AKINβ1 coding sequence 
(KONCZ_14344) and another tag in the 5’-UTR (KONCZ_66465), from which the one in the coding 
sequence was processed further. Due to alternative splicing event the KONCZ_14344 mutation is 
located in the open reading frame only in case of the longer splicing variant (At5g21170.1) whereas in 
the shorter variant the insertion is found in the 3’-UTR. One additional mutation was identified in the 
first intron of AKINβ2 (KONCZ_87453), but no mutations were found in AKINβ3.  
 The T2 generation of mutant seeds was germinated on hygromycin and the 3:1 resistant to 
sensitive segregation ratio indicated that there is probably one insert in the mutant lines. Homozygous 
mutants were identified by PCR analysis (Figure 5). As additional test, the T3 generation progeny of 
identified homozygous plants was germinated on hygromycin plates and no sensitive seedlings had 
been found. 
 
 
3.1.4. Analysis of transcript level of mutated SnRK1 beta subunit genes 
In order to test whether the T-DNA insertions caused knockout mutations, RNA was extracted from 
the mutant plants, cDNA was prepared and the samples were analyzed by RT-PCR. Potential 
transcription of the target gene sequences located downstream of LB insert junctions carrying the 
CaMV35S promoter was also tested. Primers were designed to the 5’ and 3’ ends of coding sequences 
of each SnRK1 beta subunit genes and used in combination with right and left border specific primers 
(Figure 6.) In case of AKINβ1 SALK_008325 allele the 5’-segment of coding is transcribed from 
either direction. The RT-PCR reaction was carried out with 40 cycles with 60oC annealing temperature 
and 8 min extension time. 
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AKINβ1_KONCZ_14344     
 
           AKINβ1 5’+ AKINβ1 3’                AKINβ1 5’ + FISH1 (LB)                FISH1 (LB) + AKINβ1 3’ 
expected sizes:    4.3 kb                                           1.9 kb                                                    - 
The FISH2 + AKINβ1 3’ primer combination did not yield any product 
Samples 2 and 8 were homozygous for the mutation 
 
 
AKINβ2_KONCZ_87453  
 
             AKINβ2 5’ + AKINβ2 3’                AKINβ2 5’ + FISH1 (LB)               FISH1 (LB) + AKINβ2 3’ 
expected sizes:     5.2 kb                                                3.3 kb                                                 -  
The FISH2 + AKINβ2 3’ primer combination did not yield any product 
Sample 2 was homozygous for the mutation 
 
 
AKINbeta1 5' 5'-GACCATCTCTATTCTAACCCCACC-3'  
AKINbeta1 3' 5'-CCTCATATTTGCCAACCCAACGCCTG-3'  
AKINbeta2 5' 5'-GAAGCTTCAGATCACGACTTGTTCC-3'  
AKINbeta2 3' 5'-ATCACGGCTCAGCAGGTTGGTTCAG-3'  
AKINbeta3 5’ 5’-AGTCTGAGAAGCATAGACAAGGAGTGAAG-3’ 
AKINbeta3 3’   5’-TACAAACAAACAATGCCCACGTCTATCAGC-3’ 
FISH1  5'-CTGGGAATGGCGAAATCAAGGCATC-3'  
FISH2  5'-CAGTCATAGCCGAATAGCCTCTCCA-3'  
 
Figure 5. Identification of homozygous mutant lines for the AKINβ1 and AKINβ2 KONCZ alleles 
 
 
 
3.1.5. Generation of double AKIN beta subunit mutants 
 
AKINβ1 SALK 008325 x AKINβ2 KONCZ 87453 and AKINβ1 SALK 008325 x AKINβ2 SALK 
037416 double mutants were generated by crossing the mutant Arabidopsis plants. Double 
homozygous plants were identified in the F2 generation using PCR screening with the same 
combinations of primers used for the analysis of single mutants. 
 
 
 
 
-4.3kb 
-2.3kb 
-2.0kb 
 
 
 
-0.5kb 
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AKINβ1 5’ RTPCR:        5’-GGTAGCGGTGGTGCAGATGTTACCTC-3’ 
AKINβ1 3’ RTPCR:        5’-GTGGCACTGAATTTTTAGGGTTACCGTGT-3’ 
AKINβ2 5’ RTPCR:        5’-GCTGAGATTTGTTCCTCGTGAAGCTATGT-3’ 
AKINβ2 3’ RTPCR:        5’-GAATTGCATCATCTTCACTCACCTCTGC-3’ 
FISH1 (LB)              5'-CTGGGAATGGCGAAATCAAGGCATC-3' 
FISH2 (RB)              5'-CAGTCATAGCCGAATAGCCTCTCCA-3' 
tubulin fwd (At5g62690) 5’-AGGAACTGGATCTGGTATGGGAACAT-3’ 
tubulin rev        5’-GTCACACCAGACATAGTAGCAGAAATCAAG-3’ 
 
       
 
   
 
Figure 6. RT-PCR analysis of the SnRK1 beta subunit mutants 
 
 
3.1.6. Isolation of homozygous T-DNA insertion mutants for two SnRK1 upstream 
activating kinases 
Based on sequence homology to yeast Snf1 upstream activating kinases, two genes were identified 
recently in Arabidopsis as putative SnRK1 upstream kinases [37, 57], AtSnAK1 (At5g60550) and 
AtSnAK2 (At3g45240), which can complement the yeast elm1sak1tos3 triple mutation. T-DNA 
insertion mutants are available for both genes in the public collections (Figure 7.). Here the 
    1 kb- 
 
 
 500bp- 
500bp- 
300bp- 
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C 
 
 
 
 
D 
 
 
 
 
E 
 
 
 
 
F 
A  1.)  wt     AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     2.) AKINβ1 GABI  235B06 AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     3.) wt   AKINβ1 5’ RTPCR + GABI RB 
     4.) AKINβ1 GABI  235B06 AKINβ1 5’ RTPCR + GABI RB 
     5.) wt   FISH1 (LB)  + AKINβ1 3’ RTPCR 
     6.) AKINβ1 GABI 235B06 FISH1 (LB)  + AKINβ1 3’ RTPCR     
 
B  1.) wt    AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     2.) AKINβ1 SALK 008325  AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     3.) wt   AKINβ1 5’ RTPCR + SALK LB 
     4.) AKINβ1 SALK 008325   AKINβ1 5’ RTPCR + SALK LB 
     5.) wt   FISH2 (RB) + AKINβ1 3’ RTPCR 
     6.) AKINβ1 SALK 008325 FISH2 (RB) + AKINβ1 3’ RTPCR 
 
C  1.) wt   AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     2.) AKIN β1Koncz 14344 AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     3.) wt   AKINβ1 5’ RTPCR + FISH1 
     4.) AKIN β1Koncz 14344 AKINβ1 5’ RTPCR + FISH1 
     5.) wt   FISH1 + AKINβ1 3’ RTPCR 
     6.) AKIN β1Koncz 14344 FISH1 + AKINβ1 3’ RTPCR 
 
D  1.) wt    AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     2.) AKINβ2 SALK  037416 AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
     3.) wt   AKINβ1 5’ RTPCR + SALK LB 
     4.) AKINβ2 SALK  037416 AKINβ1 5’ RTPCR + SALK LB 
     5.) wt   SALK LB + AKINβ1 3’ RTPCR 
     6.) AKINβ2 SALK  037416 SALK LB + AKINβ1 3’ RTPCR 
 
E   1.) wt   AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
      2.) AKINβ2 Koncz 87453  AKINβ1 5’ RTPCR + AKINβ1 3’ RTPCR 
      3.) wt   AKINβ1 5’ RTPCR + FISH1 
      4.) AKINβ2 Koncz 87453 AKINβ1 5’ RTPCR + FISH1 
      5.) wt   FISH1 + AKINβ1 3’ RTPCR 
      6.) AKINβ2 Koncz 87453 FISH1 + AKINβ1 3’ RTPCR 
 
F    1.) wt    tubulin fwd and rev 
      2.) AKINβ1 GABI  235B06  tubulin fwd and rev 
      3.) AKINβ1 SALK 008325 tubulin fwd and rev 
      4.) AKIN β1Koncz 14344 tubulin fwd and rev 
      5.) AKINβ2 SALK  037416  tubulin fwd and rev 
      6.) AKINβ2 Koncz 87453 tubulin fwd and rev 
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AtSnAK1_SALK_015230, AtSnAK1_SALK_000044 and AtSnAK2_SALK_142938 mutations are 
described. 
 
 
SnAK1 
junctions: 
SALK_000044 
GACAAGGTTGGTTTTACATATGATCAATGCTTTCCTTGGATCTTAAGAACTCTTTTTGAA 
             1797    LB  (downstream junction is not known) 
SALK_015230 
GCATCGATCTGTTGTTGCTACAGGATGATGACGATCAGCTGCGCCGATCTCCCGGG 
           1503  LB                                       LB    1526 
 
 
SnAK2 
junctions: 
SALK_142938 
CACGCGGAGAGGTATGCGACTTCTTGTGCTCATGTCGAATGTGCTTTGCCGAATGGTGTTCTTATACTAGCTT 
      317  LB                          LB  338 
 
Deleted target sequences are marked by red letters. 
Figure 7. T-DNA insertion mutations in genes of SnRK1 upstream kinases SnAK1 and SnAK2 
 
In order to isolate homozygous mutants, genomic DNA was extracted from 10 individual T2 lines and 
analyzed by PCR. A gene specific oligonucleotide pair was designed for both genes, which were used 
in combination with T-DNA border specific primers (FISH2, SALK LB, Figure 8.) 
 
 
3.1.7. Phenotypic analysis of SnRK1 subunit mutants 
During germination, seedling development and growth in soil none of the homozygous plants showed 
any obvious phenotypic alteration compared to wild type plants. To test for possible alteration of 
normal sugar and ABA responses, homozygous mutant seeds were germinated on 0.5x MS medium 
containing either 3% glucose, or 5% sucrose, or 1μM ABA or 2μM ABA. Germination of the mutant 
seeds was followed by monitoring the liberation of cotyledons from the testa. No difference could be 
observed between the germination speeds of the seeds. Despite 3 days of stratification treatment at 
4°C, the germination speed showed relatively great differences between and within the sample 
populations, especially when treated with ABA. Although, the germination kinetics was different 
between the samples, it was not consequent between repeated experiments. (The results are 
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summarized in Appendix 1.) As sugar content of 0.5MS seed medium (i.e., 0.5% sucrose) could also 
cause some variation in the germination speed, we also tested germination characteristics of mutants 
on sugar free medium, as well as the development of seedlings on agar solidified distilled water plates 
and germination of the mutants for 10 days in the dark. These assays revealed no significant 
differences between the different single akin10, akinβ1, akinβ2, snak1, snak2 and akinβ1akinβ2 
double mutants compared to wild type seedlings. The latter observation indicated that Arabidopsis can 
tolerate inactivation of two from three known putative subunits of SnRK1 kinases without showing 
observable alterations in sugar and ABA responses and development. 
 
 
SnAK1_SALK_000044 
 
         SnAK1 5’+ SnAK1 3’                          SnAK1 5’ + SALK LB 
expected sizes:   3.5kb                                                   2.0kb 
homozygous mutants: 1, 3  
(C = wild type control) 
(SALK LB + SnAK1 3’and FISH2 (RB) + SnAK1 3’ primer combinations did not yield product) 
 
SnAK1_SALK_015230 
 
            SnAK1 5’ + SnAK1 3’          SnAK1 5’+ SALK LB                      SALK LB + SnAK1 3’ 
expected sizes:      3,5kb                       -                 1.8kb 
homozygous mutants: 1, 2, 3, 4 
 
SnAK2_SALK_142938 
 
            SnAK2 5’ + SnAK2 3’  SnAK2 5’ + SALK LB                   SALK LB + SnAK2 3’ 
expected sizes:    3.0kb                              1.0kb          2.0kb 
homozygous mutants: 1, 3, 4, 6, 7, 8 
          
SnAK1 5'  5'-TTGAAGCCCTCGAAACCCCTTTTATC-3'   
SnAK1 3'  5'-AGCTATGGTCTCCTGGACGCACACAA-3'   
SnAK2 5'  5'-CATTTCTTCTCATGTGCCATGGATATTG-3' 
SnAK2 3'  5'-TTGGAGTTGATTTTGGCCGTTTTACCC-3'  
 
Figure 8. Isolation of homozygous SnAK mutants 
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3.2. OVEREXPRESSION OF SNRK1 BETA SUBUNITS 
3.2.1. Construction of a CaMV35S promoter driven GFP tagging vector 
 
In order to test, whether the Arabidopsis SnRK1 β subunits undergo subcellular relocalization in 
response to nutritional stress analogously to the yeast Snf1 β subunits, GFP-tagged SnRK1β constructs 
were prepared. A CaMV35S promoter driven GFP tagging vector was created by reconstruction of the 
pPILY HA epitope tagging vector [224] (see Appendix 2 for the map of pPILY). The intronic HA tag 
was substituted with the GFP version “emerald” (the “emerald” GFP template was a courtesy of Dr 
Guido Jach). The GFP fragment was obtained by PCR amplification using the primers GFPfwd and 
GFPrev, which incorporated an NcoI restriction endonuclease site to the 5’ end of the PCR product 
(including the start codon within the NcoI site), and a BamHI site downstream of the stop codon. This 
PCR fragment was inserted into NcoI-BamHI sites of pPILY vector. In the resulting GFP tagging 
vector (pGFP), the NcoI site provides a cloning site for creating and expression of C-terminal GFP 
fusion constructs. The expression cassette can easily be subcloned into the pPCV002 (KmR) or pPCV 
812(HygR) binary vectors by the rare cutting NotI restriction endonuclease.  
 
3.2.2. Overexpression of GFP-tagged SnRK1 β subunits 
Coding sequences of all three AKINβ subunits were cloned to the NcoI site of pGFP vector. The 
AKINβ subunit cDNAs were PCR amplified from a cDNA library formerly prepared from 
Arabidopsis cell suspension culture (provided by a former colleague, Klaus Salchert). Primer pairs 
were designed for all three AKINβ subunits by incorporating NcoI sites to both ends of the PCR 
product (AKINβ1GFPfwd + AKINβ1GFPrev, AKINβ2GFPfwd + AKINβ2GFPrev, AKINβ3GFPfwd 
+ AKINβ3GFPrev. NcoI does not cut in any of the AKINβ subunits.) After cloning the AKINβ 
cDNAs into pGFP, the orientation of inserts was determined (i.e., by HindIII + BglII for AKINβ1, 
HindIII for AKINβ2 and NaeI + BglII for AKINβ3) and subsequently the correct clones were 
sequenced with a 35S promoter primer (AKINβ1 is 855bp, AKINβ2 is 870bp and AKINβ3 is 345 bp 
therefore unidirectional sequencing was sufficient). The expression cassettes were excised by NotI and 
inserted into a single NotI site of pPCV 812-NotI binary vector (HygR). The resulting binary vectors 
were transformed into the Agrobacterium strain GV3101 (pMP90RK) and used for transformation of 
Arabidopsis plants, as well as root- and leaf-derived cell suspension cultures. All plant materials were 
selected for hygromycin resistance marker of pPCV812-NotI T-DNA. 
 
 
3.2.3. Analysis of SnRK1β-GFP overexpressing plants and suspension cultures 
GFP signal in cultured cells grown in MS medium was compared to that of cells transferred to 90mM 
sorbitol solution or distilled water kept in darkness for 3-4 hours. Re-localization of the AKINβ 
proteins could not be assessed, because no GFP signal was detectable in the samples that were 
cultured in MS medium with 3% sucrose regardless growing them either in the light or in darkness. In 
contrast, in samples incubated in sugar free medium in the dark GFP signal could be readily detected, 
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but it faded extremely quickly when exposed to strong blue light in the confocal microscope. The 
fading was quicker than normal photobleaching, since the initial GFP signal faded within a few 
seconds, causing a technical problem in capturing the images.  
The GFP signal produced in AKINβ1-GFP overexpressing suspension cultures appeared to be 
abnormal, since GFP was detectable throughout the cell excluding the nuclear matrix. (The image is 
shown only to illustrate that even in this abnormal state of the cell AKINβ1 is excluded from the 
nuclear matrix.) AKINβ1 in seedlings and AKINβ2 in both cell suspensions and seedling material 
looked mostly associated to the plasma-membrane and the nuclear envelope, but were not detected in 
the nuclear matrix. At lower levels, AKINβ1 and AKINβ2 were also detected in the cytoplasm as 
intense fluorescent spots that may represent artificial aggregates (pers. comm. with Dr Elmon 
Schmelzer). By contrast, AKINβ3 was present mostly in the nuclear matrix but at lower level was also 
detected in the cytoplasm (see cytoplasmic bridges in Figures 9/6B). AKINβ3 was also found in the 
peripheral region of the cell. This localization probably corresponds to periplasmic cytoplasm, because 
AKINβ3 does not carry a myristoylation motif, which would target it to the plasma membrane. In 
comparison, AKINβ1 and AKINβ2 could not be detected in cytoplasmic bridges. Expression of all 
three AKINβ proteins could be detected in both photosynthetic and root tissues of seedlings and in 
green and root derived cell suspension cultures depleted for sucrose. The observed rapid sugar-induced 
degradation of AKINβ proteins suggested the possibility of proteasomal degradation, for which 
evidence is given below in the biochemical chapter. The AKINβ-GFP fusion protein overexpressing 
heterozygous plants were grown to adult phase, but no phenotypic alteration could be observed 
compared to wild type Arabidopsis plants. 
 
 
 
 
 
Figure 9. Expression of GFP-tagged SnRK1 beta subunits 
The Figure is displayed on the next page. All photos were taken from cells and tissues exposed to sugar free 
medium and darkness. 
 
1.A and 1B AKINβ1-GFP in root derived cell suspension culture. Aberrant cells, but no signal is detected 
in the nucleus. 
2A and 2B AKINβ2-GFP in root derived cell suspension culture. GFP signal is detected in the 
plasmamembrane and nuclear envelope. 
3A and 3B AKINβ1-GFP in Arabidopsis root cells. 
4A and 4B AKINβ2-GFP in root derived cell suspension culture. GFP signal is detected mostly in the 
plasmamembrane and nuclear envelope. 
5A and 5B AKINβ3-GFP in root derived cell suspension culture. GFP signal is detected in the nucleus and 
subcortical cytoplasm. 
6A and 6B AKINβ3-GFP in root derived cell suspension culture. GFP signal is detected in the nucleus and 
cytoplasm. Note the signal in the cytoplasmic bridge. 
7A and 7B AKINβ3-GFP in root epidermal cell of an Arabidopsis seedling. 
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3.2.4. Transcription regulation of AKINβ and other SnRK1 subunit genes 
 
Data from the Genevestigator database were collected to get information about the expression profiles 
of SnRK1β subunit genes in diverse Arabidopsis tissues and developmental stages (Figure 10.). In our 
experiments the most abundant accumulation of GFP-tagged SnRK1β subunit proteins were observed 
in vascular tissues (Figure 11). 
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Figure 10. Developmental regulation of transcription of SnRK1 subunit genes 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. AKINβ1-GFP (A) and AKINβ2-GFP (B) proteins are stable and accumulate in vascular tissues 
of overexpressing plants 
 
 
Expression of SnRK1 subunits 
(Based on data from Genevestigator 
database) 
 
 
To the left: 
Expression profile of SnRK1 subunits 
from the anatomical aspect. AKIN12 was 
long believed to be a pseudogene, but 
recently its low level expression could be 
detected. 
 
 
 
 
 
 
 
To the right: 
Expression profile of SnRK1 subunits 
from the developmental aspect. 
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3.3. DEVELOPMENT OF A BIOCHEMICAL APPROACH FOR ISOLATION OF 
SNRK1 COMPLEXES FROM ARABIDOPSIS  
 
In the past years, our laboratory invested a considerable effort into isolation of proteasome-associated 
SnRK1 complexes from various plant materials. This approach primarily aimed at the identification of 
SnRK1-interacting proteins, especially in the proteasomal context. In these trials, generally ion 
exchange chromatography was applied as the first step followed by gel filtration or glycerol gradient 
centrifugation to separate differently sized protein complexes, and finally immunoaffinity 
chromatography to pull-down the epitope labeled SnRK1 subunits. Generally, two candidate 
interacting proteins (i.e., SnRK1 subunit and its candidate interacting partner) were tagged with HA 
(influenza haemagglutinin) and cMyc (human cMyc peptide) epitope tags, respectively, against which 
monoclonal antibodies and immunoaffinity matrices were commercially available. One of the tags was 
used for isolation of protein complexes by immuno-affinity chromatography and the other for 
detection of the interacting partner. Additionally, several specific antibodies were used to detect 
proteasomal components in the purified complex. Final aim was the isolation of sufficient amounts of 
protein complexes for mass spectrometric analysis and identification of yet unknown subunits of 
SnRK1-proteasome complexes. However, due to high cost and high background of immunoaffinity 
chromatorgraphy matrices and low yield of protein complexes obtained by specific peptide elution and 
competition, these approaches were severely handicapped. Further potential problems were caused by 
the high proteolytic activity. As proteasomal inhibitors, such as MG132, are extremely expensive, 
their application throughout all steps in processing large sample quantities was not feasible. In 
addition, after ion exchange chromatography and gel filtration or glycerol gradient centrifugation 
immunoblot detection was necessary to identify the chromatographic fractions, which contained the 
protein complexes of interest. During this lengthy procedure the samples were either stored on ice 
(i.e., exposed to proteolytic activity), or frozen (i.e., which might lead to disintegration of high 
molecular mass protein complexes). These technical barriers raised a demand for a fast and robust 
purification method that provide high selectivity and sufficient capacity for handling large amounts of 
samples. 
The use of histidin tag in nickel chromatography to purify proteins is a widespread technique 
in bacterial, yeast and human applications. However, in plants there are high levels of metal-binding 
proteins and therefore this method results in a high background. StrepII tag based affinity 
chromatography has also been used with success in plants, but only relatively small quantities of 
starting material can be applied to the Strep-affinity matrices because plant tissues contain biotin 
(vitamin H), which binds to the Strep-tactin Sepharose matrix and blocks the binding sites. (Avidin 
can be used to block the biotin in the sample before application to the chromatographic matrix, but it is 
extremely expensive and therefore not a practical solution with large sample quantities.) The 
combination of His and StrepII tags provides extremely high purification efficiency and widely used 
for isolation of proteins from yeast and mammals that are expressed by the help of commercially 
available vectors. However, so far no instance was reported on the use of this combination of affinity 
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chromatographies for successful isolation of recombinant proteins and protein complexes from plant 
tissues although, when using Ni-chromatography as first purification step biotin can be theoretically 
removed, and the subsequent Strep-purification is thus predicted to provide high purity. 
 
 
3.3.1. Construction of an expression vector for tandem His-Strep tag affinity 
purification of plant proteins  
 
In trials to isolate His-tagged proteins from Arabidopsis one contaminating protein accumulated to 
especially high level during nickel affinity purification (personal communication with Andreas 
Bachmair). This component was identified by mass spectrometric analysis and proved to be a putative 
cobalt-binding protein (PIP-L, PRL1 interacting partner-L, At1g15730), which carries homology to 
the Pseudomonas denitrificans CobW cobalt-binding protein. Certainly, the cobalt-binding properties 
are responsible for the high affinity to the Ni-matrix. We identified a histidine-rich low complexity 
sequence region carrying the putative cobalt-ion-binding domain. This histidine-rich region also 
contains several negatively charged residues (D, E), residues with non binding electron pair (N, S, T) 
and a cysteine, which might also play a role in metal-ion binding. The putative metal-binding 
sequence (highlighted in red bold) was exploited as natural histidine tag and it is referred to as PIP-L-
tag. 
 
PIP-L amino acid sequence: 
MATLLKLDIATTFLAFIVPRANTSLNHRFASARLSTATVSLRTKSSSFYSAALYSDSRRRFHSAVASDSSL
AVVDDEDIFDVASEILPDNRIPATIITGFLGSGKTTLLNHILTGDHGKRIAVIENEFGEVDIDGSLVAAQTA
GAEDIMMLNNGCLCCTVRGDLVRMISEMVQTKKGRFDHIVIETTGLANPAPIIQTFYAEDEIFNDVKLD
GVVTLVDAKHARLHLDEVKPEGYVNEAVEQIAYADRIIVNKTDLVGEPELASVMQRIKTINSMAHMKR
TKYGKVDLDYVLGIGGFDLERIESSVNEEEKEDREGHDDHHHGHDCHDHHNEHEHEHEHEHHHSH
DHTHDPGVGSVSIVCEGDLDLEKANMWLGALLYQRSEDIYRMKGILSVQDMDERFVFQGVHEIFEGSP
DRLWRKDETRTNKIVFIGKNLNREELEMGFRACLI. 
 
First, the Ni-binding capability and efficiency of the selected peptide sequence was tested using a 
bacterially overexpressed TRX-AKIN11-PIP-L protein. The clone was prepared by incorporating the 
PIP-L sequence into the AKIN11pET201 construct (see 3.4.1.). The PIP-L sequence was obtained by 
PCR amplification from an Arabidopsis cDNA library using the primers piplfwd and piplrev which 
both incorporated an EcoRI site. The PCR product was inserted to the EcoRI site at the downstream 
junction of the AKIN11pET201 construct. Piplrev contained a stop codon, therefore the His tag in the 
original vector is not translated. The Ni-binding properties of PIP-L tag were practically identical to 
that of the conventional His6-tag (Figure 12). The TRX-AKIN11-PIP-L protein also showed specific 
binding to a Co2+-containing resin (TALONTM BD Biosciences) and the purification factor achieved 
with Ni and Co2+ matrices was comparable (data not shown), although the patterns of contaminating 
proteins differed.  
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Figure 12. Imidazole gradient elution of TRX-AKIN11-PIP-L 
An arrow shows the position of TRX-AKIN11-PIP-L protein. His6-tagged proteins generally start to elute at 100 
mM imidazole. 
 
A vector for tandem affinity tag labeling (p3xtag) was designed to fuse genomic and cDNA sequences 
with coding sequnces of PIP-L, StrepII and intronic HA tags to express C-terminally labeled proteins 
in plants (Figure 13.). In this combination, the HA tag was designed for control immunodetection, but 
in principle it can also be used as a third, immunoaffinity tag. The vector was created by modification 
of pMenchu (SalI-) HA-tagging vector. The 105 bp long PIP-L fragment was obtained by PCR-
amplification from a cDNA library using 3xtagfwd and 3xtagrev oligonucleotide primers. 3xtagfwd 
incorporated HindIII-ATG-SalI-BglII-XbaI sites upstream of the PIP-L coding region, whereas 
3xtagrev contained a StrepII-tag (the bacterial version of Strep-tag was modified for optimal 
Arabidopsis codon usage) and a BamHI site. The PCR-product was inserted into pMenchu (SalI-) 
vector as HindIII-BamHI fragment into the HindIII-BglII sites. In this way, the vector carried a 
destroyed BglII site along with a formerly removed SalI site located downstream of the cloning site. 
Therefore, the introduced SalI, BglII and XbaI sites are unique sites, comprising the multicloning 
polylinker of the new vector. This pMenchu vector cassette can be transferred to the pPCV binary 
vectors as NotI fragment. 
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  HinDIII               SalI            BglII    XbaI                                             PIP-L tag 
AAGCTTATG GTC GAC AGA TCT AGA GGT CAT GAT GAT CAT CAC CAT GGT CAT GAC TGC  
 
CAT GAT CAC CAC AAT GAG CAT GAG CAT GAG CAT GAA CAC GAG CAT CAC CAT TCT  
 
                                                                            StrepII tag (A.t. codon usage)                  BamHI/BglII   
CAT GAT CAC ACC CAT GAC AAG TGG TCT CAT CCT CAA TTC GAA AAA GGA TCT TAT CCA  
 
   HA tag                                          intron 
TAC GAT gtaagtttctgcttctacctttgatatatatataataattatcattaattagtagtaatataatattttaaatatttttttcaaaataaaagaa 
 
                                                    intron 
tgtagtatatagcaattgcttttctgtagtttataagtgtgtatatttcaatttataacttttctaatatatgaccaaaatttgttgatgtgcag GTT CCA 
 
HA tag    filled SalI from pMenchu   BamHI        PstI         STOP 
GAT TAT GCT ggt cga tcg acG GAT CCa CTG CAG TGA att c 
 
Figure 13. Physical map and sequence of the coding region of PIP-L-Strep-HA tag of p3xtag tandem 
affinity tagging vector 
 
 
3.3.2. Cloning of SnRK1 subunits into the p3xtag tandem affinity tagging vector 
 
cDNAs encoding AKIN10 and AKIN11 were cloned into the p3xtag vector as SalI-BglII and SalI-
XbaI fragments respectively, after amplification with A10_3xfwd, A10_3xrev, A11_3xfwd and 
A11_3xrev oligonucleotide primers. Since constitutive overexpression of AKINs was predicted to be 
problematic based on former experiments, the tagged open reading frames were subcloned into the 
estradiol-inducible 35S promoter driven expression cassette of pER8 (HygR) vector. To achieve this, 
the complete tagged reading frames of AKIN10 and AKIN11 were excised as SalI-EcoRI fragments 
from p3xtag thereby loosing the 2x35S promoter. (Since an extra start codon was integrated into the 
construct with the primers, loosing the vector’s start codon by the SalI digest did not cause a problem.) 
The pER8 binary vector contains only unique SpeI and XhoI cloning sites. Therefore, the cloning was 
managed through an intermedier vector, into which the tagged reading frame was inserted as SalI-
EcoRI fragment and then subcloned into pER8 by SpeI-XhoI using the flanking cleavage sites in the 
intermedier vector. In addition, all three AKINβ subunits were cloned into the p3xtag vector as SalI-
XbaI fragments and transferred into pPCV002 (KmR) as NotI fragments.  
 
 
3.3.3. Immunoblot analysis of the overexpressed PIP-L-tagged SnRK1 subunits 
All five AKIN subunit constructs were transformed into root-derived cell suspension cultures through 
Agrobacterium-mediated transformation using Agrobacterium GV3101 (pMP90RK) as host for the 
pPCV002 constructs and GV3101 (pMP90) for the pER8 constructs. The expressed proteins were 
detected by western blot analysis using α-HA antibody. All five SnRK1 subunits were expressed at a 
low level in the cultures maintained with 3% sucrose confirming that the stability of these proteins is 
regulated by the levels of sucrose as seen in chapter 3.2.3. 
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1 AKINβ1+sucrose, light 6 AKINβ2+sucrose, light 11 AKINβ3+sucrose, light 
2 AKINβ1-sucrose, light 7 AKINβ2-sucrose, light 12 AKINβ3-sucrose, light 
3 AKINβ1-sucrose, dark 8 AKINβ2-sucrose, dark 13 AKINβ3-sucrose, dark 
4 AKINβ1+sucrose, dark 9 AKINβ2+sucrose, dark 14 AKINβ3+sucrose, dark 
5 AKINβ1+sucrose,dark, 
+MG132 
10 AKINβ2+sucrose,dark, 
+MG132 
15 AKINβ3+sucrose,dark, 
+MG132 
 
Figure 14. Proteasomal degradation of the SnRK1α and β subunits 
The expression level of the SnRK1β subunits could not be significantly increased by changing light conditions or 
sugar availability in the medium. 
 
 
The role of light and the presence or absence of sucrose in the medium was tested in case of β 
subunits, but in the root-derived cell suspension culture these conditions did not significantly alter the 
protein stability. Application of the proteasome inhibitor MG132 greatly increased protein amount of 
all the tested α and β subunits indicating proteasomal degradation of all five subunits. 
 
3.3.4. Purification of PIP-L tagged SnRK1 beta subunits from Arabidopsis cell 
suspension culture 
It was attempted to purify heterotrimeric SnRK1 kinase complex and identify its associated protein 
components from plants using the PIP-L-StrepII tagged constructs (detailed protocol is given in the 
materials and methods chapter). In the first step, total protein extract was purified on NiNTA resin 
through the PIP-L tag, and imidazole gradient elution was applied (Figure 15.). The fractions were 
analyzed by Coomassie-staining and immunoblotting with α-HA antibody. The positive fractions were 
pooled and applied onto Strep-tactin resin, washed, and eluted with 2.5mM desthiobiotin. The samples 
were analyzed by western blotting and concentrated by vacuum centrifugation or TCA-aceton 
precipitation. Purification of AKINβ2 yielded the best result from the SnRK1 subunits, but the 
extracted protein amount was still not sufficient for subsequent mass spectrometric analysis. The 
extracted AKINβ2 appeared as a double band indicating secondary modification in vivo. 
 
A: western blot 
1. overexpression of AKIN10-3xtag  
2. overexpression of AKIN11-3xtag 
 
B western blot 
1. AKIN10-3xtag uninduced 
2. AKIN10-3xtag estradiol induced  
3. AKIN10-3xtag induced + MG132 
4. AKIN11-3xag uninduced 
5. AKIN11-3xtag estradiol induced 
6. AKIN11-3xtag induced + MG132 
 
C: Coomassie loading control 
 + western blot. Loading is specified in 
the table below. 
  
RESULTS  79 
 
  
Figure 15. Tandem affinity purification of AKINβ2-PIP-L-Strep-HA protein from Arabidopsis cell 
suspension culture 
Elution from the NiNTA matrix was performed with imidazole gradient ranging from 20mM to 250mM using 
20mM steps with 500μl fraction volumes. Elution from Strep-tactin matrix was done with 2.5mM desthiobiotin 
with 500μl fractions. C: crude extract, FT: flowthrough, W: wash. 
 
It was noteworthy that in the crude extract the immunoblot analysis did not detect HA signal, which 
implies that the AKINβ2-PIP-L-StrepII-HA protein concentration was under the detection level. 
However, the method was capable to enrich the PIP-L-Strep-tagged protein. The protein concentration 
was 1.350 mg/ml in the crude extract and 0.148mg/ml in the 140mM imidazole fraction of NiNTA 
column (measured by Bradford assay). Therefore, the calculated purification was extremely high, 
9122-fold in the first step. After the second chromatography the protein concentration was too low to 
be measured by Bradford assay, therefore the purification rate could not be determined.  
 Although the protein amount can be significantly increased by the use of MG132 proteasome 
inhibitor, this is not the method of choice with large amounts of samples because of the very high 
price of this chemical. In addition, accumulation of one member of a protein complex does not help to 
identify other members, since their amount may not increase simultaneously. The above described 
purification method could also be useful to identify phosphorylation sites on monomer proteins. When 
working with plant protein samples, two relatively successful protein monomer isolation techniques 
are used: phenol extraction and TCA-aceton precipitation followed by 2D gel analysis and mass 
spectrometry of the redissolved proteins. These approaches prevent protein degradation due to 
denaturation and also preserve secondary modifications, but the proteins are precipitated and need to 
be dissolved. Proteins can be dissolved efficiently in chaotropic agents (8M urea or 6M guanidinum 
hydrochloride) which are compatible with Ni-chromatography. Chaotropic agents can be washed out 
 kDa 
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during the NiNTA purification, and afterwards the sample can be applied to the Strep matrix. 
Therefore, the method described here could add a highly selective purification step to these protein 
extraction methods. 
 
 
3.4. IN VITRO PHOSPHORYLATION OF CANDIDATE PROTEASOMAL 
SUBSTRATES 
SnRK1 kinases have been already investigated form many aspects with limited success. Reverse 
genetic approach and overexpression analyses were performed with nearly all subunits (PhD theses 
Kenneth Berendzen and Vijaya Shukla, and this work). A microarray experiment based on 2 pairs of 
chips was recently published by Jen Sheen and a similar pilot experiment was also carried out in our 
lab (PhD thesis of K.B.). Isolation of protein complexes including SnRK1 subunits was also 
attempted, as well as phosphorylation site determination on the SnRK1β subunits, but finally ended 
with no success of MALDI analyses. Moreover, GFP localization and AKIN promoter-GUS fusion 
analysis have been also completed except using GFP labeling of full-length genomic constructs (PhD 
thesis K.B.).  
Yeast two-hybrid screens with AKIN10 and AKIN11 identified the α7 proteasomal subunit 
and SKP1, a component of SCF type E3 ubiquitin ligase complexes, as SnRK1α-interacting partners. 
These interactions were verified also in vivo. The presence of a UBA domain in SnRK1 kinases 
further supports their proteasomal interaction since polyubiquitin chain formation on proteins is the 
signal for their proteasomal degradation. Since the proteasomal α7 subunit and SKP1 were proved to 
be no substrates for SnRK1 kinases in vitro, we searched SnRK1 kinase substrates amongst several 
known and candidate proteasomal substrates. Phosphorylation of proteasomal substrates often 
precedes their proteasomal degradation. In yeast, Snf1 has been shown to control proteasomal 
degradation of multiple components of sugar signalling and metabolic pathways. The mechanism 
might be conserved because sugar-controlled degradation of sugar-related enzymes was also 
demonstrated in Arabidopsis at the physiologic level. Participation of 14-3-3 proteins in the process 
both in yeast and Arabidopsis further supports the existence of a conserved mechanism. Therefore, 
proteasomal substrates and also F-box proteins, substrate recognition subunits of SCF-type E3 
ubiquitin ligase complexes, were expressed in and purified from E. coli and subjected to in vitro 
kinase reactions with recombinant AKIN10 and AKIN11. This assays were possible because in 
contrast to yeast and mammal AMPKs Arabidopsis SnRK1α catalytic subunits show 
autophosphorylation and some degree of substrate phosphorylation activity in vitro. 
 
 
3.4.1. Generation of Arabidopsis SnRK1α bacterial expression constructs 
N-terminally GST-tagged AKIN10 and AKIN11 constructs were prepared by Bhalerao et al (1999) 
[60] by cloning EcoRI-SalI cDNA inserts in the pGEX-5X-1 vector (GE Healthcare, Ref number 27-
4584-01). Thess clones were used for large-scale protein purification starting from 2l of E. coli 
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suspension, and the protein extracts were purified on Glutathion-Sepharose 4B columns. In our hand, 
most of the recombinant proteins precipitated in inclusion bodies in the bacteria and the minor soluble 
fraction was heavily degraded. Therefore, an additional histidin-tag was introduced to the C-termini of 
these constructs to allow double affinity purification and selection for intact full-length recombinant 
proteins. The C-terminal 3’-segments of AKIN10 and AKIN11 cDNAs were PCR amplified using 
MISI2 and MISI4 forward oligonucleotide primers designed to the intrinsic BglII and XbaI sites 
located at 1144 and 1026bp positions of AKIN10 and AKIN11 cDNAs, respectively. These primers 
were used in combination with reverse oligos incorporating the coding sequence of the His-tag 
upstream and a SalI site downstream to the stop codon (MISI1 and MISI3 primers for AKIN10 and 
AKIN11, respectively). The PCR amplified fragments were cloned into the original pGEX-5X-1 
constructs replacing the C-terminal coding sequences. Recombinant proteins were prepared from these 
construct and purified on Ni-NTA agarose and subsequently on Glutathion-Sepharose 4B matrix. 
Although high purity was achieved, the protein amount was very low and not sufficient for regular 
routine assays. Therefore, another bacterial tag, a thioredoxin-tag was tried in order to increase 
bacterial solubility of AKIN10 and AKIN11. The clones were prepared by subcloning the original 
GST-AKIN fragments into pET201 double-tagging vector, which contains coding sequences for an N-
terminal thioredoxin and a C-terminal His tag. The open reading frames of AKINs were excised as 
SalI and blunted EcoRI fragment and ligated into SalI and filled-in BamHI sites of pET201. As 
expected, the solubility of AKIN kinase proteins was greatly increased. Phenilarsine-agarose for the 
purification through thioredoxin tag is not available any more unfortunately. Therefore, other ways 
had to be found to achieve maximal purity. Imidazole gradient elution from NiNTA column and 
subsequent ion exchange chromatography was used to attain high purity recombinant proteins. The 
GST-His-tagged variants were kept for certain kinase assays where a higher sized AKIN kinase was 
necessary, because the GST tagged forms are approximately 10 kDa larger than the TRX-tagged 
versions due to differences in tag size (Figure 16.). 
 
 
3.4.2. Preparation of point mutant SnRK1α kinase variants 
To generate constitutively activated AKIN kinase versions, the activation-loop threonine residue was 
exchanged to asparagine (T175D in AKIN10 and T176D in AKIN11) by site-directed mutagenesis in 
order to mimick  phosphorylated state of the T-loop. Inactive kinase variants were also created by site-
specific mutagenesis of the ATP-binding site (K48R in AKIN10 and K49R in AKIN11). The inactive 
variants are still phosphorylable on their T-loop threonine by upstream actvating kinases. All mutant 
clones were generated using pET201 bacterial expression clones and recombinant proteins were 
prepared with the same protein purification strategy as described above. The site-directed mutagenesis 
was carried out by the unique site elimination method [227]. One primer was designed to the AfeI site 
of the pET201 vector backbone (pET201AfeI-) and used with combination with one of the mutagenic 
primer specific for each construct (primers AKIN10T175D, AKIN10K48R, AKIN11T176D and 
AKIN11 K49R). (See 2.1.6.3. in the Materails and Methods chapter). 
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Figure 16. Purification of recombinant SnRK1α catalytic subunits AKIN10 and AKIN11. 
 
 
 
A 
1. molecular weight standard  2. empty BL21DE3 
cell extract  3. uninduced GST-AKIN10 pGEX5X1 
in BL21DE3 cells  4. induced sample 5. crude 
extract pellet fraction  6. crude extract supernatant 
fraction  7-8. Elution from GS4B matrix with 10mM 
glutathione 9-10. after elution with 25mM 
glutathione  11. western blot with anti-GST antibody 
 
B 
1. GST-AKIN10-His purified on NiNTA matrix 2. 
flowthrough when applied onto GS4B matrix  3. 
double purifed fraction eluted from GS4B 
 
C 
TRX-AKIN10-His bacterial overexpression (75kDa) 
 
D 
Gradient elution of TRX-AKIN10-His from NiNTa 
matrix, imidazole range from 50-300mM, each 
fraction 500μl 
 
E 
Ion-exchange chromatography of NiNTA purified 
TRX-AKIN10-His protein. It elutes at 150mM NaCl 
concentration. 
 
F 
Pure recombinant TRX-AKIN-His protein variants.  
1. AKIN10wt  2. AKIN11wt  3. AKIN10 T175D  
4. AKIN11 T176D  5. AKIN10 K48R   
6. AKIN11 K49R 
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3.4.3. Candidate SnRK1-proteasome substrates 
 
To searh for candidate SnRK1 substrates, we choose proteasomal substrates which have been reported 
to either undergo sugar- or light-dependent degradation or affected by mutations causing sugar related 
phenotypes. ABI5 (At2g36270) is a proteasomal substrate and its mutation causes insensitivity to 
sugar-induced germination arrest. ABI5 is phosphorylated by SnRK2 kinases, and phosphorylation is 
necessary for its biological activity. Three phosphorylation sites were already determined on ABI5 
based on in vitro kinase reactions. We hypothesized that ABI5 might be a key factor in sugar-induced 
developmental arrest, and sugar signal could be transmitted by SnRK1 kinases. DPBF4 (At2g41070) 
is another member in the ABI5 family of bZIP transcription factors and contains the conserved 
phosphorylation sites determined previously in ABI5.  
EIN3 (At3g20770) is a transcriptional activator in the ethylene signal transduction pathway, 
and it is a proteasomal substrate. Glucose enhances EIN3 degradation. D-type cyclins are implicated in 
the sugar control of cell cycle. Proteolytic degradation of cyclinD3;1 (At4g34160) is inhibited by 
sugars, unlike that of CycD2 (At2g22490), but it is regulated by sugars at the level of transcription 
similarly to CycD3. Just like CycD3;1, CycD1 (At1g70210) is also a phosphoprotein, and 
phosphorylation enhances its proteasomal degradation. As control, CycD3;3 was also used as substrate 
in the assays.  
The stability of CO protein (CONSTANS, At5g15840), a key regulator of flowering 
transition, is controlled by day-length and CO is degraded in the dark, where SnRK1 kinases are 
supposed to be active. The CDF1 (At5g23040) transcription factor, a repressor of CO expression and 
proteasomal substrate was also tested in our in vitro kinase assays.  
shy2, a mutant form of Aux/IAA3 (At1g04240) transcriptional repressor in the auxin signaling 
pathway also shows sugar-related phenotypes similarly to axr2 (dominant mutation of IAA7, 
At3g23050). Another member of the Aux/IAA family, IAA6 (At1g52830) was also tested to 
determine whether potential phosphorylation sites are found in the conserved domains of this protein 
family. Some F-box proteins were also selected for investigation. They are the substrate recognition 
subunits of SCF type E3 ubiquitin ligase complexes, but generally are also proteasomal substrates and 
their stability is oppositely regulated compared to their targets. TIR1 (At3g62980) and the EBFs 
(EBF1, At2g25490 and EBF2, At5g25350) are amongst the closest plant relatives of yeast GRR1 and 
involved in the degradation of IAA proteins and EIN3, respectively. The F-box protein FKF1 
(At1g68050) is responsible for degradation of CDF1, and thereby involved in the control of CO level 
and flowering transition. The F-box Zeitlupe (ZTL, At5g57360) is a component of the circadian clock 
system and its function is thus connected to CO regulation. 
 To reconstruct trimeric SnRK1 kinases in vitro, the purification of non-catalytic SnRK1 kinase 
subunits was also attempted. Beta subunits are known phosphoproteins, but their kinase partner has 
not yet been identified. Since the gamma subunit is an important regulator of the kinase activity, its 
purification was critical for in vitro reconstruction of trimeric kinases to increase their activities. 
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3.4.4. Cloning bacterial expression and purification of the selected proteasomal 
substrates 
 
Cloning strategies used for generation of individual constructs are summarized in Table 2. 
(Corresponding primers are listed under 2.1.6.1. in the Materials and methods chapter). Photos of 
Coomassie-stained SDS-PAGE gels documenting the purity of obtained recombinant proteins are 
depicted in Figure 17. GST, MBP and TRX tags were used as control proteins. Some of the listed 
proteins could not be purified under natural conditions, like the AKINβγ subunit, ABI4 and CyclinD3. 
In these cases. only the overexpression is illustrated. The EIN3 protein could not even be 
overexpressed in E.coli, although thioredoxin-, GST- and MBP tagged constructs were all tested.  
 The identity of the recombinant substrate proteins was verified by mass spectrometric 
analysis. Therefore, western blot analysis was not performed in the majority of cases. Protein samples 
purified on NiNTA resin frequently contained a major bacterial contamination band at 74kDa, which 
was analyzed by mass spectrometry. This contamination corresponds to a bifunctional polymyxin 
resistance arnA protein (Swissprot database accession P77398). The reason for co-purification is that it 
contains vicinal histidine residues, which behave as a quasi His-tag. In some cases, like in the TRX-
EBF1-His purification experiment, this contaminating protein gives approximately 95% of the total 
protein in the sample. (The purified recombinant proteins can be distinguished by comparing with the 
overexpression band in the crude extract gel lane.) 
 
3.4.5. In vitro kinase reactions with radioactive γ32P-ATP 
 
In the kinase reactions generally 1μg kinase and 1μg substrate protein were used in 20μl reaction 
volume. The reaction was carried out at room temperature in a buffer containing 5mM MgCl2, 50mM 
NaCl, 20mM Tris-HCl (pH 7.5), 5mM β-mercapto-ethanol and 1μl γ32P-ATP (5000μCi/mol). In some 
cases, the recombinant substrate protein could be purified only in a very low quantity. In these cases 
generally 0.2μg substrate was used instead of 1μg (TIR1, EBF1, FKF1 and CycD1). Exposition times 
were ranging from 20 min to 1 day. Long exposition times were necessary due to the relatively low 
activity of recombinant AKIN10. For comparison, the monomeric SnRK2.6/OST1 kinase was also 
tested as control kinase in parallel reactions (not shown) on ABI5 and DPBF4 and its activity was 
found one or two magnitude higher compared to AKIN10. (A potential reason for lower AKIN10 
activity was the lack of the γ activator subunit, but its effect could not be tested since the γ subunit 
could not be purified from bacteria). Autophosphorylation intensity of AKIN10 served always as good 
internal control for comparison of phosphate incorporation intensities of various substrates.  
Although AKIN11 could be also purified using the thioredoxin-His tag combination, neither 
substrate phosphorylating activity nor autophosphorylation of AKIN11 could be observed (Figure 
18E). This result is in contrast to formerly published data using GST-AKIN11, and therefore it might 
be due to a technical problem. Therefore, only results with AKIN10 are shown here. 
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Construct Vector Cloning strategy Protein size and 
comments  
TRX-ABI5-His pET201 PCR product cut by XhoI inserted to SalI 
site 
63 kDa 
TRX-DPBF4-His pET201 PCR product to NheI +SalI 44 kDa 
TRX-ABI4-His pET201 PCR product on genomic DNA template 
was inserted to SalI (no intron in ABI4 )  
purification is not 
possible, 50 kDa 
TRX-EIN3-His pET201 PCR product, filled BamHI to filled NheI + 
filled NotI 
overexpression is not 
possible, 86kDa 
GST-EIN3-His pGEX-5X-1 PCR product of EIN3_pGEXfwd + 
EIN3rev was inserted to BamHI + SalI 
overexpression is not 
possible, 99kDa 
MBP-EIN3-His pMAL-c2 PCR product of EIN3:pMAL_fwd + 
EIN3rev was inserted to BamHI + SalI 
overexpression is not 
possible, 114kDa 
TRX-CyclinD1-His pET201 PCR product was cut by XhoI and inserted 
to SalI site 
low amount 
54 kDa 
TRX-CyclinD2-His pET201 PCR product, filled BamHI + filled BglII 
was inserted to filled NotI  
56 kDa 
TRX-CyclinD3-His pET201 PCR product, filled SalI + filled BamHI 
was inserted to filled NotI site 
58 kDa 
TRX-CyclinD3b-His pET201 PCR product cut by XhoI and inserted to 
SalI site in vector 
57 kDa 
TRX-IAA3-His pET201 PCR product was cut by SalI + XhoI and 
inserted to SalI site 
35 kDa 
TRX-IAA6-His pET201 PCR product was inserted to filled NheI + 
filled NotI 
35 kDa 
TRX-IAA7-His pET201 PCR product inserted as HindIII+XhoI  42 kDa 
TRX-CO-His pET201 PCR product inserted as BamHI+HinDIII  57 kDa 
TRX-CDF1-His pET201 PCR product was inserted to SalI site 42 kDa 
TRX-HY5-His pET201 PCR product cut by XhoI inserted to SalI 
site 
32 kDa 
TRX-TIR1-His pET201 cut out from pMenchuSalI clone, filled 
BglII to filled NotI 
low amount,84kDa 
GST-EBF1 pGEX-5X-1 PCR, EBF1pGEX + EBF1UBR_rev,BamHI low amount, 94kDa 
TRX-EBF1-His pET201 filled BamHI to filled NheI + filled NotI low amount, 81kDa 
GST-EBF2 pGEX-5X-1 PCR, EBF2pGEX + EBF2UBR_rev,BamHI low amount, 94kDa 
TRX-EBF2-His pET201 filled BamHI to filled NheI + filled NotI low amount, 81kDa 
GST-FKF1 pGEX-5X-1 PCR product, SalI to XhoI low amount, 97kDa 
TRX-FKF1-His pET201 PCR product to SalI site low amount, 85kDa 
GST-ZTL pGEX-5X-1 It was subcloned as BamHI + XhoI low amount, 93kDa 
Kinase subunits    
TRX-AKINβ1-His pET201 PCRproduct, NcoI blunt + BamHI blunt to 
SalI blunt + NotI blunt 
46 kDa 
TRX-AKINβ2-His pET201 PCR product to SalI site 47 kDa 
TRX-AKINβ3-His pET201 PCR product blunted, inserted to filled NotI  29 kDa 
TRX-AKINβγ-His pET201 PCR product to NheI + HindIII purification is not 
possible, 68kDa 
GST-AKINβγ pGEX-5X-1 PCR product, BamHI+SalI to BamHI+XhoI purification is not 
possible, 81kDa 
Controls    
TRX tag  (+His) pET201 empty vector 14 kDa 
GST tag pGEX-5X-1 empty vector 27 kDa 
MBP tag pMAL-c2 empty vector 42 kDa 
Table 1. Cloning details of of constructs used for expression of candidate kinase substrates and SnRK1 kinase 
subunits. 
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Figure 17. Bacterial expression and purification of the hypothetical substrates 
cDNA sequences of selected substrates were cloned into IPTG-inducible vectors that were transformed into the 
E. coli strain BL21DE3pLysS for protein expression. First lane: non-induced bacteria, crude extract (control). 
Second lane: IPTG induced expression, crude extract. (Note the overexpression of protein of interest). Third 
lane: Purified protein. (The protein of interest is indicated with a “<” mark, and it is not always identical to the 
most intensive protein band. The size of protein of interest equals to the overexpression band in the second lane.) 
A frequent contamination was the bifunctional polymyxin resistance arnA protein (Swissprot database accession 
P77398), which contains two vicinal histidines; therefore under less stringent washing conditions co-purifies 
with His6-tagged proteins. Less stringent wash conditions were necessary when the molecular mass of protein of 
interest was high (80-100kDa) or when its soluble fraction was limiting. 
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Figure 18. In vitro kinase assays of candidate proteasomal substrates with AKIN10 using radioactive 
γ32P-ATP. 
The reactions generally contained 1μg kinase and 1μg substrate. In few cases very low amount of substrate 
protein could be purified that limited the amount used in the kinase assay to less than 1μg. 
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A 
1.  Thioredoxin (TRX 13kDa) 
2.  Glutathion-S-transferase 
     (GST, 26kDa) 
3.  Maltose binding protein 
     (MBP, 42kDa) 
B 
1.  AKIN10 
2.  TRX 
3.  TRX + AKIN10 
4.  GST 
5.  GST + AKIN10 
6.  MBP 
7.  MBP + AKIN10 
C 
1.  AKIN10 
2.  ABI5 (63kDa) 
3.  ABI5 + AKIN10 
4.  DPBF4 (44kDa) 
5.  DPBF4 + AKIN10 
6.  IAA6 (35kDa) 
7.  IAA6 + AKIN10 
D (dose dependence of IAA6 
phosphorylation) 
1.  IAA6 
2.  IAA6 1μg + AKIN10 
3.  IAA6 2μg + AKIN10 
E (AKIN11 was not active) 
1.  AKIN10 (4μg) 
2.  AKIN11 
3.  ABI5 
4.  AKIN10 + ABI5 
5.  AKIN11 + ABI5 
F 
1.  AKIN10 
2.  IAA6 (35kDa) 
3.  IAA6 + AKIN10 
4.  IAA7 (42kDa) 
5.  IAA7 + AKIN10 
6.  TIR1 (84kDa, 0.2μg only) 
7.  TIR1 + AKIN10 
G 
1.  AKIN10 
2.  IAA6  
3.  IAA3 (35kDa) 
4.  IAA6 + AKIN10 
5.  IAA3 + AKIN10 
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Figure 19. Kinase reactions of candidate proteasomal substrates with AKIN10 using radioactive γ32P-
ATP. 
The reactions generally contained 1μg kinase and 1μg substrate (for detailed information about the reaction 
conditions see the text). In few cases very low amount of substrate protein could be purified, that limited the 
amount used in the kinase assay to less than 1μg.  
 
 
Among all substrates tested, ABI5 and DPBF4 showed the most intensive phosphorylation. Relatively 
intensive phosphate incorporation could be detected with all three AKIN β subunits. IAA6, CycD2, 
CycD3;3 and CO gave also well detectable signals, although one magnitude lower than ABI5 and 
DPBF4. The rest of proteins showed very low intensity of phosphorlation, questioning the specificity 
of kinase reactions. Control samples without kinase did not show phosphate incorporation into the 
substrate proteins. Specificity of the kinase reactions was further tested by dose dependence of IAA6 
substrate phsophorylation (Figure 18D): double amount of substrate has proportionally increased 
phosphate incorporation. In another approach, the specificity of kinase reactions was tested by the 
application of a formerly published specific SnRK1 inhibitor, the PRL1 WD40 repeat protein [60]. 
Recombinant PRL1 protein could be purified by the help of MBP-PRL1-His construct, which was 
prepared formerly by Bhalerao et al. Purification of recombinant PRL1 was carried out on NiNTA 
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matrix followed by application to maltose resin (Figure 20.). Inhibition was tested in a radioactive 
kinase reaction with one of the best substrates tested, DPBF4. In the reaction 1μg amount of each 
proteins were used. In this experiment PRL1, did not inhibit SnRK1 activity on DPBF4, at least at the 
concentration applied, but instead some radioactive phosphate incorporation was detected in PRL1. 
Phosphorylation of PRL1 is supported by an unpublished observation of Dóra Szakonyi showing that 
PRL1 appears as a double band in immunoblot analysis that indicates secondary modification. 
 
 
      
 
A) SDS-PAGE, Coomassie brillant blue staining 
1-2.  MBP-PRL1-His (100kDa) elution from NiNTA matrix 
3-4.  MBP-PRL1-His flow through on amylase resin 
5-7.  MBP-PRL1-His elution fractions from amylase resin 
 
B) Kinase reactions with radioactive γ32P-ATP 
1. AKIN10 (autophosphorylation) (75kDa) 
2. DPBF4 (44kDa) 
3. PRL1 (100kDa) 
4. AKIN10 + DPBF4 
5. PRL1 + DPBF4 
6. AKIN10 + PRL1 
7. AKIN10 + PRL1 + DPBF4 
Figure 20. Purification of recombinant PRL1 protein and testing its SnRK1 inhibitor activity 
 
 
3.4.6. Two-dimensional gel electrophoresis of phosphorylated SnRK1 substrates 
To prepare samples for mass spectrometry study of substrate phosphorylation sites, in vitro kinase 
reactions were carried out using non-radioactive ATP. The phosphorylated proteins were concentrated 
by TCA-acetone precipitation. Proteins with different phosphorylation states were separated by two-
dimensional gel electrophoresis and stained by Sypro-Ruby fluorescent stain. The analysis revealed 
multisite phosphorylation in ABI5 and DPBF4 (5-6 peaks could be distinguished that equals to 4-5 
phosphorylation sites), whereas IAA6 showed only two separated spots upon separation in the second 
dimension (Figure 21). 
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    IAA6                                                                               DPBF4 
Figure 21. Two-dimensional electrophoresis of phosphorylated IAA6 and DPBF4 
 
3.4.7. Constitutively active kinase variants 
Relatively low in vitro activity of AKIN10 made it difficult to evaluate the radioactive 
phosphorylation data. ABI5 and DPBF4 were strongly phosphorylated and were clearly substrates for 
AKIN10. In case of IAA6, CyclinD2, CyclinD3;3 and CO, the levels of phosphate incorporation were 
substantially lower. The reason for the different levels of phosphorylation intensity may be that ABI5 
and DPBF4 are phosphorylated at multiple sites, whereas the other substrates may contain single 
phosphorylation sites, which would cause nearly a magnitude weaker signal. To improve these results, 
it was attempted to generate more active kinase forms. Dominantly active T-loop mutant variants were 
prepared by the site-directed mutagenesis of the T-loop threonine to aspartate (T175D in AKIN10, 
T176D in AKIN11). The aspartate residue mimicks the phosphorylated T-loop threonine but the 
activation mutant kinase cannot be inactivated by phosphatases. Therefore, they could be useful also 
for in vivo studies of kinase functions. Mutant constructs of AKIN10 and AKIN11 were prepared and 
recombinant proteins purified as described above (Chapter 3.4.2. Figure 16F). As expected, the major 
autophosphorylation site is at the T-loop threonine and autophosphorylation disappears in the T-loop 
mutant AKIN10 (Figure 22.). The activity of AKIN10 T175D variant was approximately 3-5 times 
higher compared to the wild type AKIN10 (the activity increase is not pronounced in Figure 22 but see 
also Figure 25.). As with the thieredoxin-His-tagged AKIN11, no activity could be detected with 
AKIN11 T176D. 
 
             
 
Figure 22. Dominantly active SnRK1α kinase variants 
The upper band corresponds to autophosphorylation AKIN10. The lower arrow indicates the position of ABI5. 
The third band in sample 2 is a background activity, which is also present in the ABI5 control sample. The 
autophosphorylation band of AKIN10 disappeared in the T175D mutant, but ABI5 phosphorylation activity was 
retained. This indicated that the autophosphorylation site is at the T-loop. AKIN11 and its “dominantly active“ 
variant T176D did not show any activity in these experiments. The T175D mutation caused 3-5 times increase in 
AKIN10 activity (on this image it is not visible but see also Figure 25.) 
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3.4.8. Inactive kinase variants 
Inactive SnRK1α kinase variants were generated by site-directed mutagenesis of a lysine residue to 
arginine at the ATP-binding site (K48R in AKIN10, K49R in AKIN11). These variants lack 
autophosphorylation activity, but their intact T-loop threonine can still be phosphorylated by an 
upstream activating kinase. It was tested by using these inactive variants whether AKIN10 can activate 
AKIN11 and vica versa by being potential substrates for each other. In order to be able to distinguish 
the size of the two kinases, the active kinase variants were purified as GST-tagged versions, which 
have approximately 10kDa higher molecular mass than the thioredoxin tagged inactive variants. GST-
AKIN11 was not active, and AKIN10 did not phosphorylate itself or AKIN11 in an intermolecular 
reaction (Figure 23.). 
 
  kDa 
           
 
 
Figure 23. AKIN10 and AKIN11 do not activate each other in vitro 
The arrow indicates a 84kDa molecular weight band that corresponds to the GST-tagged AKIN10 
autophosphorylation. Similarly to TRX-AKIN11, GST-AKIN11 was also not active in vitro. AKIN10 did not 
activate AKIN11 or itself by intermolecular phosphorylation. 
 
 
3.4.9. Testing the effect of SnRK1 upstream activating kinases on AKIN10 activity 
An in silico systematic trans-genomic comparison of all yeast and Arabidopsis kinases in 2003 
revealed that the Arabidopsis genome contains two protein kinases, the sequences of which are closely 
related to the yeast Snf1 upstream activating kinases Elm1, Sak1 and Tos3. As the Arabidopsis kinase 
sequences are most similar to Tos3, they were named by our laboratory Tos3-like kinases, TLK1 
(At5g60550) and TLK2 (At3g45240). Parallelly to our work, another group recently published that 
these kinases can restore Snf1 activity in yeast, which has lost all three of its Snf1 upstream activating 
kinases. We obtained the open reading frames of TLK1 and TLK2 by PCR amplification from an 
Arabidopsis cDNA library using gene specific oligonucleotide primers (TLK1fwd, TLK1rev, 
TLK2fwd and TLK2rev). The two open reading frames were cloned into the SalI site of pET201 
vector to generate thioredoxin-His double tagged bacterial expression constructs. Recombinant 
proteins were expressed in E. coli cells, purified on NiNTA matrix and subjected to in vitro kinase 
reactions to test whether TLKs can increase AKIN10 activity in vitro or not (Figure 24). TLK1 could 
indeed phosphorylate AKIN10 in vitro, but surprisingly it did not lead to increased AKIN10 kinase 
activity on substrates, such as DPBF4 and IAA6, in vitro. In comparison to AKIN10, much higher 
autophosphorylation activity was observed by TLK1, whereas TLK2 was completely inactive.  
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1.  GST-AKIN10-His (84kDa) 
2.  GST-AKIN11-His (84kDa) 
3.  TRX-AKIN10-His K48R 
4.  TRX-AKIN10-His K48R + GST-A10-His 
5.  TRX-AKIN10-His K48R + GST-A11-His 
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Figure 24. TLK upstream kinases phosphorylate AKIN10 but do not significantly increase its activity in 
vitro. 
In B) the middle arrow indicates TLK1 autophosphorylation, whereas the upper arrow shows increased 
phosphate incorporation into AKIN10 compared to its autophosphorylation activity. The lower arrow shows the 
substrates, IAA6 in picture B, and DPBF4 on picture C. 
 
3.4.10. Testing the activity of truncated kinase forms 
In addition to the autoinhibitory domain, also the UBA domain of AMPKs and AMPK-related kinases 
appears to play a role in the kinase activation. However, it is still not clear whether the UBA domain 
plays a negative or positive regulatory role, because it was reported as both activator and inhibitor in 
the literature in different AMPK-related kinases. In order to generate a more active kinase form, two 
truncated AKIN10 variants were prepared with C-terminal deletions. The first construct lacked only 
the autoinhibitory domain, whereas in the second a larger deletion removed also the UBA domain. The 
location of the UBA domain was determined by in silico domain analysis (using the SMART 
homepage: smart.uni-heidelberg.de) and by alignment to other UBA domain containing AMPK-
related kinases. The length of the UBA domain-containing variant was 340 amino acids, whereas the 
UBA domain deleted version was 280 amino acids long. Both clones were prepared by amplifying the 
corresponding AKIN10 cDNA sequences with the polymerase chain reaction using specific primers. 
The primer AKIN10fwd incorporated a SalI restriction endonuclease recognition site and was used in 
combination with AKIN10_280_rev and AKIN10_340_rev, incorporating SalI and XhoI sites, 
respectively. The DNA fragments were ligated to the SalI site of pET201 vector to generate TRX-His 
double-tagged constructs. Similarly, the T175D T-loop mutant, dominantly active truncated kinase 
variants were also prepared. Recombinant proteins were purified from all constructs and subjected to 
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in vitro kinase reactions (Figure 25). The T175D dominantly active variants were approximately five 
times more active in vitro than wild type AKIN10. Deletion of the autoinhibitory domain had only a 
minor effect on AKIN10 activity but when the UBA domain was additionally deleted, the kinase 
activity was greatly reduced. Therefore, the UBA domain seems be crucially important for the activity 
of AKIN10. 
 
                                                                                   
Figure 25. Activity of the truncated AKIN10 variants.  
A: Bacterial expression and purification of truncated AKIN10 variants. B: Radioactive kinase reaction using the 
truncated AKIN10 variants. C: Radioactive kinase reaction using the truncated AKIN10 kinase variants. 
 
 
       
 
Figure 26. Partial reconstruction of the AKIN10 SnRK1 kinase complex with AKINβ3 
The addition of AKINβ3 did not change the phosphorylation intensity of DPBF4 by AKIN10. Intriguingly, in 
this experiment AKINβ3 itself was phosphorylated at a very low level (in contrast to earlier assays). 
(TRX-AKIN10-His = 75kDa, TRX-DPBF4-His = 44kDa, TRX-AKINβ3-His = 29kDa) 
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3.4.11. Partial reconstruction of the SnRK1 kinase complex 
 
The activator AKINβγ subunit could not be purified from bacteria under native conditions, and 
therefore reconstruction if trimeric SnRK1 kinase was not possible. However, the potential role of beta 
subunits was assayed. One of the best substrates in the in vitro kinase assays was the DPBF4 
transcription factor, which is a nuclear protein. AMPK beta subunits might play a role in the substrate 
recognition and binding therefore the effect of presence of a beta subunit in the kinase reaction was 
tested. Based on subcellular localization of GFP-tagged beta subunits, the β3 subunit was the most 
obviously nuclear. Therefore, this combination was used in the kinase assay. The addition of AKINβ3 
to the reaction mixture did not alter the intensity of DPBF4 phosphorylation (Figure 26.). 
 
 
3.5. IDENTIFICATION OF PHOSPHORYLATION SITES IN SNRK1 KINASE 
SUBSTRATES 
 
3.5.1. Mass spectrometric analysis of phosphorylated substrates 
To determine the positions of AKIN10 phosphorylation sites, the substrate proteins were 
phosphorylated with non-radioactive ATP and subsequently digested either with trypsin (EC 3.4.21.) 
or alternatively glutamyl-endopeptidase (on other names Glu-C or V8, EC 3.4.21.19.). The resulting 
samples were enriched for phosphoproteins using Calbiochem ProteoExtract Phosphopeptide Capture 
Kit. The phosphorylated peptide fragments were identified by MALDI-TOF mass spectrometer. The 
identified phosphopeptides were further analyzed by tandem mass spectrometry using ESI-Q-TOF 
configuration equipped with an ion-trap device to precisely locate the phosphorylation sites. (The 
charts of the analysis are shown in Appendix 3.)  
Five conserved phosphorylation sites were identified in ABI5 and DPBF4 (S42, S64, S145, 
T201 and S439 in ABI5 and S21, S43, S66, T104 and S259 in DPBF4) (Figure 27.). One of the sites 
was formerly identified in in vitro experiments by [232] and could not be verified in DPBF4 (S74), 
and shown that this site is not conserved in ABI5 (there is no phosphorylable residue at the 
corresponding location). However, a new atypical site was found in both substrates (ABI5 S64, 
DPBF4 S43). In the new site, a positively charged amino acid residue was found in to position -4 
relative to the phosphorylated serine, instead of position -3 expected according to the hypothesized 
kinase recognition motif. The new site is conserved in the ABI5 homologs from other organisms (rice, 
barley, wheat), whereas the formerly described site, which was not identified by us, is neither 
conserved in these proteins. A single phosphorylation site was detected in IAA6 at the amino acid 
position Ser39, which is conserved in many other members of the Aux/IAA protein family. No other 
phosphorylation sites could be detected in any other substrates exmined. 
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Figure 27. Conserved phosphorylation sites were identified in ABI5 and DPBF4 by mass spectrometric 
analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. The phosphorylation site revealed in IAA6 is conserved in many members of the Aux/IAA 
protein family of auxin signalling repressors. 
 
 
3.5.2. Phosphopeptide mapping of IAA6 
Although the exact position of a phosphorylation site in IAA6 could be determined by tandem MS 
analysis, the site did not match as well the predicted consensus as the phosphorylation sites mapped in 
ABI5 and DPBF4. The identified IAA6 tryptic peptide contained a dehydroxy serine at position S39 
after collision-induced decay (CID), which indicated the loss of phosphate group from an originally 
phosphorylated serine (the phosphate is generally lost during CID fragmentation mode). However, the 
peptide was not enriched during the phosphopeptide enrichment procedure, and the corresponding 
peptide could not be found in the V8 enzyme digested sample. Therefore, additional methods were 
applied to assure the existence of this phosphorylation site. Phosphopeptide mapping was carried out 
by enzymatic fragmentation of radioactively phosphorylated IAA6 protein. Unincorporated γ32P-ATP 
was removed by TCA-acteton precipitation of the peptides followed by washing the pellet in pure 
acetone. The peptides were solubilized in Tris-tricine SDS gel loading buffer and the peptide 
fragments were separated on Tris-tricine buffered SDS-PAGE gel system, which can resolve peptides 
as small as 1kDa. The radioactive peptide fragments were visualized by X-ray film exposition. The 
cutting agents were selected based on computer analysis of IAA6 amino acid sequence. The predicted 
phosphorylation motif of calcium/calmodulin dependent protein kinase superfamily, to which also 
SnRK1 kinases belong to, is K/R-X-X-S/T. The amino acid sequence of IAA6 contains only one such 
site, corresponding exactly to the site which had been identified by the MS analysis. We chose such 
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enzymes and chemicals, which cleave in close proximity of the predicted site resulting in peptide 
fragments overlapping only at the predicted position. Thus, we selected Arg-C protease (E.C. 
3.4.21.35) that cuts at arginine residues at P1 position, and cyanogen bromide, which chemically 
cleaves proteins at methionine groups at P1 position. The selected agents cut upstream and 
downstream to the predicted kinase motif, respectively, resulting in not too small peptide fragments 
(Figure 29.). Indeed, CNBr fragmentation of IAA6 identified the expected fragment as 
phosphopeptide (Figure 30.). 
     CNBr         ArgC                  ArgC CNBr|                   
         |            |                     |    ||                   
         MAKEGLALEITELRLGLPGDNYSEISVCGSSKKKKRVLSDMMTSSALDTENENSVVSSVE 
     1   ---------+---------+---------+---------+---------+---------+   60   
                                                 
                           ArgC                     ArgC              
                          ArgC|              CNBr  CNBr|              
                             ||                 |     ||              
         DESLPVVKSQAVGWPPVCSYRRKKNNEEASKAIGYVKVSMDGVPYMRKIDLGSSNSYINL 
    61   ---------+---------+---------+---------+---------+---------+  120 
                                                               ArgC   
                                         CNBr              ArgC   |   
                                      ArgC  |     CNBr   ArgC |   |   
                                         |  |        |      | |   |   
         VTVLENLFGCLGIGVAKEGKKCEYIIIYEDKDRDWMLVGDVPWQMFKESCKRLRIVKRSD 
   121   ---------+---------+---------+---------+---------+---------+  180 
 
 
                   
         ATGFGLQQD 
   181   ---------   189 
 
Position of 
cleavage site 
Name of cleaving 
enzyme(s) Resulting peptide sequence  
Peptide length 
[aa] 
Peptide mass 
[Da] 
14 Arg-C proteinase MAKEGLALEITELR 14 1573.868  
36 Arg-C proteinase LGLPGDNYSEISVCGSSKKKKR 22 2366.718  
81 Arg-C proteinase VLSDMMTSSALDTENENSVVSSVEDESLPVVKSQAVGWPPVCSYR 45 4844.369  
82 Arg-C proteinase R 1 174.203  
107 Arg-C proteinase KKNNEEASKAIGYVKVSMDGVPYMR 25 2815.255  
153 Arg-C proteinase KIDLGSSNSYINLVTVLENLFGCLGIGVAKEGKKCEYIIIYEDKDR 46 5122.924  
172 Arg-C proteinase DWMLVGDVPWQMFKESCKR 19 2355.773  
174 Arg-C proteinase LR 2 287.362  
178 Arg-C proteinase IVKR 4 514.669  
189 end of sequence SDATGFGLQQD  11     1138.156  
 
Position of 
cleavage site 
Name of 
cleaving 
enzyme(s) 
Resulting peptide sequence Peptide length [aa]
Peptide 
mass [Da] 
1 CNBr M 1 149.208  
41 CNBr AKEGLALEITELRLGLPGDNYSEISVCGSSKKKKRVLSDM 40 4337.030 
42 CNBr M 1 149.208  
100 CNBr TSSALDTENENSVVSSVEDESLPVVKSQAVGWPPVCSYRRKKNNEEASKAIGYVKVSM 58 6302.006 
106 CNBr DGVPYM 6 680.774  
156 CNBr RKIDLGSSNSYINLVTVLENLFGCLGIGVAKEGKKCEYIIIYEDKDRDWM 50 5711.606 
165 CNBr LVGDVPWQM 9 1044.234 
189 end of sequence FKESCKRLRIVKRSDATGFGLQQD  24    2783.201 
Figure 29. Proteolytic map of IAA6 and the molecular mass of resulting peptides 
Orange color indicates CNBr fragment, whereas the Arg-C peptide containing the putative phosphorylation site 
is marked in blue. Violet color shows the overlapping part of the two fragments. Red color marks the 
phosphorylated serine residue. The table shows the molecular mass values of peptide fragments. 
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                Coomassie brillant blue stain                       radioactive assay 
 
Figure 30. Phosphopeptide mapping of IAA6 with Arg-C enzyme and CNBr 
Black arrow indicates partially cleaved peptides, which are larger than the size of the largest fully cut peptide 
fragment, 6.3kDa (see Figure 29. for peptide sizes). Red arrow indicates a peptide with a size of about 4 kDa 
which identifies the predicted phosphopeptide fragment. 
 
 
3.5.3. Site-directed mutagenesis of the IAA6 S39E residue in bacterial expression 
clones 
Site-directed mutagenesis was carried out on IAA6 to generate S39A non-phosphorylable variant and 
S39E, in which the glutamine residue mimicks phosphoserine. The constructs were prepared in the 
pET201 bacterial expression vector to generate thioredoxin-IAA6-His fusion proteins, using 
IAA6_S39A, IAA6_S39E and pET201AfeI- oligonucleotides for the mutagenesis. In order to verify 
the phosphorylation sites, recombinant proteins were purified from the mutant constructs and were 
subjected to in vitro kinase assays (Figure 31.). Phosphate incorporation into the mutant proteins 
versions was greatly reduced compared to the wild type protein. Interestingly the solubility of IAA6 
S39E construct in bacteria was also greatly reduced, but not that of IAA6 S39A. Residual 
phosphorylation of mutant proteins nonetheless suggested that potentially a second AKIN10 
phosphorylation site is present in IAA6. 
                                                                                                                        
  
  
 
 
 
Figure 31. Bacterial expression and kinase assay of the IAA6 S39A and IAA6 S39E mutants 
 
 
 
 
← 
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Coomassie staining 
1-2. Overexpression size of IAA6 
3.  IAA6 S39E  
4.  IAA6 S39A 
Radioactive kinase reaction 
1.  AKIN10 
2.  IAA6 wt 
3.  IAA6 S39E 
4.  IAA6 wt (1μg) + AKIN10 
5.  IAA6 S39E  (1μg)+ AKIN10 
loading control is indicated 
   1         2            3           4                1        2        3         4         5 
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3.5.4. Preparation of IAA6 plant overexpression constructs 
 
CaMV35S promoter driven overexpressor constructs of IAA6 cDNA were prepared in combination 
with an intron tagged C-terminal HA-tag (influenza haemagglutinin) coding sequence including all 
three IAA6 variants (i.e., wild type, S39A and S39E mutants). Mutant IAA6 cDNAs encoding the 
S39A and S39E variants were PCR amplified from the pET201 bacterial expression vector using 
IAA6_fwd and IAA6_rev oligonucleotide primers containing extra NcoI and BglII sites, respectively. 
The product was inserted into the intermedier vector pPILY [224], verified by DNA sequencing and 
subcloned as NotI fragment into pPCV002 binary vector, which carries a kanamycin resistance plant 
selectable marker gene. The constructs were transformed into S17.1 E. coli strain and conjugated into 
the GV3101 (pMP90RK) Agrobacterium host and subsequently transformed into Arabidopsis thaliana 
(Col-0) plants. Transformants were selected on kanamycin. (IAA6 S39A mutant seeds were not 
available by the date of submission.) 
 
3.5.5. Analysis of phenotypes conferred by overexpression of IAA6 phosphorylation 
site variants and immunoblot analysis of modified IAA6 in transgenic plants  
 
IAA6 is a proteasomal substrate, and based on data from the literature, its overexpression does not 
result in increased IAA6 protein concentration in vivo, nor does it produce phenotypic alteration. 
However, a point mutation in its degradation domain (amino acid residues 70-81) responsible for its 
interaction with the TIR1 F-box leads to increased IAA6 protein level and to slightly shorter hypocotyl 
phenotype during germination.  
In our experiments, IAA6 overexpressor plants reached normal height, rosette size and silique length 
but petal development was reduced (Figure 32. and 33.). Petals and sepals also fell off earlier from the 
plants. The effect of overexpression of IAA6 S39E mutant for was much more pronounced. The plants 
were severely stunted with a maximum height of fully developed plants of approximately 10cm. In 
addition, silique length was reduced to approximately half size in the IAA6 S39E overexpressor 
plants, whereas it was wild type length in IAA6 overexpressors.  The Aux/IAA proteins function as 
repressors in the auxin signal transduction and, based on the observed phenotype, mimicking 
phosphorylation of IAA6 appeared to increase the repressor activity of IAA6. One potential screnario 
is that phosphorylation of IAA6 would prevent its proteasomal degradation and thereby reduce the 
turnover speed of the protein. In order to examine the effect of Ser39 phosphorylation on the stability 
of IAA6 protein, western blot analysis of proteins extracted from IAA6 S39E and wild type IAA6 
overexpressing lines was performed. For the immunoblot analysis one complete IAA6 S39E 
overexpressor plant and same weight of tissues from an IAA6wt overexpressor plant were frozen in 
liquid nitrogen and mortared to fine powder with a pestle. 500μl buffer ice cold buffer was added to 
the sample with composition of 50mM Tris-HCl (pH 7.0), 0.5%SDS, 5mM βME, 50mM NaCl, 
protease inhibitor cocktail (Sigma) to 5x final concentration and proteasome inhibitor (50μM MG132). 
No IAA6 protein could be detected in any of the samples indicating that IAA6 protein turnover is so 
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quick that overexpression could not increase the protein concentration to detection level. Although the 
IAA6 S39E mutation increases the biological activity of the protein, the mutation does not seem to 
affect the concentration (and likely stability) of IAA6, which in the absence of auxin treatment is 
under the detection limit. 
 
                  
 
Figure 32. Overexpression of IAA6 S39E mutant protein strongly reduces plant development 
The photos show 4 weeksold soild grown T1 plants. A: wild type control; B: wild type IAA6 overexpressing 
plants. The plants reach normal height and rosette size but petal development is reduced (see also Figure 33). C: 
IAA6 S39E overexpression results in severely stunted plants. Rosetta diameter is approximately 1-1.5cm. Petal 
development and silique size is reduced. Bars are 1 cm. 
 
 
 
 
A                B 
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Figure 33. Flowers and siliques of IAA6 overexpressor plants 
1a : Wild type flower, 1b: Flower of a wild type IAA6 overexpressing plant. Petals are underdeveloped and fall 
off early.2a:Wild type flowers in different developmental stages. 2b: Flowers of IAA6wt overexpressor plants in 
different developmental stages. 3a: Wild type flower, 3b: Flower of an IAA6 S39E overexpressor plant. Petal 
development is reduced. 4a: Siliques of wt and IAA6 overexpressor plants (no difference). 4b: Siliques of IAA6 
S39E overexpressor plants are shortened to approximately half length compared to those of wild type 
 
 
 
3.6. ANALYSIS OF THE EFFECT OF SNRK1 KINASES ON SUBSTRATE 
STABILITY IN VIVO 
A special protein stability testing vector was employed to study the effect of SnRK1 kinases on 
substrate stability in vivo (Figure 34.). This vector was developed by A. Bachmair [232]. The system 
uses a C-terminal fusion of dihydrofolate reductase (DHFR) to a defective ubiquitin as proteolysis 
reference protein, which is quite stable in vivo. DHFR-UBI is expressed in equal molar quantity with 
the test protein of interest in form of a translational fusion. The fusion protein construct is cleaved to 
DHFR-HA-UBI and target protein-HA units by ubiquitin specific proteases in vivo. As both DHFR-
UBI and the target protein are labelled with the same C-terminal haemagglutinin (HA) tag, their 
amount can be precisely quantified by immunoblot detection with fluorescently labeled secondary 
antibodies and a laser scanning device (Odyssey). Although the protein stability testing vector was 
1a                        1b                           2a 
 
 
 
 
                                                           2b 
3a                        3b                         4a                          4b 
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originally designed to generate only one cleavage site downstream to C-terminal double glycine motif 
of DHFR ubiquitin tag, in practice the cleavage occurs both upstream and downstream to the ubiquitin 
tag. The ubiquitin tag carries a K48R mutation, which prevents ubiquitin chain formation on it, which 
would artificially target the system’s components to proteasomal degradation. The reference protein 
serves as an internal standard to which parallel samples can be normalized and also indicates the 
general expression level of the fusion protein. 
cDNAs of candidate SnRK1 kinase substrates were cloned into the stability testing vector and 
tested in combination with estradiol-inducible AKIN10 kinase in order to study the effect of AKIN10 
overexpression on the stability of substrates. 
 
      
 
Figure 34. Schematic presentation of the pUBRX protein stability testing vector 
 
 
3.6.1. Preparation of DNA constructs for in vivo test of stability of candidate AKIN10 
substrates  
 
First, the original stability testing vector was modified to make it compatible with the pPCV binary 
vector family, whose members carry a NotI cloning site. The DHFR-HA-UBI stability testing cassette 
was isolated as HindIII fragment and upon filling-in the ends with T4 DNA polymerase inserted into 
the pPCV compatible pPILY vector, from which the CaMV35S expression cassette was previously 
removed by KpnI followed by T4 polymerase treatment. Two NotI sites flanking the DHFR-HA-UBI 
stability testing cassette in the resulting vector allowed its transfer into the binary vectors pPCV002 
(KmR) and pPCV812 (HygR). We named the resulting vector pUBRX similarly to its predecessor. 
 When cloning into this vector, it should be considered that the C-terminus of ubiquitin R48K 
should be fused in frame with the native N-terminal methionine of protein of interest. Any artificial 
amino acid introduced to the N-terminus might change the degradation speed of the protein of interest 
due to the N-end rule degradation pathway (referring to different degradation intensity of a 
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proteasomal substrate depending on the quality of its N-terminal amino acid). Thus, although there is a 
convenient BglII site directly downstream of the ubiquitin specific cleavage motif (Gly-Gly), it is not 
suitable for cloning because the sequence of all test proteins would start then with Arg corresponding 
to the AGA triplet in the BglII site. Instead, long primers were designed with a tail including the 
upstream region from the double glycine motif reaching to the nearby SalI site (about 50 nucleotides 
upstream) and containing a complementary region to the substrate cDNA inserted directly downstream 
to the the position of double glycine (GGTGGT) codons.  
 In the construction of stability testing plasmids, the first step was tagging the PCR amplified 
cDNA of interest with coding sequences of the HA epitope. (We used intron-containing HA-tags, 
therefore the otherwise short tags become too long to incorporate them into a single primer and a 
second cloning step was necessary for tagging.) The forward PCR primers contained an extra NcoI site 
(IAA6, EIN3, EBF1, EBF2,) or a HindIII (IAA7) or a BglII (TIR1, ABI5) site upstream of the SalI site 
and the reverse PCR primers carried a BglII site in order to insert the PCR product first in an HA-
tagging vector (pMenchu SalI-; i.e., to generate C-terminal HA-tagged constructs). The pMenchu SalI- 
vector contained a destroyed SalI site downstream of the HA tag sequence. Since a stop codon is 
positioned downstream of this SalI site, it was necessary to eliminate it using an EcoRI site located 
downstream to the stop codon. So, the PCR product was inserted into pMenchu SalI- as NcoI-BglII 
fragment than the cDNA fused to the intron-containing HA-tag sequence and a stop codon was 
transferred into SalI and blunted XbaI sites of stability testing vector as SalI and blunted EcoRI 
fragment. Finally, the complete stability testing cassette was subcloned into pPCV002 binary vector as 
a NotI fragment. (EBF1 was transferred into the stability testing vector in two pieces, because it 
contained an internal SalI site.) 
 
3.6.2. In vivo stability test of candidate substrate proteins in combination with AKIN10 
overexpression 
The effect of potential AKIN10 phosphorylation on substrate stability was studied in vivo in an 
inducible AKIN10 overexpressor background. As inducible AKIN10 kinase, the formerly prepared 
PIP-L tagged construct was used, which contained a C-terminal HA-tag for the simultaneous detection 
of kinase expression. The constructs were transformed into plants and root-derived dark-grown cell 
suspension cultures as well. Former trials of AKIN10 overexpression in green cell cultures failed, 
which is in accordance with recently published transcript profiling data showing antagonism between 
light and sugar signaling and AKIN kinase activity.  
 In the experiments 1-week-old stabilized double-transformant cell suspension cultures were 
pelleted at 200g for 1 min, resuspended in fresh medium and split into two samples. In the first 
sample, the kinase expression was induced with 10μM 2-estradiol, whereas the second sample was 
used as uninduced control. The samples were incubated in darkness for 4 hours, then collected and 
frozen in liquid nitrogen. Proteins were extracted from the samples by grinding the cells with sand in a 
mortar chilled with liquid nitrogen and taken up in 1ml ice cold buffer composed of 20mM Tris-HCl  
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Figure 35. Results of in vivo substrate stability tests 
A: stability testing of substrates in dark-grown Arabidopsis cell suspension. 6A: IAA6; 6B: IAA6 + AKIN10 
induced (not detectable); 7A: IAA7; 7B: IAA7 + AKIN10 induced (not detectable). B-G: all MG132 treated 
samples collected in 10 min. intervals after MG132 removal. Western blot with αHA antibody. B: IAA6 (not 
detectable, it would be 20kDa); C: IAA6 + AKIN11 (~70kDa); D: IAA7 (not detectable, it would be 26kDa); E: 
IAA7 + AKIN11; F: IAA6 (not detectable); G: IAA6 + AKIN10 
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(pH 7.0), 10% glycerol, 5mM 2-mercapto-ethanol, 50mM NaCl and protease inhibitor cocktail in 
1/100 dilution (Sigma 9939) and 25μM MG132. Cell debris was removed by pelleting at 20000xg in a 
cold tabletop centrifuge. The protein concentration of the supernatant was measured by Bradford assay 
(BIO-RAD) and equal amounts of 30μg protein samples were separated by SDS-PAGE. The result of 
immunoblot analysis of IAA6 and IAA7 (control) with α-HA antibody is shown in Figure 35. 
Unfortunately, in these experiments the formerly obtained very weak kinase expression signal could 
not be reproduced, nor the substrate proteins could be detected. The characteristic reference protein 
derived two bands could be observed in each samples, indicating expression and processing of the 
fusion protein. (According to personal communication of A. Bachmair, a characteristic double protein 
band appears as signal derived from the DHFR-HA-UBI part of the construct. The bands are 
approximately 34 and 24kDa, with 8kDa difference, which corresponds to the size of DHFR with and 
without ubiquitin.) 
Since AKIN10 is degraded in a proteasome dependent way, in a second approach the cells 
were treated with specific proteasome inhibitor MG132 for 3 hours and then transferred into MG132-
free medium to test the degradation of substrate proteins IAA6 and IAA7 by taking samples in 5-10 
minute intervals. (There is data available in the literature for the half lives of a few IAA proteins, 
which ranges on an average between 5 to 10 minutes.) In the MG132-treated cells estradiol-induced 
expression of AKIN10 and AKIN11 kinases could be readily detected. Nonetheless, expression of 
IAA substrates was not detectable, although the characteristic bands for the proteolytically cleaved 
DHFR-HA-UBI reference protein were well visible. From the two expected cleavage products of 
DHFR-HA-UBI, the amount of lower band substantially decreased during the first 10 minutes, 
indicating a weakening effect of removed inhibitor proteasome inhibitor MG132. 
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4.  DISCUSSION  
 
The structurally and functionally conserved AMP-activated protein kinases are present in all 
eukaryotes. Plant and mammal AMPK orthologs can functionally replace their yeast ortholog, Snf1, in 
vivo [74, 78, 104]. Despite high level of conservation, AMPK orthologs show functional differences, 
indicating that their functions in single and multicellular eukaryotic organisms are considerably 
different. For instance, Snf1 is activated by the depletion of fermentable sugars, and its activation 
leads to reserve nutrient accumulation in yeast, whereas plant SnRK1 kinases also play a role in starch 
accumulation, but it occurs during the light period, when carbohydrates and energy are available due 
to photosynthetic activity. The physiological context is also different between species. For example, 
high concentration of external sugars causes rapid proliferation of yeast cells, whereas it inhibits early 
development of Arabidopsis seedlings. Another puzzling example is that despite high level of 
structural conservation of AMP/ATP binding γ subunits that confer AMP-dependent activation for 
mammalian AMPKs in vitro, AMP does not activate the trimeric yeast Snf1 complex in vitro [75]. 
These examples indicate that information gained about one ortholog might provide guidelines to 
studying another one, but it does not apply directly. 
Snf1 controls the activity of metabolic enzymes in yeast and, importantly, it plays a wide role 
in nutrient signal transduction. Similarly, several metabolic enzymes were identified also in plants as 
targets of SnRK1 kinases. Nonetheless, our knowledge about the role of SnRK1 kinases in plant signal 
transduction is rather poor, although efforts have been taken to elucidate it.  
 
4.1. IDENTIFICATION OF INSERTION MUTATIONS IN SNRK1 SUBUNIT 
GENES 
Reverse genetic approach applied to functional dissection of Arabidopsis SnRK1 subunits is 
almost completed by now. Previously, the SNF4/AKINβγ mutations were characterized and revealed 
that they prevent male transmission (PhD thesis of Vijaya Shukla). Therefore, no homozygous mutant 
plants can be generated and the somatic phenotype of snf4/akinβγ can not be yet studied. In present 
work, one akin10 insertion mutation was characterized, in which the T-DNA insertion is located in 
sequences encoding C-terminal regulatory sequences of the kinase. In addition, several mutant alleles 
of AKINβ1 and AKINβ2 subunit genes were identified, which conferred no phenotypic alterations in 
response to glucose and sucrose treatments during germination and seedling development. So far, no 
mutations are available for AKIN11 and AKINβ3. By contrast, several akin12 knockouts are available, 
but the functional analysis of seed-specific AKIN12 kinase is hampered by the fact that AKIN12 and 
AKIN11 show co-expression during embryogenesis and seed development. Former experiments with 
AKIN promoter-GUS fusion constructs (PhD thesis, Kenneth Berendzen), as well as compilation of 
microarray data available in the Genevestigator database indicate that AKIN10 and AKIN11 are the 
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most widely expressed SnRK1 variants, probably being responsible for the majority of SnRK1 
functions in Arabidopsis. 
4.2. FUNCTIONAL ANALYSIS OF SNRK1 SUBUNITS 
 
Transgenic RNA interference silencing of SnRK1α subunits was carried out in several plant species, 
recently also in Arabidopsis, but the results are controversial. More recent and profound studies 
propose that SnRK1 kinases might play a role in starch mobilization (rice, Arabidopsis) and sugars 
inhibit SnRK1 kinase activity [233, 159], whereas former data indicate that SnRK1 is necessary for 
starch accumulation and sugar might induce SnRK1. SnRK1α overexpression lead to starch 
accumulation in potato [152], whereas RNA interference mediated silencing resulted in reduced starch 
content [151]. Furthermore, SnRK1 kinase inhibition is necessary for the herbivore attack mediated 
carbohydrate transport from the aerial part to the root, which also indicates that SnRK1 kinase would 
promote starch accumulation [155]. Although several articles indicate the implication of SnRK1 
kinases in starch and sugar metabolism, the exact mechanism is still not clear, after mutant analysis, 
overexpression and RNA interference studies. So far, very limited information could be obtained 
about the signalling events upstream and downstream to SnRK1 kinases at the molecular level. 
The present work documents that SnRK1 kinase subunits can be expressed by 35S promoter 
only at a very minimal level in Arabidopsis because their stability of SnRK1 kinase subunits is strictly 
regulated by proteasomal degradation. Recently, a transcript profiling experiment was carried out in 
Arabidopsis protoplast system using transient overexpression [159]. The results suggest that SnRK1 
kinase activity should be inhibited by sugars and activated by darkness and metabolic stress. One of 
the genes whose transcription was upregulated by AKINs is DIN6 (dark induced) and its promoter 
analysis revealed that a G-box element is responsible for the expression changes. Co-expression of 
AKINs with several G-box binding bZIP transcription factors revealed that bZIP TFs may be frequent 
substrates of AKINs [159]. 
In yeast, the Snf1 beta subunits are responsible for targeting the trimeric Snf1 kinase to 
different subcellular compartments and substrates. In order to reveal whether a mechanism would 
exists in Arabidopsis by which SnRKβ subunit confers nuclear localization to the holoenzyme 
complex, GFP-tagged AKINβ subunits were overexpressed in Arabidopsis cell suspension culture and 
plants. In accordance with N-myristoylation of AKINβ1 and AKINβ2 [104], they were found mostly 
attached to membranes (plasma membrane and nuclear membrane), but AKINβ1 and AKINβ2 were 
also detected in the cytoplasm. By contrast, AKINβ3, which carries no myristoylation site, was not 
associated to the membranes but found exclusively in the nucleus. Localization of AKINβ1 and 
AKINβ2 appears to be similar. This is the first instance when these proteins were found in the nuclear 
membrane. This finding may support the reverse recruitment model, which states that many genes – 
such as glucose repressed genes in yeast - are transcribed in distinct ultrastructural nuclear bodies and 
surfaces, such as the internal surface of nuclear envelope. Therefore, potentially all three Arabidopsis 
SnRK1β subunits could participate in nuclear events of signal transduction. For the analysis of 
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potential relocalization under nutritional stress conditions, AKINβ expressing suspension cells and 
seedlings were transferred into distilled water and kept in the dark. Instead of relocalization, these 
experiments revealed light and sugar dependent degradation of the SnRK1 beta subunits (proteasomal 
degradation of β subunits was also shown in a biochemical assay). This observation supports that 
SnRK1 kinases are likely active in the dark and thus could indeed play a role in starch mobilization. 
 Previously, a key observation revealed a mechanism by which AMPK kinases participate in 
signal transduction. Yeast two-hybrid screen identified SKP1 (SCF-type E3 ubiquitin ligase subunit) 
and the proteasomal α7 subunit as Arabidopsis SnRK1α interacting partners [88]. In support of this 
result, in Arabidopsis both trimeric SnRK1 kinases and their catalytic α-subunits alone have been 
detected in purified proteasomal complexes in vivo. Also in the better studied yeast system many 
instances have been found that Snf1 participates in the control of degradation of proteasomal 
substrates. Potential role of AMPKs in proteasomal control also appears to be underscored by the fact 
that most AMPK and AMPK-related kinases contain a ubiquitin-associated (UBA) domain. However, 
ubiquitin binding capability of UBA-domains has recently been questioned and it is now believed to 
UBA-domains play a structural role in AMPK regulation.  
 
4.3. SEARCHING FOR CANDIDATE SNRK1 SUBSTRATES 
As continuation of initial promising experiments, our laboratory invested a considerable effort into 
purification of proteasomal SnRK1 complexes from Arabidopsis. Epitope-tagged ubiquitin ligase 
subunits (SKP, Cullin, F-box proteins), proteasomal substrates and SnRK1 kinase subunits were 
overexpressed in Arabidopsis, subjected to multistep purification by conventional chromatography and 
immuno-affinity pull-down techniques. The isolated complexes were analyzed by immunoblot 
analysis and mass spectrometry. However, due to intrinsic instability of most mentioned SnRK1 and 
SCF components, this approach remained largely unsuccessful, despite considerable time and 
resources invested.  
 The present work describes an improved biochemical approach for purification of SnRK1 
complexes. It was already tested that SKP1 and the proteasomal α7 subunit are not substrates for 
SnRK1 kinase in vitro. Therefore, we searched for candidate SnRK1 substrates, including known 
proteasomal substrates and F-box proteins (which are generally also substrates for proteasomal 
degradation). The number of F-box proteins and proteasome substrates is very high (in Arabidopsis 
there are 694 F-box proteins). Those proteins were selected as potential SnRK1 substrates, which are 
in connection with sugar signal transduction (i.e. their mutations confers sugar hypo- or 
hypersensitivity), and whose stability has been shown to be regulated by glucose. The candidates 
SnRK1 substrate proteins were overexpressed in and purified from bacteria, and subjected to in vitro 
kinase reactions using highly purified recombinant SnRK1 kinase AKIN10 and radioactive 32P-γATP. 
These assays were facilitated by the unique property of plant SnRK1 catalytic subunits that allows 
their autophosphorylation and auto-activation, which provides moderate kinase activity in vitro. 
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ABI5 is a basic leucine zipper transcription factor that plays a key role in sugar induced post-
germination developmental arrest. As mentioned above, few proteins from the bZIP family had been 
already suggested to function as possible SnRK substrates [159]. The cellular level and activity of 
ABI5 is regulated by phosphorylation and proteasome mediated degradation. Members of the ABI5 
family, such as AREB1, are phosphorylated by SnRK2 kinases, which contain very similar conserved 
kinase domain as SnRK1 kinases. Our results indicated that AKIN10 phosphorylates ABI5 whereas no 
activity could be detected with AKIN11 in vitro (neither substrate phosphorylation nor 
autophosphorylation), although its activity was reported formerly. 
The Arabidopsis ABI5 protein family contains 13 members, from which 9 show especially 
high homology and conservation of formerly identified AREB1 phosphorylation sites [231]. Such a 
closer relative is DPBF4/EEL1, which similarly to ABI5 is specifically expressed during embryo and 
seed development, and phosphorylated by members of the SnRK2 kinase family in vitro (unpublished 
data). We found that recombinant DPBF4 is also phosphorylated by AKIN10. In vitro phosphorylated 
ABI5 and DPBF4 proteins were analyzed by 2D-gel electrophoresis and mass spectrometry, which 
lead to the identification of 5 conserved SnRK1 phosphorylation sites in both proteins. In earlier 
studies [234], three phosphorylation sites were identified in immunoprecipitated ABI5 and additional 
sites were found in its somatically expressed relative, AREB1, by in vitro phosphorylation of its 
synthetic peptide fragments by SnRK2 kinases [231]. These formerly determined phosphorylation 
sites follow the general recognition motif of CDPK superfamily kinases (K/R-X-X-S/T), which 
include all SnRKs, whereas one of the newly identified site is atypical and contains a positively 
charged amino acid residue (K/R) in position -4 (i.e., relative to the phosphorylated S residue). This 
novel phosphorylation site is present in both ABI5 and DPBF4. By contrast, one less conserved site, 
which was reported earlier for AREB1 [231], could not be confirmed in our experiments. Site-directed 
mutagenesis of 5 phosphorylation sites of ABI5 to either alanine or aspartate residues is in progress in 
order to generate non-phosphorylable and dominantly active ABI5 versions, respectively. 
Based on these experiments, ABI5 and DPBF4 provide the first examples for that SnRK1 and 
SnRK2 kinases can have common substrates. Although these data derived from in vitro 
phosphorylation experiments, one may speculate that ABI5-mediated post-germination developmental 
arrest could be activated in response to different signals, which are transduced by different kinases 
through phosphorylation of ABI5 and other members of the ABI5 family. Five of the ten SnRK2 
kinases are activated in response to ABA and 9 in response to hyperosmotic stress. On the other hand, 
our data indicate that SnRK1 kinases probably act in regulation of sugar-dependent germination arrest. 
SnRK1-mediated phosphorylation of ABI5 suggests that, at least in germinating seedlings, SnRK1 
kinases may be activated by high sugar concentration, which is opposite to the result derived from a 
recent microarray experiment [159].  
The recognition motives and substrate sets of SnRK1 and SnRK2 kinases are probably not 
identical, although overlapping. Our collaborators from the group of Jeff Leung (CNRS, Gif sur 
Yvette, France) experimentally determined the sequence of an optimal peptide substrate motif for both 
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SnRK1 and SnRK2 kinases. Synthetic peptide substrates with combinatoric amino acid sequences 
were phosphorylated with the distinct SnRK kinases, including our purified AKIN10, in vitro using 
γ32P-ATP. The identified motives are substantially different, although a positively charged amino acid 
residue in position -3 relative to the phosphorylated serine enhances the phosphorylation most. 
However, in nitrate reductase, a known substrate of SnRK1 kinases, the amino acid sequence around 
phosphorylate Ser 521 residue, which is responsible for the activity of NR, does not contain positively 
charged residues at positions -3 or-4 indicating considerable plasticity of the kinase motif.  
ABI5 and DPBF4 also play a role in reserve accumulation phase during embryo development, 
when sugars are provided by the mother plant and absorbed by the embryo. In this process, the embryo 
develops high desiccation tolerance and its growth stops similarly to the post germination 
developmental arrest. Therefore, SnRK1 kinases are probably involved in the determination of source-
sink relations of different tissues that provides an explanation for the starch accumulation defect 
observed in seeds of SnRK1 kinase knock-down plants. AKIN12 is the third SnRK1α variant in 
Arabidopsis, which is expressed only in siliques (Genevestigator data and PhD thesis of Kenneth 
Berendzen). Therefore, it is possible that in vivo AKIN12 is responsible for ABI5 and DPBF4 
phosphorylation. 
Compared to ABI5 and DPBF4, many other candidate SnRK1 substrates showed weaker 
phosphate incorporation in the in vitro kinase assays. Interestingly, HY5, another bZIP transcription 
factor, a positive regulator of nitrate reductase whose stability is regulated by light and 
phosphorylation, was not phosphorylated by AKIN10 in vitro. A few interesting candidate substrates, 
such as EIN3 (whose degradation is enhanced by glucose and ABI4, a key transcriptional factor in 
sugar and ABA signaling) could not be purified unfortunately from bacteria. Nonetheless, we 
observed that several cyclins showed weak SnRK1-mediated phosphorylation, but their 
phosphorylation sites could not be determined by mass spectrometry. These included cyclinD3;1, 
which is also a proteasomal substrate, and involved in the regulation of G1/S transition of cell cycle. 
Abundance of cyclinD3;1 was reported to fall rapidly in response to sucrose starvation. Its degradation 
is probably promoted by phosphorylation similarly to CyclinD1. However, CyclinD2 seems to be a 
more stable protein. 
IAA7, transcriptional repressor in the auxin signaling pathway, represents a well-known 
proteasomal substrate. We have analysed potential SnRK1-mediated phosphorylation of IAA7, 
because its gain of function mutation (axr2) confers insensitivity for externally applied glucose. Other 
members of the Aux/IAA protein family were also tested because of their partial sequence 
conservation. Similarly to IAA7, IAA3 also shows constitutive photomorphogenesis phenotype, 
whereas IAA6 does not. In contrast to the anticipated results, significant phosphate incorporation 
could be detected using IAA6 as SnRK1 substrate, whereas SnRK1 did not show significant 
phosphorylation activity with IAA7 and IAA3. In IAA6, a single phosphorylation site (Ser39) was 
successfully identified by mass spectrometric analysis. Two-dimensional gel electrophoresis analysis 
of in vitro phosphorylated IAA6 also predicted no more than one potential phosphorylation site. 
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Moreover, the identified phosphorylation site contains the only serine residue in the IAA6 sequence, 
which is flanked by a positively charged residue at position -4. Phosphopeptide mapping of 
radioactively phosphorylated IAA6 also supported phosphorylation of the same position. Intriguingly, 
a serine residue with a positively charged amino acid at this position is found in several Aux/IAA 
proteins, including IAA7 and IAA3, although we failed to observe in vitro phosphorylation of these 
proteins. Overexpression of S39E mutant IAA6 in Arabidopsis plants caused severely stunted 
phenotype. In comparison, overexpression of wild type IAA6 showed only petal developmental defect. 
IAA6 is a proteasome substrate and its degradation requires a conserved degron (domain II), which is 
the binding site for members of the TIR1 F-box protein family. shy1 is a gain of function mutation in 
the conserved degron sequence (domain II) of IAA6. shy1 shows only minor phenotypic changes, such 
as slightly reduced hypocotyl length and upcurled leaves. Clearly, the phenotype of IAA6 S39E 
overexpressing plants differs from the shy1 mutant mutant phenotype and reflect more severe 
disturbance of proper auxin signaling leading to drastic reduction of elongation growth and fertility. 
Although our results do not probe that AKIN10 is implicated in phosphorylation of IAA6 also 
in vivo, the observed drastical developmental effect of IAA6 S39E overexpression suggests that the 
site is of functional importance in vivo. This result is in contrast to the prevailing view, which suggests 
that the IAA proteins are no phosphoproteins. In parallel to our data, oat PhyA was found to 
phosphorylate some IAA proteins in vitro (IAA1, IAA3, IAA9 and IAA17). The site was mapped to a 
fragment between domain I and domain II, which includes the position that was identified in the 
present work. However, these data are quite artificial, because PhyA itself does not contain a kinase 
domain, but only a kinase-related domain [235]. Potential regulatory role of S39 residue is indicated 
by the fact that at position -4 realtive to the phosphorylated serine there is an invariant lysine residue, 
which was identified as potential ubiquitylation site [236]. This lysine residue seems to be necessary 
for basal degradation rate of the short-lived AUX/IAA proteins, but is dispensable for their rapid 
auxin-mediated degradation. Nonetheless, our preliminary results using western blot analysis of wild 
type and S39E mutant IAA proteins show that the S39E mutation of IAA6 does not lead to extreme 
stabilization of the protein. As IAA6 levels are rather low in the absence of auxin induction, further 
experiments are needed to determine whether the S39E mutation affects the stability of IAA6 or 
enhanced its activity, potentially by promoting better binding to ARFs (auxin response factors). 
Stabilization of IAA7 in the axr2 gain of function mutant shows insensitivity to sugars that means 
under high sugar concentration the level of IAA7 should be lower. Therefore, in theory low sugar 
conditions should stabilize IAA7. Considering the structural similarity between yeast and plant 
AMPKs together with recent SnRK1 microarray data, SnRK1 should be generally activated by low 
sugar conditions. Therefore, in principle, phosphorylation is expected to stabilize IAA proteins, but 
this remains to be proven by further experiments.  
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4.4. AN ASSAY SYSTEM FOR ANALYSIS OF STABILITY OF CANDIDATE 
SNRK1 SUBSTRATES IN VIVO 
 
In order to study the effect of SnRK1 kinases on the stability of candidate substrates in vivo, a special 
stability testing vector system was developed based on previous work of Andreas Bachmair in our 
department. The system takes advantage of a reference protein, which is expressed in a translational 
fusion with the protein of interest. The two proteins expressed in a translational fusion are separated 
from each other in vivo by ubiquitin specific proteases. The reference protein DHFR-HA-UBI is 
stabilized by a mutation that prevents ubiquitin chain formation and its subsequent proteasomal 
degradation. In fact, degradation of the reference protein occurs but it still can serve as a gel loading 
control for the comparison of parallel samples. The comparison is carried out in the same immunoblot 
experiment, because both the DHFR-HA-UBI reference protein and the protein of interest carry C-
terminal HA epitope-tags for detection. cDNAs of selected test proteins (IAA6, IAA7, TIR1, EIN3, 
EBF1, EBF2 and ABI5) were cloned into this vector system and the stability of candidate SnRK1 
substrates was tested in response to estradiol-induced SnRK1 kinase AKIN10 expression in 
Arabidopsis cell suspension cultures. (Arabidopsis plants transformed with these constructs were not 
ready by the date of submission.) The SnRK1 kinase also contains a C-terminal HA epitope tag, 
therefore its expression level can be monitored simultaneously with the two other proteins. The 
experiments showed that in vivo separation of the fusion DHFR-HA and test proteins occurred, 
because the characteristic bands of DHFR-HA-UBI and DHFR-HA internal standards could be 
detected. However, none of the substrate proteins could not be detected under these conditions 
suggesting that they are extremely instable in the cell suspension system, which is maintained in the 
presence of 3% sucrose and auxin.  
Another possibility and a potential trivial reason is that the tested candidate proteins are not in 
vivo substrates for the SnRK1 kinases. However, it is more likely that degradation of the tested IAA 
proteins, as well as that of EIN3 and others, are extremely fast and can only be monitored using chase 
experiments in combination with proteasome inhibitor treatments. A possible improvement may be the 
application of multiple tandem epitope tags (for instance 16x HA was applied in Pascal Genschik’s 
laboratory in order to detect EBF1). However, in each case it is a question whether phosphorylation 
stabilizes or destabilizes the substrates and this should be experimentally answered. Another problem 
of the experimental set up is the very low level of SnRK1 kinase expression. To circumvent this 
problem, the samples were initially treated with proteasome inhibitor (MG132) to enhance SnRK1 
expression. Later, the MG132 was removed and samples were collected in short time intervals, and 
analyzed by immunoblotting. In this way, SnRK1 expression could be readily detected. However, the 
IAA substrate proteins still could not be visualized, not even in the MG132-treated samples. So, it 
remains to be seen whether in young seedlings, where auxin induction and subsequent degradation of 
IAA was successfully established, an effect of SnRK1 overexpression or S39E mutation can be 
observed at the levels of regulation of stability of IAA6. 
DISCUSSION  112 
Another question is whether the overexpression of single SnRK1 catalytic α-subunits can 
effectively increase the kinase activity in vivo. Specific physiological conditions may be required to 
activate the overexpressed α-subunit involving T-loop phosphorylation and γ-subunit related 
activation. The overexpressed kinase may only be partially assembled into trimeric complexes because 
the other subunits are not present in stoichiometric amounts (or not at all) in the transformed cells. In 
order to enhance the effectiveness of in vivo experiments, we tried to increase the activity of SnRK1 
catalytic subunits by mutations. The autophosphorylation site at the T-loop threonine was mutated to 
aspartate residue, which mimicks its phosphorylated state and prevents the inactivation of SnRK1 by 
specific protein phosphatases in vivo. The activating T-loop mutation increased the activity of SnRK1 
kinase AKIN10 about 3 times in vitro. Furthermore, we found that the UBA domain of AKIN10 is 
also necessary for the kinase activation. The fact that deletion of UBA domain did not result in 
elevated kinase activity indicated on the other hand that the UBA domain is not part of the 
autoinhibitory kinase domain. Deletion of the proposed C-terminal autoinhibitory domain from the 
SnRK1 catalytic subunit AKIN10 did not increase the SnRK1α activity either.  
 
4.5. IMPROVED TECHNOLOGY FOR AFFINITY PURIFICATION OF SNRK1 
KINASES 
We have attempted to isolate SnRK1 kinase complexes from various plant materials, but the SnRK1 
subunits proved to be very unstable proteins in vivo, and this caused a considerable obstacle. 
Immunoblot analysis could detect SnRK1 subunits in the chromatographic fractions but their quantity 
was not sufficient for mass spectrometric analysis of the complex components and their 
phosphorylation patterns. Therefore, we developed a novel tandem affinity chromatography method 
combining the application of His, Strep and HA affinity tags. In plant tissues, protein concentrations 
are generally lower than in animal cells, and after tissue homogenization the sample is exposed to a 
high proteolytic activity of the vacuolar contents, which in practice cannot be fully inhibited by the use 
of externally added protease inhibitors. Therefore, the most successfully applied protein extraction 
strategies from plant material involve immediate precipitation after sample homogenization and a 
short filtration. These approaches destroy complex protein structures, and therefore are not suitable for 
isolation of larger protein complexes without the application of chemical cross-linking. Conventional 
chromatographic approaches capture the protein of interest by ion-exchange chromatography, which 
does not provide high selectivity (i.e., max. purification rate is between 20 to 50-fold). Therefore, the 
ion-exchange chromatography fractions often are contaminated with considerably high protease 
activities and their subsequent processing e.g., through size fractionation by gel filtration may also 
result in a dilution of protein of interest below the detection treshold. Furthermore, in order to identify 
chromatographic fractions containing the protein of interest, immunoblot analysis has to be carried 
out, which takes many hours during which the proteolytic activity may destroy the samples. 
Alternatively, the sample can be frozen, but this is accompanied by protein precipitation, especially if 
more freeze-thaw cycles are needed because of multiple purification steps. Therefore, rapid and highly 
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selective purification is necessary to minimize protein degradation when purifying native proteins. To 
achieve these goals, we established tandem affinity purification using Ni-chromatography and 
subsequent strep-tactin chromatography. Both steps are highly selective and the elution happens in one 
step, and therefore immunoblot analysis between the steps is not necessary. We have demonstrated 
that this technology is applicable to purification of AKINβ2 subunit and showed that already the first 
step Ni-affinity chromatography yields about 10,000-fold enrichment. Thus, scaling up this approach 
with using effective means for stabilization of SnRK1 subunits (e.g., low sucrose, darkness, 
proteasome inhibitors etc.) is expected to improve the efficiency of subunit analysis of SnRK1-
proteasome complexes in the future. 
 
4.6. SNRK1-ACTIVATING KINASES 
 
To study the roles of putative SnRK1-activating kinases first genetically and later 
biochemically, we have identified two putative Arabidopsis SnRK1 activating kinases (SnAK1/TLK1 
and SnAK2/TLK2) based on sequence similarity to yeast Snf1 upstream activating kinases [38]. In 
order to gain information about the SnRK1-activating physiological conditions, homozygous T-DNA 
insertional mutations were identified in both SnAK genes. The individual snak mutants do not show 
any phenotypic alteration compared to wild type plants, neither when treated with sugars or ABA. 
Therefore, we initiated the construction of double snak mutant lines. In addition, we have 
demonstrated that recombinant SnAK1 is an active enzyme, which shows intensive 
autophosphorylation, but nevertheless only weakly phosphorylates AKIN10 in vitro. In our 
experiments, recombinant SnAK2 was not active suggesting that potentially other proteins (i.e., SnAK 
subunits) may be required for proper activity of these kinases. Intriguingly, SnAKs were found by 
others to be able to functionally replace their yeast orthologs, which implies a considerable 
conservation of SnAKs and their putative regulatory partners in yeast and plants.  
 
4.7. OUTLOOK 
After four years of efforts invested into the development of genetic and biochemical tools for 
functional analysis of plant SnRK1 kinases, the studies have now arrived to a stage when most genetic 
tools are available along with improved biochemical technologies. Several observations made in this 
work indicate that functional analysis of plant SnRK1 kinases can be expected to reveal surprising 
unique regulatory functions of AMP-actvated kinases in plants. Our data showing that the akinβ1akin 
β2 double knockout lines display no stress, sugar, hormone and developmental alterations contradict a 
recently published highlight suggesting that N-terminal myristoylation of these subunits would be 
required for meristem differentiation and leaf development [104]. Rather these data strengthen our 
observations that the catalytic subunits of plant SnRK1 enzymes can act as active kinases in the 
absence of other regulatory subunits, in analogy e.g., to several animal AMPK-like kinases. 
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Furthermore, it is still a question whether AKINβ3 is a genuine subunit of trimeric SnRK1 enzymes as 
interaction of AKINβ3 with other SnRK1 subunits awaits confirmation in vivo.  
From the data described in this thesis it is apparent that there is a great need for additional 
studies for precise definition of temporal and spatial cellular localization, traffic and expression level 
of different SnRK1 subunits proteins during plant development and in response to sugar and stress 
stimuli. These studies can only be performed with native gene constructs in combination with the 
available knockout mutations. Our data clearly illustrate that artificial overexpression of various 
SnRK1 subunits is not suitable to address specific questions concerning the activation of SnRK1 
kinases and mechanisms controlling their in vivo stability. Nonetheless, these previous studies using 
artificial overexpression of kinases subunits shed light onto one important regulatory aspect of SnRK1 
functions by identifying important light and sugar-dependent post-translational control mechanisms. 
Along with other emerging data, these observations support the model that SnRK1 kinases play central 
regulatory roles in the coordination of light, sugar and stress signaling pathways in plants. At the same 
time, destabilization of SnRK1 subunits by sucrose and light treatments question some recently 
published data, which have derived from the analysis of transcriptional regulatory effects of SnRK1 
catalytic α-subunits in an artificial protoplast system (i.e., maintained in the presence of 3% sucrose 
and 3% sorbitol, [159]). Furthermore, data derived from RNAi inhibition of AKIN kinases also remain 
to be confirmed by application of inducible, gene specific artificial microRNAs instead of using 
silencing constructs for targeting the conserved catalytic α-subunits of SnRK1 kinases. Finally, precise 
functional dissection of SnRK1 kinases, especially their roles in the regulation of transcription and 
proteolysis of transcription factors, requires precise resolution of subunits of various nuclear SnRK1 
complexes, which will be impossible without a breakthrough in their purification and subsequent 
analysis using mass spectrometry. 
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5. APPENDIX 
5.1. GERMINATION DATA OF T-DNA INSERTION MUTANTS IN SNRK1 
SUBUNIT AND SNAK KINASE GENES 
Supplementary data to the chapter 3.1.7. 
 
1. TLK1 Salk 000044 T2/1 
2. TLK1 Salk 000044 T2/3 
3. TLK1 Salk 015230 T2/1 
4. TLK1 Salk 015230 T2/2 
5. TLK2 Salk 142938 T2/1 
6. TLK2 Salk 142938 T2/3 
7. AKIN10 GABI 579E09 T2/3 
8. AKIN10 GABI 579E09 T2/6 
9. AKINβ1 Koncz 14344 T3 from T2/13 
10. AKINβ1 GABI T3 from T2/2 
11. AKINβ1 Salk 008325 T3 from T2/2 
12. AKINβ2 Salk 037416 T3 from T2/10 
13. AKINβ2 Koncz 87453 T3 from T2/2 
14. AKINβ1 Salk x AKINβ2 Koncz T2/9 
15. AKINβ1 Salk x AKINβ2 Salk T2/11 
16. AKINβ1 Salk x AKINβ2 Salk T2/15 
17. Col-0 wt 
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  3% glucose in MSAR 
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  5% sucrose in MSAR 
 
 
 
APPENDIX   117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  1μM ABA in MSAR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  2μM ABA in MSAR 
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5.2. MAP OF pPILY VECTOR 
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5.3. MASS SPECTROMETRIC IDENTIFICATION OF PHOSPHORYLATION 
SITES IN ABI5, DPBF4 AND IAA6 PROTEINS 
 
Phosphorylated proteins were digested with trypsin or gultamyl endopeptidase. Isolated 
phosphopeptides were fragmented by electrotransfer decay (ETD) or collision induced decay (CID) 
before the second mass spectrometer unit. Mass of the expected fragment ions are listed below. In red 
bold the actually detected fragment ions are highlighted. Amino acid residues marked with asterisk are 
phosphorylated based on the molecular mass difference of neighboring peptides. 
 
ABI5 V8 (Glu-C) ETD 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 132.0768 66.5420 N       12 
2 189.0982 95.0527 G 1309.4589 655.2331 1293.4401 647.2237 1294.4480 647.7276 11 
3 317.1932 159.1002 K 1252.4374 626.7223 1236.4187 618.7130 1237.4265 619.2169 10 
4 431.2361 216.1217 N 1124.3424 562.6749 1108.3237 554.6655 1109.3315 555.1694 9 
5 578.3045 289.6559 F 1010.2995 505.6534 994.2808 497.6440 995.2886 498.1479 8 
6 635.3260 318.1666 G 863.2311 432.1192 847.2124 424.1098 848.2202 424.6137 7 
7 802.3243 401.6658 S* 806.2096 403.6085 790.1909 395.5991 791.1987 396.1030 6 
8 933.3648 467.1860 M 639.2113 320.1093 623.1926 312.0999 624.2004 312.6038 5 
9 1047.4077 524.2075 N 508.1708 254.5890 492.1521 246.5797 493.1599 247.0836 4 
10 1178.4482 589.7278 M 394.1279 197.5676 378.1091 189.5582 379.1170 190.0621 3 
11 1293.4752 647.2412 D 263.0874 132.0473 247.0687 124.0380 248.0765 124.5419 2 
12   E 148.0604 74.5339 132.0417 66.5245 133.0495 67.0284 1 
MS/MS Fragmentation of NGKNFGSMNMDE 
Monoisotopic mass of neutral peptide Mr (calc): 1422.4945 
S7: Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 132.0768 66.5420 N       12 
2 189.0982 95.0527 G 1325.4538 663.2305 1309.4351 655.2212 1310.4429 655.7251 11 
3 317.1932 159.1002 K 1268.4323 634.7198 1252.4136 626.7104 1253.4214 627.2143 10 
4 431.2361 216.1217 N 1140.3374 570.6723 1124.3186 562.6630 1125.3265 563.1669 9 
5 578.3045 289.6559 F 1026.2944 513.6508 1010.2757 505.6415 1011.2835 506.1454 8 
6 635.3260 318.1666 G 879.2260 440.1166 863.2073 432.1073 864.2151 432.6112 7 
7 802.3243 401.6658 S* 822.2045 411.6059 806.1858 403.5965 807.1936 404.1005 6 
8 933.3648 467.1860 M 655.2062 328.1067 639.1875 320.0974 640.1953 320.6013 5 
9 1047.4077 524.2075 N 524.1657 262.5865 508.1470 254.5771 509.1548 255.0810 4 
10 1194.4432 597.7252 M 410.1228 205.5650 394.1041 197.5557 395.1119 198.0596 3 
11 1309.4701 655.2387 D 263.0874 132.0473 247.0687 124.0380 248.0765 124.5419 2 
12   E 148.0604 74.5339 132.0417 66.5245 133.0495 67.0284 1 
MS/MS Fragmentation of NGKNFGSMNMDE 
Monoisotopic mass of neutral peptide Mr (calc): 1438.4894 
S7     : Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
M10: Oxidation (M), with neutral losses 0.0000 (shown in table), 63.9983 
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# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 132.0768 66.5420 N       20 
2 269.1357 135.0715 H 2231.0380 1116.0226 2215.0193 1108.0133 2216.0271 1108.5172 19 
3 366.1884 183.5979 P 2093.9791 1047.4932 2077.9604 1039.4838 2078.9682 1039.9877 18 
4 513.2568 257.1321 F 1996.9263 998.9668 1980.9076 990.9574 1981.9154 991.4613 17 
5 614.3045 307.6559 T 1849.8579 925.4326 1833.8392 917.4232 1834.8470 917.9271 16 
6 701.3365 351.1719 S 1748.8102 874.9088 1732.7915 866.8994 1733.7993 867.4033 15 
7 814.4206 407.7139 L 1661.7782 831.3927 1645.7595 823.3834 1646.7673 823.8873 14 
8 871.4421 436.2247 G 1548.6941 774.8507 1532.6754 766.8413 1533.6832 767.3453 13 
9 1027.5432 514.2752 R 1491.6727 746.3400 1475.6539 738.3306 1476.6618 738.8345 12 
10 1155.6018 578.3045 Q 1335.5716 668.2894 1319.5528 660.2801 1320.5607 660.7840 11 
11 1242.6338 621.8205 S 1207.5130 604.2601 1191.4943 596.2508 1192.5021 596.7547 10 
12 1409.6321 705.3197 S* 1120.4810 560.7441 1104.4622 552.7348 1105.4701 553.2387 9 
13 1522.7162 761.8617 I 953.4826 477.2449 937.4639 469.2356 938.4717 469.7395 8 
14 1685.7795 843.3934 Y 840.3985 420.7029 824.3798 412.6935 825.3876 413.1975 7 
15 1772.8116 886.9094 S 677.3352 339.1712 661.3165 331.1619 662.3243 331.6658 6 
16 1885.8956 943.4515 L 590.3032 295.6552 574.2845 287.6459 575.2923 288.1498 5 
17 1986.9433 993.9753 T 477.2191 239.1132 461.2004 231.1038 462.2082 231.6077 4 
18 2100.0274 1050.5173 L 376.1714 188.5894 360.1527 180.5800 361.1605 181.0839 3 
19 2215.0543 1108.0308 D 263.0874 132.0473 247.0687 124.0380 248.0765 124.5419 2 
20   E 148.0604 74.5339 132.0417 66.5245 133.0495 67.0284 1 
MS/MS Fragmentation of NHPFTSLGRQSSIYSLTLDE 
Monoisotopic mass of neutral peptide Mr (calc): 2344.0736 
S12: Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
 
ABI5 trypsin ETD 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 146.0924 73.5498 Q       15 
2 243.1452 122.0762 P 1706.7747 853.8910 1690.7560 845.8816 1691.7638 846.3855 14 
3 424.1592 212.5832 T* 1609.7219 805.3646 1593.7032 797.3552 1594.7110 797.8592 13 
4 571.2276 286.1174 F 1428.7079 714.8576 1412.6892 706.8482 1413.6970 707.3522 12 
5 628.2490 314.6282 G 1281.6395 641.3234 1265.6208 633.3140 1266.6286 633.8179 11 
6 757.2916 379.1495 E 1224.6181 612.8127 1208.5993 604.8033 1209.6072 605.3072 10 
7 888.3321 444.6697 M 1095.5755 548.2914 1079.5567 540.2820 1080.5646 540.7859 9 
8 989.3798 495.1935 T 964.5350 482.7711 948.5163 474.7618 949.5241 475.2657 8 
9 1102.4639 551.7356 L 863.4873 432.2473 847.4686 424.2379 848.4764 424.7418 7 
10 1231.5065 616.2569 E 750.4032 375.7053 734.3845 367.6959 735.3923 368.1998 6 
11 1346.5334 673.7703 D 621.3606 311.1840 605.3419 303.1746 606.3497 303.6785 5 
12 1493.6018 747.3045 F 506.3337 253.6705 490.3150 245.6611 491.3228 246.1650 4 
13 1606.6859 803.8466 L 359.2653 180.1363 343.2466 172.1269 344.2544 172.6308 3 
14 1705.7543 853.3808 V 246.1812 123.5942 230.1625 115.5849 231.1703 116.0888 2 
15   K 147.1128 74.0600 131.0941 66.0507 132.1019 66.5546 1 
MS/MS Fragmentation of QPTFGEMTLEDFLVK 
Monoisotopic mass of neutral peptide Mr (calc): 1833.8260 
T3: Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
 
 
 
 
 
APPENDIX   121 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 146.0924 73.5498 Q       21 
2 233.1244 117.0659 S 2392.0527 1196.5300 2376.0339 1188.5206 2377.0418 1189.0245 20 
3 400.1228 200.5650 S* 2305.0206 1153.0140 2289.0019 1145.0046 2290.0097 1145.5085 19 
4 513.2068 257.1071 I 2138.0223 1069.5148 2122.0036 1061.5054 2123.0114 1062.0093 18 
5 676.2702 338.6387 Y 2024.9382 1012.9727 2008.9195 1004.9634 2009.9273 1005.4673 17 
6 763.3022 382.1547 S 1861.8749 931.4411 1845.8562 923.4317 1846.8640 923.9356 16 
7 876.3863 438.6968 L 1774.8429 887.9251 1758.8241 879.9157 1759.8320 880.4196 15 
8 977.4339 489.2206 T 1661.7588 831.3830 1645.7401 823.3737 1646.7479 823.8776 14 
9 1090.5180 545.7626 L 1560.7111 780.8592 1544.6924 772.8498 1545.7002 773.3537 13 
10 1205.5450 603.2761 D 1447.6271 724.3172 1431.6083 716.3078 1432.6162 716.8117 12 
11 1334.5875 667.7974 E 1332.6001 666.8037 1316.5814 658.7943 1317.5892 659.2982 11 
12 1481.6560 741.3316 F 1203.5575 602.2824 1187.5388 594.2730 1188.5466 594.7769 10 
13 1609.7145 805.3609 Q 1056.4891 528.7482 1040.4704 520.7388 1041.4782 521.2427 9 
14 1746.7735 873.8904 H 928.4305 464.7189 912.4118 456.7095 913.4196 457.2135 8 
15 1817.8106 909.4089 A 791.3716 396.1894 775.3529 388.1801 776.3607 388.6840 7 
16 1930.8946 965.9510 L 720.3345 360.6709 704.3158 352.6615 705.3236 353.1654 6 
17 2090.9253 1045.9663 C 607.2504 304.1289 591.2317 296.1195 592.2395 296.6234 5 
18 2219.9679 1110.4876 E 447.2198 224.1135 431.2011 216.1042 432.2089 216.6081 4 
19 2334.0108 1167.5090 N 318.1772 159.5922 302.1585 151.5829 303.1663 152.0868 3 
20 2391.0323 1196.0198 G 204.1343 102.5708 188.1155 94.5614 189.1234 95.0653 2 
21   K 147.1128 74.0600 131.0941 66.0507 132.1019 66.5546 1 
MS/MS Fragmentation of QSSIYSLTLDEFQHALCENGK 
Monoisotopic mass of neutral peptide Mr (calc): 2519.1039 
S3: Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 146.0924 73.5498 Q       21 
2 233.1244 117.0659 S 2392.0527 1196.5300 2376.0339 1188.5206 2377.0418 1189.0245 20 
3 400.1228 200.5650 S* 2305.0206 1153.0140 2289.0019 1145.0046 2290.0097 1145.5085 19 
4 513.2068 257.1071 I 2138.0223 1069.5148 2122.0036 1061.5054 2123.0114 1062.0093 18 
5 676.2702 338.6387 Y 2024.9382 1012.9727 2008.9195 1004.9634 2009.9273 1005.4673 17 
6 763.3022 382.1547 S 1861.8749 931.4411 1845.8562 923.4317 1846.8640 923.9356 16 
7 876.3863 438.6968 L 1774.8429 887.9251 1758.8241 879.9157 1759.8320 880.4196 15 
8 977.4339 489.2206 T 1661.7588 831.3830 1645.7401 823.3737 1646.7479 823.8776 14 
9 1090.5180 545.7626 L 1560.7111 780.8592 1544.6924 772.8498 1545.7002 773.3537 13 
10 1205.5450 603.2761 D 1447.6271 724.3172 1431.6083 716.3078 1432.6162 716.8117 12 
11 1334.5875 667.7974 E 1332.6001 666.8037 1316.5814 658.7943 1317.5892 659.2982 11 
12 1481.6560 741.3316 F 1203.5575 602.2824 1187.5388 594.2730 1188.5466 594.7769 10 
13 1609.7145 805.3609 Q 1056.4891 528.7482 1040.4704 520.7388 1041.4782 521.2427 9 
14 1746.7735 873.8904 H 928.4305 464.7189 912.4118 456.7095 913.4196 457.2135 8 
15 1817.8106 909.4089 A 791.3716 396.1894 775.3529 388.1801 776.3607 388.6840 7 
16 1930.8946 965.9510 L 720.3345 360.6709 704.3158 352.6615 705.3236 353.1654 6 
17 2090.9253 1045.9663 C 607.2504 304.1289 591.2317 296.1195 592.2395 296.6234 5 
18 2219.9679 1110.4876 E 447.2198 224.1135 431.2011 216.1042 432.2089 216.6081 4 
19 2334.0108 1167.5090 N 318.1772 159.5922 302.1585 151.5829 303.1663 152.0868 3 
20 2391.0323 1196.0198 G 204.1343 102.5708 188.1155 94.5614 189.1234 95.0653 2 
21   K 147.1128 74.0600 131.0941 66.0507 132.1019 66.5546 1 
MS/MS Fragmentation of QSSIYSLTLDEFQHALCENGK 
Monoisotopic mass of neutral peptide Mr (calc): 2519.1039 
S3     : Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
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N-term. ion b b-17 b-18 b-Pi y y-17 y-18 y-Pi C-term. ion 
1 N 115.050 98.024 0.000 0.000 147.113 130.086 0.000 0.000 9 K 
2 P 212.103 195.076 0.000 0.000 262.140 245.113 244.129 0.000 8 D 
3 S* 379.101 362.075 361.091 281.124 375.224 358.197 357.213 0.000 7 L 
4 C 539.132 522.105 521.121 441.155 488.308 471.281 470.297 0.000 6 L 
5 P 636.185 619.158 618.174 538.208 585.361 568.334 567.350 0.000 5 P 
6 L 749.269 732.242 731.258 651.292 745.391 728.365 727.381 0.000 4 C 
7 L 862.353 845.326 844.342 764.376 912.390 895.379 894.379 814.413 3 S* 
8 D 977.380 960.353 959.369 879.403 1009.442 992.416 991.432 911.466 2 P 
9 K 1105.475 1088.448 1087.464 1007.498 1123.485 1106.459 1105.475 1025.508 1 N 
MS/MS fragmentation of NPSCPLLDK 
S3: Phospho (ST) 
 
 
 
DPBF4 trypsin ETD 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 146.0924 73.5498 Q       8 
2 203.1139 102.0606 G 823.4073 412.2073 807.3886 404.1979 808.3964 404.7019 7 
3 370.1122 185.5597 S* 766.3859 383.6966 750.3672 375.6872 751.3750 376.1911 6 
4 483.1963 242.1018 L 599.3875 300.1974 583.3688 292.1880 584.3766 292.6920 5 
5 584.2440 292.6256 T 486.3035 243.6554 470.2847 235.6460 471.2926 236.1499 4 
6 697.3280 349.1677 L 385.2558 193.1315 369.2371 185.1222 370.2449 185.6261 3 
7 794.3808 397.6940 P 272.1717 136.5895 256.1530 128.5801 257.1608 129.0840 2 
8   R 175.1190 88.0631 159.1002 80.0538 160.1081 80.5577 1 
MS/MS Fragmentation of QGSLTLPR 
Monoisotopic mass of neutral peptide Mr (calc): 950.4586 
S3     : Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 146.0924 73.5498 Q       8 
2 260.1353 130.5713 N 904.4176 452.7124 888.3988 444.7031 889.4067 445.2070 7 
3 427.1337 214.0705 S* 790.3746 395.6910 774.3559 387.6816 775.3637 388.1855 6 
4 540.2177 270.6125 L 623.3763 312.1918 607.3576 304.1824 608.3654 304.6863 5 
5 703.2811 352.1442 Y 510.2922 255.6498 494.2735 247.6404 495.2813 248.1443 4 
6 790.3131 395.6602 S 347.2289 174.1181 331.2102 166.1087 332.2180 166.6126 3 
7 903.3972 452.2022 L 260.1969 130.6021 244.1781 122.5927 245.1860 123.0966 2 
8   K 147.1128 74.0600 131.0941 66.0507 132.1019 66.5546 1 
MS/MS Fragmentation of QNSLYSLK 
Monoisotopic mass of neutral peptide Mr (calc): 1031.4688 
S3     : Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 131.1179 66.0626 L       25 
2 268.1768 134.5920 H 2670.2957 1335.6515 2654.2770 1327.6421 2655.2848 1328.1460 24 
3 397.2194 199.1133 E 2533.2368 1267.1220 2517.2181 1259.1127 2518.2259 1259.6166 23 
4 496.2878 248.6475 V 2404.1942 1202.6007 2388.1755 1194.5914 2389.1833 1195.0953 22 
5 624.3464 312.6768 Q 2305.1258 1153.0665 2289.1070 1145.0572 2290.1149 1145.5611 21 
6 725.3941 363.2007 T 2177.0672 1089.0372 2161.0485 1081.0279 2162.0563 1081.5318 20 
7 862.4530 431.7301 H 2076.0195 1038.5134 2060.0008 1030.5040 2061.0086 1031.0079 19 
8 975.5370 488.2722 L 1938.9606 969.9839 1922.9419 961.9746 1923.9497 962.4785 18 
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9 1032.5585 516.7829 G 1825.8765 913.4419 1809.8578 905.4325 1810.8656 905.9365 17 
10 1119.5905 560.2989 S 1768.8551 884.9312 1752.8363 876.9218 1753.8442 877.4257 16 
11 1206.6226 603.8149 S 1681.8230 841.4152 1665.8043 833.4058 1666.8121 833.9097 15 
12 1263.6440 632.3257 G 1594.7910 797.8991 1578.7723 789.8898 1579.7801 790.3937 14 
13 1391.7390 696.3731 K 1537.7696 769.3884 1521.7508 761.3791 1522.7587 761.8830 13 
14 1488.7918 744.8995 P 1409.6746 705.3409 1393.6559 697.3316 1394.6637 697.8355 12 
15 1601.8758 801.4415 L 1312.6218 656.8146 1296.6031 648.8052 1297.6109 649.3091 11 
16 1658.8973 829.9523 G 1199.5378 600.2725 1183.5190 592.2632 1184.5269 592.7671 10 
17 1825.8956 913.4515 S* 1142.5163 571.7618 1126.4976 563.7524 1127.5054 564.2563 9 
18 1956.9361 978.9717 M 975.5179 488.2626 959.4992 480.2532 960.5070 480.7572 8 
19 2070.9790 1035.9932 N 844.4775 422.7424 828.4587 414.7330 829.4666 415.2369 7 
20 2184.0631 1092.5352 L 730.4345 365.7209 714.4158 357.7115 715.4236 358.2155 6 
21 2299.0901 1150.0487 D 617.3505 309.1789 601.3317 301.1695 602.3396 301.6734 5 
22 2428.1326 1214.5700 E 502.3235 251.6654 486.3048 243.6560 487.3126 244.1600 4 
23 2541.2167 1271.1120 L 373.2809 187.1441 357.2622 179.1347 358.2700 179.6387 3 
24 2654.3008 1327.6540 L 260.1969 130.6021 244.1781 122.5927 245.1860 123.0966 2 
25   K 147.1128 74.0600 131.0941 66.0507 132.1019 66.5546 1 
MS/MS Fragmentation of LHEVQTHLGSSGKPLGSMNLDELLK 
Monoisotopic mass of neutral peptide Mr (calc): 2782.3725 
S17    : Phospho (ST), with neutral losses 0.0000(shown in table), 97.976 
 
 
 
N-term. ion c c-1 z z+1 z+2 C-term. ion
1 T 119.082 118.074 130.086 131.094 132.102 9 K 
2 N 233.124 232.117 245.113 246.121 247.129 8 D 
3 S* 400.123 399.115 344.182 345.159 346.197 7 V 
4 A 471.160 470.152 457.266 458.273 459.281 6 L 
5 S 558.192 557.184 544.298 545.306 546.313 5 S 
6 L 671.276 670.268 615.335 616.343 617.350 4 A 
7 V 770.344 769.337 782.333 783.341 784.349 3 S* 
8 D 885.371 884.364 896.384 897.384 898.392 2 N 
9 K 1013.466 1012.458 998.432 998.432 999.439 1 T 
MS/MS fragmentation of TNSASLVDK 
S3: Phospho (ST) 
 
 
 
DPBF4 V8 (Glu-C) ETD 
 
 
# c c++ Seq. y y++ z+1 z+1++ z+2 z+2++ # 
1 117.1022 59.0548 V       19 
2 245.1608 123.0840 Q 1966.8576 983.9324 1950.8389 975.9231 1951.8467 976.4270 18 
3 346.2085 173.6079 T 1838.7990 919.9031 1822.7803 911.8938 1823.7881 912.3977 17 
4 483.2674 242.1373 H 1737.7513 869.3793 1721.7326 861.3699 1722.7404 861.8739 16 
5 596.3515 298.6794 L 1600.6924 800.8499 1584.6737 792.8405 1585.6815 793.3444 15 
6 653.3729 327.1901 G 1487.6084 744.3078 1471.5896 736.2985 1472.5975 736.8024 14 
7 740.4050 370.7061 S 1430.5869 715.7971 1414.5682 707.7877 1415.5760 708.2916 13 
8 827.4370 414.2221 S 1343.5549 672.2811 1327.5361 664.2717 1328.5440 664.7756 12 
9 884.4585 442.7329 G 1256.5228 628.7651 1240.5041 620.7557 1241.5119 621.2596 11 
10 1012.5534 506.7803 K 1199.5014 600.2543 1183.4827 592.2450 1184.4905 592.7489 10 
11 1109.6062 555.3067 P 1071.4064 536.2068 1055.3877 528.1975 1056.3955 528.7014 9 
12 1222.6902 611.8488 L 974.3537 487.6805 958.3349 479.6711 959.3428 480.1750 8 
13 1279.7117 640.3595 G 861.2696 431.1384 845.2509 423.1291 846.2587 423.6330 7 
14 1446.7101 723.8587 S* 804.2481 402.6277 788.2294 394.6183 789.2372 395.1223 6 
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15 1593.7455 797.3764 M 637.2498 319.1285 621.2310 311.1192 622.2389 311.6231 5 
16 1707.7884 854.3978 N 490.2144 245.6108 474.1956 237.6015 475.2035 238.1054 4 
17 1820.8725 910.9399 L 376.1714 188.5894 360.1527 180.5800 361.1605 181.0839 3 
18 1935.8994 968.4533 D 263.0874 132.0473 247.0687 124.0380 248.0765 124.5419 2 
19   E 148.0604 74.5339 132.0417 66.5245 133.0495 67.0284 1 
MS/MS Fragmentation of VQTHLGSSGKPLGSMNLDE 
Monoisotopic mass of neutral peptide Mr (calc): 2064.9187 
S14    : Phospho (ST), with neutral losses 0.0000 (shown in table), 97.9769 
M15    : Oxidation (M), with neutral losses 0.0000 (shown in table), 63.9983 
 
 
IAA6 Trypsin CID 
 
# b b++ b* b*++ b0 b0++ Seq. y y++ y* y*++ y0 y0++ # 
1 100.08 50.54     V       32 
2 213.16 107.08     L 3294.52 1647.77 3277.50 1639.25 3276.51 1638.76 31 
3 282.18 141.59   264.17 132.59 S* 3181.44 1591.22 3164.41 1582.71 3163.43 1582.22 30 
4 397.21 199.11   379.20 190.10 D 3112.42 1556.71 3095.39 1548.20 3094.41 1547.71 29 
5 528.25 264.63   510.24 255.62 M 2997.39 1499.20 2980.36 1490.69 2979.38 1490.19 28 
6 659.29 330.15   641.28 321.14 M 2866.35 1433.68 2849.32 1425.17 2848.34 1424.67 27 
7 760.34 380.67   742.33 371.67 T 2735.31 1368.16 2718.28 1359.65 2717.30 1359.15 26 
8 847.37 424.19   829.36 415.18 S 2634.26 1317.64 2617.24 1309.12 2616.25 1308.63 25 
9 934.40 467.70   916.39 458.70 S 2547.23 1274.12 2530.20 1265.61 2529.22 1265.11 24 
10 1005.44 503.22   987.43 494.22 A 2460.20 1230.60 2443.17 1222.09 2442.19 1221.60 23 
11 1118.52 559.76   1100.51 550.76 L 2389.16 1195.08 2372.14 1186.57 2371.15 1186.08 22 
12 1233.55 617.28   1215.54 608.27 D 2276.08 1138.54 2259.05 1130.03 2258.07 1129.54 21 
13 1334.60 667.80   1316.59 658.80 T 2161.05 1081.03 2144.02 1072.52 2143.04 1072.02 20 
14 1463.64 732.32   1445.63 723.32 E 2060.00 1030.51 2042.98 1021.99 2041.99 1021.50 19 
15 1577.68 789.34 1560.66 780.83 1559.67 780.34 N 1930.96 965.98 1913.93 957.47 1912.95 956.98 18 
16 1706.72 853.87 1689.70 845.35 1688.71 844.86 E 1816.92 908.96 1799.89 900.45 1798.91 899.96 17 
17 1820.77 910.89 1803.74 902.37 1802.76 901.88 N 1687.87 844.44 1670.85 835.93 1669.86 835.44 16 
18 1907.80 954.40 1890.77 945.89 1889.79 945.40 S 1573.83 787.42 1556.81 778.91 1555.82 778.41 15 
19 2006.87 1003.94 1989.84 995.42 1988.86 994.93 V 1486.80 743.90 1469.77 735.39 1468.79 734.90 14 
20 2105.94 1053.47 2088.91 1044.96 2087.93 1044.47 V 1387.73 694.37 1370.70 685.86 1369.72 685.36 13 
21 2192.97 1096.99 2175.94 1088.47 2174.96 1087.98 S 1288.66 644.84 1271.64 636.32 1270.65 635.83 12 
22 2280.00 1140.50 2262.97 1131.99 2261.99 1131.50 S 1201.63 601.32 1184.60 592.81 1183.62 592.31 11 
23 2379.07 1190.04 2362.04 1181.52 2361.06 1181.03 V 1114.60 557.80 1097.57 549.29 1096.59 548.80 10 
24 2508.11 1254.56 2491.09 1246.05 2490.10 1245.55 E 1015.53 508.27 998.50 499.76 997.52 499.26 9 
25 2623.14 1312.07 2606.11 1303.56 2605.13 1303.07 D 886.49 443.75 869.46 435.23 868.48 434.74 8 
26 2752.18 1376.59 2735.15 1368.08 2734.17 1367.59 E 771.46 386.23 754.43 377.72 753.45 377.23 7 
27 2839.21 1420.11 2822.19 1411.60 2821.20 1411.10 S 642.42 321.71 625.39 313.20 624.41 312.71 6 
28 2952.30 1476.65 2935.27 1468.14 2934.29 1467.65 L 555.39 278.20 538.36 269.68   5 
29 3049.35 1525.18 3032.32 1516.67 3031.34 1516.17 P 442.30 221.65 425.28 213.14   4 
30 3148.42 1574.71 3131.39 1566.20 3130.41 1565.71 V 345.25 173.13 328.22 164.62   3 
31 3247.49 1624.25 3230.46 1615.73 3229.48 1615.24 V 246.18 123.59 229.15 115.08   2 
32       K 147.11 74.06 130.09 65.55   1 
MS/MS Fragmentation of VLSDMMTSSALDTENENSVVSSVEDESLPVVK 
Monoisotopic mass of neutral peptide Mr (calc): 3490.56 
S3     : Phospho (STY), with neutral losses 97.98 (shown in table), 0.00 
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